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Abstract
The aggregation and deposition o f  |3-amyloid (Ap) in the brain has long been 
im plicated in the neurotoxic pathways causing A lzheim er’s disease (AD). Recent data 
suggests that early, soluble oligomers o f  A p are the toxic species. Oxidative stress 
may be partly responsible for the toxicity o f  the peptide as hydrogen peroxide (H 2 O 2 ) 
has been found to be produced during the early stages o f  aggregation. This study 
investigates the generation o f  H 2 O 2 by Ap during the process o f  aggregation and 
presents evidence supporting the hypothesis that some form o f  Ap oligom er has the 
capacity for H 2 O 2 generation. A  technique developed to immobilise Ap during its 
aggregation suggested H 2 O 2 generation to be an event associated with early Ap-A p 
interactions, whereas fibrillar Ap degraded H 2 O 2 . The developm ent o f  cross-linking 
techniques to generate stable oligomeric Ap found Ap42 to be the m ost susceptible to 
these reactions, correlating with its increased tendency for aggregation. TyrlO was 
found to be critical for these reactions, but not for the formation o f  Ap fibrils, nor the 
generation o f  H 2 O 2 by Ap, indicating that dityrosine dim ers are not the sole source o f 
H2 O 2 generation from Ap. The binding o f  copper to Ap, but not iron, was found to be 
central to the redox reactions enabling generation o f  H 2 O2 , in addition to having 
com plex effects on the aggregation o f  Ap. Zinc m ay also play a regulatory role in 
m ediating Ap aggregation state and redox potential.
Research o f  potentially toxic Ap oligom ers is problem atic due to the heterogeneous 
and dynamic nature o f  AP solutions. Developm ent o f  techniques to cross-link and 
im mobilise Ap may be useful for studying early oligom eric Ap, not only in respect o f  
H2 O 2 generation but also in identification o f  Ap oligom ers responsible for 
neurotoxicity in AD. This may enable identification o f  a potential diagnostic m arker 
and also a potential therapeutic target.
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A lzheim er’s disease (AD) is one o f  a large group o f  diseases called am yloidoses. 
These diseases are characterised by the accum ulation o f  a fibrillar proteinaceous 
deposit in the affected organ(s). A lzheim er’s is am ong several am yloidoses that target 
the brain, such as Parkinson’s disease (PD), prion disease and m otor neuron disease 
(M ND). In each o f  these diseases, the progressive death o f  neurons is observed in a 
d ifferent neuronal population, with consequent presentation o f  neurological 
sym ptoms. W ith AD, neuronal loss causes dem entia. In fact, A lzheim er’s is the m ost 
com m on form o f  senile dem entia accounting for -6 2 %  o f  cases (Knapp, 2007).
Although the first described case o f  “presenile dem entia” , reported by Alois 
A lzheim er in 1906, referred to a subject with an early-onset form  o f  the disease, over 
97%  o f  cases present after the age o f  65 years (Knapp, 2007). It is progressive in 
nature, showing gradual but irreversible cognitive decline. The earliest m anifestation 
is im pairm ent o f  memory. However, tow ards the later stages m otor and sensory 
functions may also be disrupted. The m ajor risk factor for the disease is aging yet it 
also exhibits great genetic complexity. The m ajority o f  cases are sporadic in onset 
(sporadic AD, sAD). However, 5-10%  o f  cases show autosom al dom inant inheritance 
(fam ilial AD, fAD). By and large fAD corresponds to early-onset AD (under 60 




1.1.1. E pidem iology
Dem entia is a global health problem . W ith an aging population, due to increasing life 
expectancy, in both developed and developing countries, its prevalence is set to 
increase. Over 24 m illion people w orldwide have dem entia. W ith another 4.6 million 
people developing AD every year, worldw ide prevalence figures are predicted to 
double every 20 years (Ferri et al., 2005). Recent UK research puts the num ber o f 
dem entia sufferers in the UK at over 820 thousand people (1.3%  o f  the population), 
with more than 15 thousand under the age o f  65 (Knapp, 2007; Luengo-Fem andez, 
2010). An estim ated 37% o f these patients are in long-term  care institutions, with 
each patient costing the UK econom y over £27000 each year. That is m ore than the 
mean national salary. Com pared to the care costs o f  other public health concerns such 
as cancers and heart disease, research into dem entia has been found to be grossly 
underfunded (Luengo-Fernandez, 2010).
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F ig u re  1.1. E xpected  rise in p revalence o f UK  dem en tia  cases
Graph demonstrating the predicted increase in dementia cases until the year 2051, split into age bands 
(Knapp, 2007).
The cost o f  care is predicted to escalate, due to increasing life expectancy; prevalence 
in 60-64 year olds is approxim ately 1% yet this rises exponentially w ith age to 24-
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33%  in individuals aged 85 and older in the western w orld (Ferri et al., 2005). In the 
UK, a report funded by the A lzheim er’s Society predicts over 1.7 m illion sufferers by 
2051, w ith the greatest percentage increases occurring in the o lder categories o f  90-94 
and 95-99 years, corresponding w ith the grow ing percentage o f  the population 
reaching these ages (see Figure 1.1.) (Knapp, 2007)
1.1.2. Clinical features
The onset o f  AD can often be m isinterpreted as a part o f  the norm al aging process, as 
the earliest symptom is often m em ory loss (Selkoe, 2002). However, being 
progressive in nature, the clinical m anifestations becom e increasingly profound. The 
instrum ental signs associated with AD are aphasia, apraxia, agnosia and a variety o f  
general cognitive symptoms including im pairm ent o f  decision m aking, judgem ent and 
orientation (Blennow  et al., 2006). These sym ptoms present with a higher severity in 
the presenile form o f  AD and correspond to the areas o f  the brain prim arily affected 
by the neurodegeneration, i.e. the m em ory and language centres (See Figure 1.2). 
Critical to diagnosis and treatm ent strategies is the fact that neurodegeneration is 
thought to start 20-30 years prior to the clinical onset o f  sym ptoms (B lennow  et al., 
2006).
M ild cognitive impairm ent (M CI) is a condition diagnosed w hen an individual shows 
m em ory im pairm ents greater than what would be expected adjusted for age and 
education, yet other AD associated cognitive impairm ents are largely not present 
(Petersen, 2004). It is often thought o f as a risk factor for AD. However, it can be 
sym ptom atic o f  other disorders (e.g. vascular dem entia) or com pletely benign and part 
o f  normal aging. When symptoms are predom inantly m em ory associated a subtype, 
am nestic MCI, may be diagnosed. This may be considered a transitional stage
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between normal aging and AD, with som e reports showing early AD 
neuropathological changes occurring in am nestic MCI patients. This has lead to 
speculations o f  am nestic MCI actually representing early AD. Still, the conversion 
rate to AD has been estim ated at 12% o f  patients per year (B lennow  et al., 2006; 
Petersen, 2004).
Brain Cross-Sections
S u l c u sSulcus
ventr ic le
Normal Alzheimefs
F ig u re  1.2. AD causes d egenera tion  o f m em ory  an d  language cen tres.
A diagram comparing the cross-section o f  a normal brain alongside the gross atrophy observed in a late 
A lzheim er’s brain. The loss o f  neurons in the memory and language centres is directly responsible for 
clinical symptoms observed in patients. (Copyright © American Health Assistance Foundation 
Alzheim er Disease, http://www.ahaf.org/alzdis/about/BrainAlzheim er.htm )
1.1.3. Physiological m ark e rs
The finding that characteristic histopathological m arkers are shared by w hat was 
originally thought o f as two separate conditions (pre-senile and senile dem entia) has 
lead to them being join tly  referred to as AD. N eurodegeneration is accom panied by 
abnorm alities o f the synapse with the cholinergic system specifically affected. 
N eurotransm ission by acetylcholine is essential for m em ory and learning, and is 
decreased in AD patients. The activity o f  its degrading enzyme, acetylcholinesterase,
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is also reduced. These cholinergic deficits contribute towards symptoms and lead to 
loss o f  the affected neurons m aking the dam age irreparable (Chauhan and Chauhan, 
2006). Classical AD pathology consists o f  the presence o f  extracellular senile plaques 
and intracellular neurofibrillary tangles (NFTs) (pictured in Figure 1.3), often together 
w ith cerebrovascular amyloid deposits.
F ig u re  1.3. Senile p laques an d  n eu ro fib rilla ry  tang les in AD ce reb ra l co rtex
Senile plaques and neurofibrillary tangles are indicated by arrows. Plaques accum ulate extracellularly 
and are composed o f  P-amyloid (Ap). The tangles are composed o f  hyperphosphorylated tau and 
accumulate intracellularly (Blennow et al., 2006).
It has been suggested that during the preclinical phase, plaque and tangle load increase 
to a threshold at which the symptoms start to appear (Blennow et al., 2006). Early 
onset AD shows a greater plaque and tangle load and also exhibits greater cholinergic 
deficits, correlating strongly with the severity o f  dem entia, yet, this association is not 
found in elderly AD patients (Hansen et al., 1988; W ilcock and Esiri, 1982). This has 
brought into question whether pre-senile and senile dem entia should be considered as 
one disease or whether they represent different regions on a scale o f  





N eurofibrillary Tangles (NFTs) are com posed o f  polym erised, hyperphosphorylated 
tau protein in the form o f  paired helical filam ents (PHFs) (Grundke-Iqbal et al., 1986; 
Kidd, 1963). Tau is a norm al axonal protein w hich binds m icrotubules (M T) via its 
M T binding dom ains. The largest o f  the tau isoform s has 4 M T binding dom ains with 
exons 2 and 3 spliced in. It functions to aid assem bly o f  M Ts and stabilise them. 
Phosphorylation o f  tau regulates its activity and is m odulated by m ultiple kinases and 
phosphatases (B lennow  et al., 2006; Iqbal et al., 2005). There are norm ally 2-3 m oles 
o f  phosphate per m ole o f  tau. However, in AD this is 3-4 folds higher, seem ingly due 
to aberrant activity o f  these enzymes. This abnorm al phosphorylation renders tau 
incom petent in its role in M T assembly and it is subsequently sequestered into NFTs. 
These tangles become ubiquitinated for non-lysosom al degradation. Nonetheless, this 
appears to be inefficient as they persist in the AD brain (Grundke-Iqbal et al., 1986; 
Iqbal et al., 2005; Kopke et al., 1993). Tau pathology is generally regarded as a 
downstream  event in the developm ent o f AD but m ay also contribute to neuronal 
dysfunction and cognitive symptoms. M Ts are disrupted and axonal transport 
becom es impaired, com prom ising both neuronal and synaptic function. It has been 
suggested that the presence o f  these NFTs could effectively “choke” affected neurons 
by preventing axonal transport (Grundke-Iqbal et al., 1986; Iqbal et al., 2005; Kopke 
et al., 1993; Oddo et al., 2006).
1.1.3.2. Cerebrovascular deposits
The detection o f  cerebrovascular amyloid deposits in AD patients occurred early in 
research (Benedek and M cGovern, 1949), yet they were only identified as being 
largely com posed o f the same peptide as senile plaque am yloid in W ong et al (1985).
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At this tim e the principal hypothesis was that these cerebrovascular deposits were the 
origin o f  the senile plaques (W ong et al., 1985). However, it is now believed that the 
opposite is the case, w ith clearance o f  am yloid proceeding from the brain via the 
cerebrovasculature. The neurovascular hypothesis states that dysfunctional blood 
vessels contribute to cognitive sym ptoms. This m ay be due to im paired nutrient 
delivery to neurons with resulting neuronal stress (Farkas and Luiten, 2001; M ayeux, 
2003). There is also evidence to suggest that pathogenic m echanism s converge 
between Ap and cerebrovascular pathology: abnorm alities o f  the blood vessels also 
appear to reduce the clearance o f  Ap from the brain presum ably due to a lack o f  blood 
supply to carry the Ap away. Several links have em erged in this respect:
1. V ascular endothelial growth factor (VEGF) polym orphism s (reportedly associated 
w ith sAD) indicate a role for the vascular system in pathogenesis.
2. Cerebrovascular pathology with reduced blood supply reportedly generates a rise 
in APP expression with subsequent deposition o f  Ap (Sadowski et al., 2004a).
3. D own-regulation o f  a vascular differentiation gene, M EOX2, causes cerebral 
m icrovessel loss and consequently a reduction in Ap efflux (W u et al., 2005).
O ther research maintains that these links are independent o f  the disease process; 
coexisting cerebrovascular pathology may only serve to increase the probability o f  
dem entia in otherwise asym ptom atic patients (Blennow et al., 2006). Potentially 
cerebrovascular pathology together w ith vascular disease risk factors (such as 
coronary heart disease, atherosclerosis, hypercholesterolem ia, hypertension, diabetes, 
obesity and smoking) may accelerate developm ent o f  AD (Luchsinger and M ayeux, 
2004; M ayeux, 2003). Nonetheless, where AD has been identified 
neuropathologically, concom itant cerebrovascular am yloid pathology is also observed 




Senile or am yloid plaques accum ulate during norm al aging, but to a greater extent in 
AD, in the cerebral parenchym a and cortical interstitium  in a characteristic m anner 
(G aeta and Hider, 2005; Selkoe, 1991). The central region o f  these plaques is largely 
constructed from insoluble, SDS-resistant am yloid fibrils. The peptide com ponent o f  
these was purified from the plaques found in AD brains and identified as P-am yloid 
(AP) (Allsop et al., 1983; G lenner and W ong, 1984). N orm ally Ap is a soluble 
m etabolic product found in blood serum and CSF. However, in AD (and Down 
syndrom e (DS) (discussed in 1.3.1.)) it accum ulates, becom es insoluble and is 
sequestered into fibrils and subsequently into plaques. A lthough the presence o f  these 
plaques was held accountable for the neuronal loss exhibited and the resultant 
developm ent o f  AD, they are now considered “tom bstones” , signifying the dam age 
already transpired. A ttention has more recently focused on Ap, the peptide m aking up 
these fibrils and its aggregation process, as all biochem ical, genetic and 
neuropathological data suggest that Ap is central to AD pathogenesis (Selkoe, 2001).
1.2. p-amyloid
Ap is an am phipatic peptide which is 39-43 residues in length. A t -4 .5  kDa, A p40 is 
the m ajor Ap species produced under normal conditions (G lenner and Wong, 1984; 
M asters et al., 1985). It is soluble and can be found in CSF at nanom olar 
concentrations (Vigo-Pelfrey et al., 1993). Ap42 is a m inor species produced and is 
found heavily enriched in senile plaques. It is generally agreed that it is the 
accum ulation o f  this species that is more closely related to AD pathogenesis. For
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some reason the production o f  Ap in the brain becom es pathogenic in AD, possibly 
due to a m ultitude o f  factors that result in increased Ap42 levels.
As the tertiary structure o f  m onom eric Ap is critical to its subsequent aggregation, and 
hence, to AD pathogenesis, m uch research has set out to determ ine the structure o f  
Ap. Scanning tunnelling m icroscopy (STM ) has been successful at exam ining the 
structure o f  Ap40 m onom ers at low concentrations where it is thought to be stable. 
The globular structures observed by Losic et al, are consistent with m onom ers being 
3-4 nm diam eter. Using atom ic force m icroscopy (AFM ) a typical volum e o f  5.3 n m 3 
w as m easured, sim ilar to that expected for a m onom er. They reported internal 
m orphology o f  a polypeptide chain folded into 3 or 4 dom ains as parallel strands 3-4 
nm  in length, consistent with a single Ap peptide chain (Losic et al., 2006). Due to 
the tendency o f  Ap42 to aggregate, structural inform ation on the Ap42 m onom er is 
m uch harder to ascertain.
Ap is a m etalloprotein showing high affinity for binding Cu(II), Zn(II) and Fe(II) ions 
(A twood et al., 2000b; Huang et al., 1999a). The binding site for Cu(II) has been 
m apped to the region between residues 6-28 at the hydrophilic N -term inus o f  the 
peptide and has been shown to have a square planar configuration. C o-ordination is 
m ediated via the electrons o f  3 nitrogen atom s contained in the im idazole rings o f  
histidine residues. These are His6 , H is l3 and H isl4 . An oxygen is also needed for 
coordination w hich is thought to be donated from the hydroxyl group o f  TyrlO. 
How ever several other candidates are also suggested; the carboxylate o f  Glu5, an N- 
term inal aspartate, the amino term inus itself, or perhaps even a water m olecule (Karr 
et al., 2005; Smith et al., 2007a; Streltsov et al., 2008). It has been reported that Cu(I) 
coordination is via His 13 and His 14, with Cu(I) central in an alm ost linear 
arrangem ent (Himes et al., 2008; Shearer and Szalai, 2008). N ot only does Ap
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contain a metal binding site, but M et35 has m etal reducing ability. This m eans that 
Ap can potentially bind and utilise redox active metal ions in reactions form ing H 2 O 2 , 
such as the reduction o f  Cu(II) to Cu(I) (Butterfield and Bush, 2004).
F ig u re  1.4. Ap42 sequence
The amino acids involved in metal binding are identified along at the N-term inus with the putative 
metal reducing site at Met35 at the C-terminus. (G aeta and Hider, 2005)
1.2.1. A m yloid p re c u rso r  p ro te in
Ap is generated from a precursor protein identified as Am yloid Precursor Protein 
(APP). This protein is a type 1 integral m em brane glycoprotein ubiquitously 
expressed in the human body. Alternative splicing o f  APP m RNA leads to m ultiple 
isoform s o f  APP being created o f  different lengths (Selkoe, 2001). The largest 
isoform, APP770, has both a kunitz-type protease inhibitor (KPI) dom ain and an OX- 
2 antigen dom ain (Blennow et al., 2006). D ifferential expression o f  the different APP 
isoform s has been hypothesised to be one o f  the factors m ediating sAD. In particular, 
the presence o f  the KPI dom ain has been im plicated with a shift to KPI containing 
isoforms being identified in the AD (M atsui et al., 2007). The function o f  this protein 
is still unknown. Potential functions have been suggested to include intracellular 
calcium  regulation (M attson et al., 1993), cell adhesion (Storey et al., 1996), cell 
growth (Small et al., 1994), vesicle transport along axons (Gunaw ardena and 











independent o f  the Ap region. Structurally it has a growth factor-like dom ain next to 
a large cysteine-rich region containing the metal binding dom ain in its large N- 
term inal extracellular tail (see figure 1.5).
Its metal binding ability is o f  particular interest and is assum ed to be critical to its 
biological function. It has a strong affinity for copper ions (kd ~  10 nM ) and the metal 
binding dom ain is sim ilar in structure to copper chaperones such as SOD1 (Barnham  
et al., 2003). In fact APP knockout mice show raised levels o f  copper in the liver and 
brain cortex, and when mice over-express APP, brain m etal levels, specifically 
copper, are dim inished, supporting a role in metal hom eostasis (M aynard et al., 2002; 
W hite et al., 1999). The Ap dom ain o f  APP lies partially em bedded in the plasm a 
m em brane (PM ) with 12-14 residues residing inside the transm em brane (TM ) dom ain 
o f  APP. The rem aining 28 residues lie outside the m em brane (Blennow et al., 2006).
18 123 189 289 498  624 648 695
KPI 0 x 2
GFD CBD Acidic E2 U n s t r u c t u r e d  CP j
F ig u re  1.5. T h e  dom ains o f A PP.
The domains o f  the 695 amino acid APP isoform are shown. GFD = growth factor domain, CBD = 
copper binding domain, Acidic = rich in acidic residues, E2 = glycosylated domain, TM = 
transmem brane domain, CP = cytoplasmic tail. The KPI and OX2 domains are spliced out o f  this 
isoform. The numbers represent the residue boundaries o f  each domain. The fragment that forms the 
A f  peptide is shown, with the cleavage sites for the secretases ((3, a  and y) also indicated (adapted from 
(Kong et al., 2007)).
1.2.2. A P P  secretases
APP is cleaved at 3 m ajor sites: the a-cleavage site precludes Ap generation, whilst 
the P- and y-cleavage sites permit Ap generation. Several zinc m etalloproteinases 
have been identified that are able to cleave APP at the a-secretase cleavage site:
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1. A D A M 10 (a disintegrin and m etalloproteinase) -  strong evidence supports this 
m ultidom ain TM  protein in a role in both constitutive and regulated cleavage at 
the L ysl6 -L eu  17 a-cleavage site (review ed in (Allinson et al., 2003)). 
Interestingly, w hen the peptide corresponding to the A D -associated am ino acid 
substitution AP-A21G was tested, it was cleaved at a slow er rate to the w t peptide. 
This substitution corresponds to a naturally occurring AD m utation w hich also 
causes cerebral hem orrhages due to am yloid accum ulation in the 
cerebrovasculature (Hendriks et al., 1992).
2. A D A M 17/TA CE (TN F-a convertase) -  this potential a-secretase is involved in 
the shedding o f  a range o f  integral m em brane proteins in addition to TN F-a. 
H ow ever cleavage o f  APP at the a-secretase site is reported to be at a far reduced 
efficiency to the cleavage event generating T N F-a. It has been suggested that the 
action o f  A D A M -17 in respect to a-site cleavage o f  APP m ay be restricted to the 
regulatory pathway (Allinson et al., 2003).
3. A D A M 9/M D C9 (m etalloprotease/disintegrin/cysteine-rich protein 9) -  evidence 
for the involvem ent o f  this ADAM  is less convincing. Expression o f  ADA M 9 in 
several different studies appears to suggest increased a-site  cleavage, yet some 
evidence suggests this site is m odified to H is l4 -G ln l5  (Roghani et al., 1999). It 
has been suggested that this cleavage event may be restricted to certain cell types 
(Allinson et al., 2003)
There has also been an aspartyl protease, BACE2, identified that is capable o f  a - 
cleavage (Thinakaran and Koo, 2008). What appears clear from knockout mice 
studies is that there is a functional overlap between several a-secretases, acting in 
concert to cleave APP at the a-site (Allinson et al., 2003; Thinakaran and Koo, 2008).
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The m ajor p-secretase has been identified as (3-site A PP-cleaving enzym e 1 or 
BACE1. This is an integral m em brane aspartyl protease and is found w ithin the trans- 
golgi netw ork and also w ithin endosom es (V assar et al., 1999). The high levels o f  
neuronal BACE1 suggest APP processing is preferentially channelled through the 
am yloidogenic pathway (discussed in 1.2.3) (Thinakaran and Koo, 2008). An 
intram em brane protein com plex was identified as the APP cleaving y-secretase. It is 
com posed o f  4 essential com ponents: the proteins nicastrin, PEN-2, APH-1 and 
presenilin. Together these form the active site w hich is able to cleave at m ultiple sites 
w ithin the TM  dom ain o f  Ap (Thinakaran and Koo, 2008; V assar et al., 1999).
1.2.3. APP processing
The secretases identified in APP cleavage w ork according to tw o separate proteolytic 
pathways determ ined via w hether initial cleavage is perform ed by  a - or p-secretase 
(see figure 1.6). Cleavage by a-secretase allows the non-am yloidogenic pathw ay to 
be followed. This cuts APP within the Ap dom ain (at K16-L17 o f  Ap) betw een the p 
and y secretase cleavage sites. This generates N -term inal soluble APP fragm ents 
(sA PPa) which are released extracellularly. The C-term inal fragm ent that rem ains 
em bedded in the m em brane (CTF, a-C TF or C83) is then cleaved by the y-secretase 
com plex within the TM domain, releasing the p3 peptide extracellularly (B lennow  et 
al., 2006; Selkoe, 2001; Smith et al., 2007a).
The cleavage o f  APP by p-secretase permits the am yloidogenic pathw ay as it cleaves 
w ithin the ectodom ain o f  APP, at the N -term inus o f  the Ap domain. This releases the 
N-term inal, soluble sAPPp fragment. The y-secretase com plex cleaves the rem aining 






















































F ig u re  1.6. T he  processing p athw ays o f A PP
Proteolytic processing o f  APP is dependent on cleavage by either a  or p secretase. This is followed by 
cleavage by y-secretase. Amyloidogenic: APP is initially cleaved by p-secretase, the Ap fragment can 
be formed and can lead to its aggregation. Non-amyloidogenic: APP is initially cleaved by a-secretase, 
the AP fragment cannot be formed and hence it cannot aggregate. PM = Plasma mem brane, EC = 
extracellular protein/fragm ent, IC = intracellular protein/fragm ent (AICD).
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This enzyme shows some heterogeneity in the exact site o f  cleavage w ith this enzym e, 
thus the AP peptide fragm ent that is released can be o f  varying length. The C-term inal 
APP intracellular dom ain (AICD) that rem ains in both pathways, is m etabolised 
w ithin the cytoplasm  (B lennow  et al., 2006; Selkoe, 2001; Smith et al., 2007a).
Ap is norm ally degraded or cleared from the brain through the BBB. Neprilysin, 
insulin-degrading enzym e (IDE), endothelin-converting enzym e (ECE) and 
angiotensin-converting enzyme (ACE) have been found to degrade Ap in the brain 
(Carson and Turner, 2002; Iwata et al., 2000; M iller et al., 2003; M iners et al., 2008; 
Zou and M ichikaw a, 2008). The efflux o f  Ap across the BBB is m ediated by a low- 
density lipoprotein receptor-related protein (Tanzi et al., 2004). This is balanced in 
the brain by the receptor for advanced glycation end products which m ediates its 
influx back into the brain (Hardy and Selkoe, 2002). N either o f  these processes has 
been found to be altered in AD. Nonetheless, Ap production and m etabolism  is 
sensitive to a variety o f  influences that m ay contribute to disease state. The build-up 
o f  the potentially pathogenic Ap in AD is generally thought to be due to altered 
proteolytic processing o f  APP with resulting overproduction o f  the m ore neurotoxic 
form s o f  Ap (B lennow et al., 2006; Tamagno et al., 2006).
1.3. Risk factors
W ithout question, the biggest risk factor for all dem entias is aging. fAD has several 
genetic predispositions associated with it (discussed in 1.3.1-3). A lthough sAD has 
environm ental influences a large genetic involvem ent has been reported. A  large tw in 
study has reported 80% hereditability for sAD (Gatz et al., 2006). The A lz gene 
database (w ww .alzgene.org) has details on all the published genetic studies o f  AD.
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Verification o f  genes associated with sAD is problem atic due to its heterogeneity. 
The contribution o f  any one gene product to the risk o f  AD is probably very small. 
N um erous gene products m ay act in concert acting to increase AD risk together with 
environm ental factors form ing a com plex interacting netw ork (B lennow et al., 2006).
W here genetic predisposition has not been established, o ther risk factors have been 
suggested from  epidem iological studies. M any o f  these factors are linked to a reduced 
reserve capacity o f  the brain. This is governed by neuron num ber, synaptic and 
dendritic arborisation along w ith lifestyle associated cognitive strategies and has been 
linked to early presentation o f  AD pathological changes (M ortim er et al., 2003). 
Com m only proposed causes o f  a low reserve capacity are:
•  Small brain size
•  Low educational and occupational achievem ent
•  Low mental ability in early life
•  Low mental and physical activity in later life
O ther studies link head injury to risk o f  AD. This m ay also be due to creating reduced
reserve capacity although it has also been proposed as a possible initiating pathogenic
event, inducing a cascade o f  events resulting in AD neuropathology (B lennow  et al., 
2006; Jellinger, 2004).
Genetic factors resulting in fAD are generally associated w ith m utations in the genes 
for the APP (Brown, 1991), presenilin 1 and presenilin 2 (part o f  y-secretase) (Hutton 
and Hardy, 1997) providing links to the m etabolism  o f  Ap (discussed in 1.2.5). sAD 
is m ore elusive in its etiopathology being highly polygenic and m ulti factorial 
(Cum m ings et al., 1998; Liu et al., 2006).
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1.3.1. Mutations in the gene encoding APP
The first genetic m utation identified was in the gene for APP located on chrom osom e 
21 (G oate et al., 1991). Further studies have identified 23 m utations o f  the APP gene, 
19 o f  w hich are clearly associated w ith the disease o r other dem entias. H ow ever APP 
gene m utations account for less than 1% o f  AD cases (Lam bert and A m ouyel, 2007).
The disease causing m utations in the gene for APP cause am ino acid substitutions 
either clustered at the P and y cleavage sites or involve residues im portant for A p se lf 
interactions (residues 21-23) (see figure 1.7) (B lennow et al., 2006; Crews et al., 
2010). Consequently, these m utations increase Ap generation or prom ote Ap 
aggregation. M ultiple m utations around the y-secretase cleavage site specifically 
cause increased production o f  the m ore am yloidogenic Ap42 com pared to Ap40 
(T714I, V715M , V715A, 1716V, V717I and V717L) (De Jonghe et al., 2001). Those 
substitutions clustered around residues 21-23 (A 21G  (Flem ish), E22G (A rctic), E22Q 
(Dutch), E22K  (Italian), D23N (Iowa)) lead to A lzheim er’s-like sym ptom s yet these 
sym ptom s can be secondary to inter-cerebral haem orrhage (Bharadwaj et al., 2009; 
Crews et al., 2010; Dahlgren et al., 2002).
The idea that increased Ap production causes AD is supported by in vivo gene dosage 
evidence from DS patients. These individuals always develop early onset AD due to 
an extra chrom osom e 21 (Trisomy 21). Consequently, these individuals have three 
copies o f  the gene for APP resulting in an overproduction o f  Ap, accelerated plaque 
deposition and increased lipid oxidation (Lynch et al., 2000; Odetti et al., 1998). The 
gene dose effect is also supported by a report o f  a family with fAD with a duplication 
o f  the APP locus with resultant over-expression (Rovelet-Lecrux et al., 2006). This 
evidence from genetic studies im plicates Ap as being central to the pathogenic 
pathway leading to AD.
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F ig u re  1.7. C om m on am in o  acid  su b s titu tio n s  caused  by A P P  gene m u ta tio n s
Common disease causing mutations in the gene for APP are clustered around the secretase cleavage 
sites. APP is shown in blue, Ap in red and the cleavage sites are indicated by red arrows (adapted from 
(Crews et al., 2010))
1.3.2. M u ta tio n s  in th e  genes encoding  th e  p resen ilin s
The m ajority o f  fAD cases are explained by m utations in the highly hom ologous 
genes for presenilin 1 and presenilin 2 (PSEN1 and PSEN2) located on chrom osom es 
14 and 1 respectively (Blennow et al., 2006; Levy-Lahad et al., 1995; Sherrington et 
al., 1995). These gene mutations cause altered APP processing and consequently up- 
regulation o f Ap generation, especially Ap42, further supporting the pivotal role o f  Ap 
in the developm ent o f  AD (Lynch et al., 2000; Odetti et al., 1998).
1.3.3. A P O E  v a r ia n ts
One o f  the most com m on risk factors for sAD is the possession o f  the apolipoprotein 
E (APOE) c4 allele located on chrom osom e 19. The allele com es in 2 other m ajor 
forms, APOE s2 and APOE s3. It is suggested that carrying the APOE s4 allele
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actually accounts for the m ajority o f  the genetic risk connected with sAD cases (R aber 
et al., 2004). The association o f  this allele was reported independently by two groups 
in 1993 (C order et al., 1993; Poirier et al., 1993). Individuals heterozygous for this 
allele are 3 tim es m ore likely to develop AD than an individual w ith the other variants. 
However, an individual hom ozygous for APOE s4 has 15 tim es the risk o f  developing 
AD (Farrer et al., 1997; M eyer et al., 1998). It appears that possession o f  each APOE 
s4 allele lowers AD onset by 10 yrs (C order et al., 1993).
The ApoE protein is the m ajor lipoprotein expressed in the brain (B utterfield and 
Bush, 2004). It is a lipid and cholesterol transporter needed for the recycling o f  
m em brane lipids and for neuronal repair (Poirier, 1994). The ApoE4 transporter is 
less efficient than the other variants at perform ing these functions, strengthening links 
betw een vascular disease, fat intake and AD. An association is also observed between 
ApoE4 and oxidative stress. M ouse studies w ith knock-in hum an APO E e4 alleles 
under the m ouse prom oter show significantly m ore oxidative stress w hen incubated 
w ith A{342, than the other alleles (Lauderback et al., 2002). H om ozygous A POE s4 
individuals have increased lipid oxidation and those w ith one APOE s4 allele show 
heightened catalase and glutathione peroxidise activities, enzym es im portant for 
detoxification o f  ROS (Ram assamy et al., 1999). For these reasons, APOE s4 allele 
has been suggested to increase risk o f  AD as it is less able to cope w ith Ap induced 
oxidative stress. In addition, ApoE has been found to prom ote Ap fibrillisation and 
deposition into plaques and has been proposed to act as a biological chaperone for this 
process perhaps due to m odulation o f  metal ion content (Holtzm an et al., 2000; M oir 
et al., 1999). ApoE4 has been found to be least effective at acting as a chaperone for 
solubility o f  Ap insulted with metal ion stresses (M oir et al., 1999).
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1.4. p-amyloid and Alzheimer’s disease
M ost researchers would agree that Ap is central to AD pathogenesis, in particular the 
longer Ap42 w hich is found enriched in plaques. These plaques are not considered 
pathogenic. H ow ever the brain tissue also contains sm aller, soluble forms o f  Ap, not 
yet sequestered into plaques. It is these “oligom eric” species that m any hold 
accountable for the neurodegeneration in AD. This soluble pool o f  Ap in the A D  
brain m ay be a direct determ inant o f  neurodegeneration severity (M cLean et al., 
1999). It has been observed that these species inhibit hippocam pal LTP and disrupt 
synaptic plasticity. M onom ers and fibrils do not exert this effect (W alsh et al., 2002).
The deposition o f  Ap is accom panied by m ajor and w idespread oxidative stress in the 
neocortex (Lynch et al., 2000). It is posited that oligom eric Ap is the source o f  this 
oxidative stress, possibly through ROS form ation, and is potentially the root o f  
neurodegeneration. The oligom erisation and aggregation o f  Ap through various 
interm ediate species (discussed in 1.4.2.) gaining some sort o f  toxic property during 
this process is central to thinking on AD pathogenesis and is the basis o f  the am yloid 
cascade hypothesis.
1.4.1. Amyloid cascade hypothesis
The am yloid cascade hypothesis was first proposed in 1991 by John Hardy and D avid
Allsop to explain pathogenesis o f  AD caused by Ap (H ardy and Allsop, 1991). This
hypothesis has been applied to many neurodegenerative diseases to explain the source
o f  amyloid toxicity. Key to this idea is an im balance in the production and clearance
o f  the am yloidogenic protein: in the fam ilial disease there is often increased
production; in the sporadic forms there is presum ed to be decreased clearance
(possibly due to reduced degradation by neprilysin (Iw ata et al., 2000) or IDE (M iller
20
Chapter 1 Introduction
et al., 2003), reduced perivascular drainage (W eller et al., 1998) or less microglial 
clearance (Frautschy et al., 1992)). All the factors connected to Ap aggregation are 
not understood yet, the process by w hich soluble Ap is converted to aggregating Ap is 
critical. A nything that alters this process m ay be considered a trigger and contribute 
to disease state in sAD (Bharadwaj et al., 2009; Hureau and Faller, 2009).
This hypothesis has proved resilient and although some revisions have been made, it is 
still central to the beliefs on am yloid toxicity (Hardy and Selkoe, 2002). It is now 
thought that som ewhere during the aggregation o f  the protein into fibrils the protein 
gains some form o f  toxicity, inducing cellular dysfunction and cell death.
O ligom erisa tion
- T oxicity  induced
- O x idative  s tress?
F am ilia l
disease
S p o rad ic
disease
F ib rillisa tio n  
in to  p laques
D ecreased
am yloid
c lea ran ce
In c reased
am yloid
p ro d u c tio n
F ig u re  1.8. S im plified schem atic  o f the  am ylo id  cascade hypothesis.
A consequence o f  genetic and environmental factors is an imbalance between production o f  the 
amyloid and its clearance. In general, the familial disease (governed by genetic influences) is the 
product o f  increased generation o f  the amyloidogenic protein; the sporadic disease (with environmental 
stimuli) is associated with decreased clearance o f  it. Soluble oligom eric species exert their toxicity 
prior to sequestration into insoluble plaques. This results in cellular dysfunction and subsequent cell 
death o f  vulnerable cell populations.
1.4.2. Ap aggregation
The mechanism by which Ap ultim ately leads to neuronal degeneration and dem entia 
appears to critically depend on a conform ational change o f  soluble, m onom eric Ap to 
a structure with high p-sheet content, perm itting subsequent aggregation. The 
denaturation o f  the peptide may be the initial event allow ing the subsequent mis- 
folding to occur. Ap42 is more prone to adopting the p-rich conform ation, aggregates
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faster and has also been suggested to be able to trigger the m is-folding o f  the o ther Ap 
species, prom oting aggregation (Jarrett et al., 1993).
M onom eric Ap can be found in AD brains up to 6  tim es the level o f  control brains. 
The increased Ap concentration drives oligom erisation o f  Ap. It is these early, 
soluble oligom ers that seem to be fundam ental in the developm ent and early 
progression o f  AD as it has been found that the level o f  soluble Ap and the degree o f  
cognitive im pairm ent and synaptic loss are strongly correlated (Klein et al., 2001; Lue 
et al., 1999; M cLean et al., 1999). In particular, high-m olecular w eight soluble Ap 
oligom ers (40-200kDa) have been found to be elevated in the CSF o f  A lzheim er’s 
patients, the levels o f  which negatively correlated with M M SE scores (Fukum oto et 
al., 2010). O ligom eric Ap m ay be the predom inant neurotoxic species, being found to 
kill m ature neurons in hippocam pal slices at nanom olar concentrations (H artley et al., 
1999; W alsh et al., 2002). Oligom ers are thought to grow in size in a tim e-dependant 
m anner form ing protofibrils, finally producing the insoluble m ature fibrils that 
com prise senile plaques (See Figure 1.9) (W alsh et al., 1997). However, the exact 
sequence o f  oligom er species that Ap becom es fibrils through is up for debate.
It is thought the increased hydrophobicity o f  AP42 com pared to Ap40 drives p-sheet 
form ation and fibrillogenesis. In support o f  this, Ap40 w ith a glutam ine instead o f 
glutam ate at residue 22 (E22Q-AP40) is slightly more hydrophobic than w t A p40 and 
fibrillises faster. Consistent w ith this idea, substitutions that decrease the 
hydrophobicity o f  the peptide reduce its rate o f  polym erisation: A 21G -A p40
aggregates much slower than wt Ap40 and F19P-AP40 rem ains totally dissociated 
(C lem ents et al., 1996; Walsh et al., 1997). Structural elem ents in the central 
hydrophobic core o f  the peptide may play a key role in controlling aggregation, 
crucially residues 17-21, together with the C -term inus o f  the peptide. Am ino acid
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substitutions created in this region prevent the se lf associations necessary for 
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F ig u re  1.9. T he  process o f A p aggregation
M onomeric A f is thought to aggregate through a series o f  small soluble oligomeric species. These are 
subsequently sequestered into protofibrils and later into mature fibrils. It is early, soluble, oligom eric 
A f that is believed to cause neurotoxicity.
1.4.2.1. S tru c tu re  o f A p an d  its agg reg atio n  in te rm ed ia te s
Following cleavage from the parent APP m olecule, Ap presum ably adopts a random
coil conform ation. From here it is hypothesised that the peptide can potentially adopt
an a-helical or p-sheet predominated structure, dependant on its environm ent. The
nature o f  Ap42 m akes its structure invariably difficult to resolve by N M R. Under
mem brane m im icking conditions (using SDS) Shao and colleagues found the a-helical
conform ation to be promoted, preventing its aggregation. They observed an extended
chain from A spl-G ly9 , followed by 2 a-helical regions between T yrl0 -V al24  and
Lys28-Ala42, connected by a short looped region (G ly25-Ser26-A sn27) (Shao et al.,
1999). The exact locations o f  these helices are dependent on experim ental conditions.
Figure 1.10 shows these a-helices in an apolar environm ent. With the large proportion
o f  the 2nd helix being hydrophobic and considering its proxim ity to the m em brane
following cleavage by y-secretase, it would seem logical to assum e this to be the
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normal structural impetus. Here, the peptide is thought to be stabilised but does not 
fully insert into the hydrocarbon interior o f  the m em brane (Shao et al., 1999).
F ig u re  1.10. T h e  s tru c tu re  o f A042 in an  a p o la r  en v iro n m en t
The 2 a-helical regions are shown in pink. The residues are coloured to reflect their hydrophobicity 
(blue = hydrophilic, red = hydrophobic). Structure imaged using Cn3D 4.1 using M M BD ID: 21966, 
PDB ID: 1IYT (Crescenzi et al., 2002) from M M DB (Chen et al., 2003; W ang et al., 2007).
An earlier study o f  Ap40 reported a sim ilar a-helical structure, with the loop region 
potentially lying at the w ater/lipid boundary (Coles et al., 1998). They observed that 
deprotonation o f  E22 and D23 destabilised the helix w hich may be the forerunner for 
aggregation. In support o f this, the shortest fragm ent o f  Ap sequence that retains fibril 
form ing ability is Ap 14-23 and Ap lacking this sequence is unable to form fibrils 
(Tjernberg et al., 1999). In addition, residues 21-23 are substituted in some AD 
causing m utations. W hether aggregation proceeds from a-helix  to P-sheet or from 
random coil to P-sheet is unclear. In either case, an altered m icroenvironm ent, such as 
high AP concentration, decreases in pH or metal association, the specific side chain 
interactions are replaced by hydrogen bonding between the am ino and carbonyl 
groups o f  the main chain; a p-sheet conform ation is adopted and oligom erisation 
proceeds instigating Ap toxicity (Barrow  and Zagorski, 1991; Burdick et al., 1992; 
Fraser et al., 1991; Huang et al., 2004; Liu et al., 2006; Shao et al., 1999).
Initial oligomerisation presumably involves the form ation o f  Ap dim ers w hich have 
been found to be stable structures and are often observed prior to aging o f  Ap
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solutions. These have been described as being 6-7nm  by 3nm and show a 
characteristic internal structure, w ith 3-4nm  strands o f  the peptide orientated at 90° to 
the long axis o f  the dim er (Losic et al., 2006). The A p dim er m ust have intrinsic 
stability as follow ing rigorous deseeding o f  Ap preparations structures described as 
dim eric have been reported to persist (W alsh et al., 1997).
The structure o f  the neurotoxic, soluble oligomers is elusive due to indications that the 
aggregates are highly polym orphic together w ith the dynam ic, heterogeneity o f  
aggregation solutions. Losic and colleagues have reported them  to be 3-4nm  in w idth 
consisting o f  end-to-end association o f  the m onom er units. As w ith the orientation o f  
m onom ers in the dimer, the polypeptide chain is at 90° to the axis o f  the oligom er, 
otherw ise known as a cross-P conform ation (as shown in figure 1.11). This w ould 
suggest that it is the linear association o f  Ap subunits that creates oligom ers (Losic et 
al., 2006). Indeed, W alsh and colleagues have observed only three stable species, 
being A p dim ers, protofibrils and m ature fibrils. This was the case w hen they tested 
both Ap40 and Ap42. Initially sam ples were dom inated by dim ers. These decreased 
in a tim e-dependant m anner with a concom itant increase in protofibril levels (W alsh et 
al., 1997). This evidence does not mean these are the only Ap species or the m ost 
im portant Ap species in neuronal degeneration seen in AD. However, it is consistent 
w ith the hypothesis that Ap oligom erises through a series o f  short-lived interm ediates 
form ing protofibrils. These then act as centres for growth o f  m ature fibrils. This 
seems to be the accepted hypothesis in the m ajority o f  reports, yet secondary and 
tertiary structures o f  oligom ers have been reported to differ betw een preparation 
techniques. There may be oligom er form ing events independent from the fibrillisation 
pathway or several m echanisms o f  aggregation; oligom ers form ed through different 
m echanism s may be structurally different (Klug et al., 2003; Losic et al., 2006).
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Protofibrils are usually described as curved fibrils less than 200 nm in length formed 
from linear (3-sheet packing o f  Ap m olecules (see figure 1.11). Residues 18-40 form 
two p-strands w hilst residues 1-17 remain relatively unstructured. An interm olecular 
salt bridge between D23 and K28 stabilises the linear structural arrangem ent o f  the 
m olecular subunits (Luhrs et al., 2005). M ature fibrils are observed as being 6-8nm 
wide and are formed from association o f  these protofibrils (Balbach et al., 2002; 
M alinchik et al., 1998). Luhrs and colleagues report a mature fibril to contain 4 
protofibrils coiled around each other, with a tw ist o f  0.45° per m olecule (Luhrs et al., 
2005). There also is some evidence that sm aller Ap peptides can also form anti­
parallel p-strands (Hou and Zagorski, 2004).
L eu  17 V a l4 0
F ig u re  1.11. T he cross-P confo rm ation  o f Ap
Diagram shows the core P-structure o f  residues 17-40. Each AP molecule is coloured differently to 
show how inter-P-strand interactions occur. The direction o f  the fibril axis is indicated by an arrow 
(adapted from (Luhrs et al., 2005).
1.4.3. O ligom eric  p-am yloid  induced  neu ro tox ic ity
The links between Ap and the neurodegeneration observed in AD are robust, with the 
general consensus agreeing that the oligom eric species are critical. Less clear is 
which oligom er species are important in the pathogenesis o f  AD. N um erous groups 
have reported the observation o f  a wide range o f  polym ers prior to the form ation o f 
protofibrils, several o f  which have been im plicated as being the oligom eric culprit.
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These include the dityrosine dim er (Bam ham  et al., 2004; Smith et al., 2007a), 
tetram er (Ono et al., 2009) up to hexam ers (Butterfield and Bush, 2004), 12-mers that 
are able to bind receptors inducing toxicity (Lam bert et al., 1998), and a 56kD a Ap 
species (Ap*56) that induces m em ory deficits in transgenic m ice (Lesne et al., 2006). 
Identification o f  the toxic species is inherently troublesom e due to the heterogenic and 
changing nature o f  Ap solutions. It m ay be that one or several o f  these oligom eric 
species are inherently toxic to neuronal cells. On the other hand, the actual process o f 
oligom erisation from m onom er/dim er to protofibril m ay be the root o f  its toxicity.
O ligom eric Ap is believed to affect normal neuronal functioning in vivo altering the 
efficacy o f  hippocam pal synapses at physiological concentrations. Ap affected 
neurons show electrophysiological changes involving increased m em brane 
depolarisation. Action potentials may be m ore easily elicited w ith the potential to 
cause chronic stress and eventually cause cell death (Hartley et al., 1999; W alsh et al., 
2002). This m ay be directly due to oligom er dependent increases in m em brane 
perm eability and subsequent raised intracellular calcium  (Dem uro et al., 2005). 
Furtherm ore, m any signalling pathways are either directly or indirectly regulated by 
calcium  levels or m em brane depolarisation, including those pathways that lead to 
autophagy and cell death (Abramov et al., 2004).
It has been reported that oligomers can actually form discrete pores in m em branes. 
This has been called the “channel hypothesis” o f  am yloid pathogenesis. M any 
disease-associated amyloid proteins have been reported to form  these pores, inserting 
irreversibly as discrete channels into the m em brane increasing bilayer conductance 
(Arispe et al., 1993; Hirakura et al., 2000; Kagan et al., 2004; Lashuel et al., 2002; 
M irzabekov et al., 1996). O ther research has found that perm eabilisation o f 
m em branes by oligomeric Ap insertion does not require pore form ation (Kayed et al.,
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2004). Generation o f  ROS by Ap w ithin the m em brane w ould oxidatively dam age the 
phospholipid hydrocarbon tails, thus increasing m em brane perm eability. B rain 
m em brane phospholipids are largely com posed o f  polyunsaturated fatty acids w hich 
are particularly sensitive to oxidation. This process generates aldehydes, indicative o f  
oxidative stress and clearly increased in AD brains (Pratico, 2008).
The interaction o f  metal ions w ith Ap is central to potential oxidative toxic 
m echanism s o f  the peptide. Redox active m etal ions, such as copper and iron, are 
found to interact w ith Ap, prom ote auto-aggregation o f  the peptide and provide the 
biochem ical m eans for ROS generation. Zinc ions are also found to prom ote 
aggregation o f  Ap although the ion does not perm it redox chem istry (H uang et al., 
2004; Liu et al., 2006). The binding o f  zinc to Ap has been suggested to be in 
com petition w ith copper ions, protecting against ROS form ation by the petide-copper 
ion com plex (Cuajungco et al., 2000; Smith et al., 2007a). These ideas are 
investigated in Chapter 7.
It is w idely thought that oligomers are the toxic entity. Indeed, it has been reported 
that Ap42 owes its greater toxicity to its tendency to form stable early oligom ers 
whereas Ap40 tends to remains m onom eric (Chen and Glabe, 2006). O ligom ers m ay 
be a transient phase in the fibrillisation process rather than a stable subset o f  structures 
(Oddo et al., 2006). It is also possible that only some oligom ers are stable, potentially 
formed independent o f  the fibrillisation pathway; oligom ers m ay be a particular stage 
o f  the aggregation process, or separate structures formed aw ay from the fibrillisation 
process. W ith the num ber o f  reported structural conform ations o f  Ap, it w ould seem 
naive to preclude the possibility o f  a com plex inter-changing o f  low -order species, 
some o f  w hich are “o f f ’ the fibrillisation pathway and dependent on all m anner o f 
m icro-environm ental factors. N evertheless, the aggregation o f  Ap42 in vitro has been
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found to involve the form ation o f  several distinct transient species, som e o f  w hich 
have been found in the AD brain. These m ay then slow ly rearrange into protofibrils 
and m ature fibrils (Bitan et al., 2003a; B itan et al., 2003b).
1.4.4. Ap and the oxidative changes in AD
O xidative dam age is a m ajor feature in AD pathophysiology exhibited by the dam age 
to lipid m em branes along with various other cellular com ponents. This alters the 
properties o f  the m em branes affecting fluidity, ion transport, enzym atic activity, 
protein cross-linking, and can result in cell death (Chauhan and Chauhan, 2006). 
Evidence for oxidative stress in AD neurons com es from the observation o f  lipid 
peroxidation products (HNE) along with DNA oxidation products ( 8 -HO -guanidine) 
and protein oxidation products (producing free carbonyls, carbonyl m odified 
neurofilam ent protein, glycation and glycoxidation products) (Sm ith et al., 1996). 
Protein nitration is also observed along with DNA adducts to both m itochondrial and 
nuclear DNA accom panied by antioxidant activity disruptions (Smith et al., 2007a). 
Autopsy specim ens o f  the frontal lobe from AD brains exhibit these m odifications 
together w ith reductions in oxidation sensitive enzym atic activity (i.e. creatine kinase 
and glutam ine synthase). These alterations m ay contribute to sym ptoms exhibited by 
affecting susceptible neurons (Aksenova et al., 1999; Lynch et al., 2000). There is 
evidence that following initial elevation o f  these m arkers they then decrease as the 
disease progresses to advanced AD. This m ay be due to the fact neurons that have 
evaded apoptotic death have responded to the insults by increasing cellular defences 
(Perry et al., 2002). However, by this tim e the neurodegenerative dam age exerted 
may be extensive and irreparable.
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The A(3-induced oxidative stress model is an attractive hypothesis for the oxidative 
adducts observed in AD. However, it rem ains unclear whether the generation o f  A|3 is 
the cause or effect; Ap induces oxidative stress yet generation o f  AP is increased as a 
result o f  oxidative stress (Chauhan and Chauhan, 2006). Once at a sufficient 
concentration to induce oxidative dam age, AP is thought to actually induce its own 
production creating a positive feedback cycle (Atwood et al., 2003; Gaeta and Hider, 
2005). In fact, many pro-oxidising agents increase Ap generation via an increase in 
BACE-1 expression and activity pointing tow ards an antioxidant role for Ap (Paola et 
al., 2000; Tam agno et al., 2006; Tam agno et al., 2005).















F ig u re  1.12. S chem atic o f how cell d ea th  m ay be b ro u g h t on by ox idative 
m echanism s
ROS generation may be central to the mechanism by which neuronal death is caused. Aging causes 
general increases in ROS, whereas genetic and environmental factors increase soluble oligom er load. 
These influences bring about AD plaques and tangles and result cellular dysfunction and cell death.
Ap is able to scavenge free radicals and chelate metal ions, both neuroprotective 
properties (M oreira et al., 2006) yet both may result in altered Ap properties including
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its aggregation state. This effect may be com plex and critically regulated. Low 
concentrations o f  Ap m ay be anti-oxidative, w ith production o f  Ap kept at base levels. 
H ow ever as it detoxifies ROS it becom es itself oxidatively m odified and aggregates, 
identifying senile plaques as com pensatory responses to oxidative stress. Over a 
specific threshold and prom oted by increased A p42:A p40 the Ap is no longer an 
antioxidant, but a pro-oxidant, binding redox metals, generating H 2 O 2 and critically 
up-regulating its own production creating a se lf  propagating feedback loop (Chauhan 
and Chauhan, 2006).
It is suggested that tau and neurofilam ent protein m ay act sim ilarly to scavenge toxic 
aldehydes form ed during m etabolism  hence protecting com ponents o f  the axon. In 
this way, initial A p aggregation and N FT form ing events m ay act to prevent oxidative 
stress yet perm it subsequent neuronal toxicity (M oreira et al., 2006; W ataya et al., 
2002).
1.5. Project aims
This study aim s to investigate the generation o f  H2 O 2  by Ap during its aggregation. 
Our hypothesis was centred on determ ining w hether an early oligom eric form  o f  Ap is 
responsible for generating H2 O 2 (Tabner et al., 2005) and if  this is catalytic in nature. 
To test this several lines o f  investigation were followed:
1. The Ap to be used in this study needed to be o f  optimum  quality. The tendency o f  
AP to aggregate has the consequence o f  form ing pre-aggregated Ap (called 
“seeds”) even within lyophilized peptide stocks. To investigate the early stages o f 
aggregation the peptide needed to be deseeded as far as possible, ideally to a point 
at which only m onom eric Ap remained.
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2. H 2 O 2 generation was assessed during the aggregation process from A(340 and 
Ap42 and from different Ap am ino acid substituted peptides, to draw  conclusions 
on the aggregation associated events that are involved w ith Ap m ediated H 2 O 2  
generation.
3. The aggregation o f  Ap is dynam ic and heterogeneous in nature therefore we could 
not attribute H 2 O 2 generation to any specific sub-species. For this reason we 
attem pted to m ake stably cross-linked oligom ers to test specifically for their H 2 O 2 
generating abilities but to also characterize some o f  their other properties.
4. A  technique was developed to attem pt to capture and im m obilize Ap species to 
determ ine if  Ap prevented from further aggregation could retain its ability to 
generate H 2 O 2 . We aim ed to test different tim e points during the aggregation o f  
Ap to assess their F^C^ generating capacity, but also the ability o f  Ap to degrade 
H 2 0 2.
5. The effect o f  a range o f  redox active m etals im plicated in A p-toxicity  on the 
generation o f  H 2 O 2 during the aggregation o f  Ap was investigated. From this we 
hoped to deduce the metal ions im portant for H 2 O 2 generation and their effects on 
aggregation o f  Ap.
6 . Inhibition o f  aggregation was investigated for its effect on H2 O 2 generation by Ap, 
using a group o f  short peptide inhibitors being developed. These are specifically 
designed to target the early Ap-A p associations that initiate aggregation, therefore 
may inhibit the formation o f  H 2 O 2 by oligom eric Ap.
The intention o f  these objectives was to help to identify and characterise the processes
involved in the early generation o f  H 2 0 2 during the aggregation o f  Ap (Tabner et al.,
2005). This has lead to conclusions on the role o f  A p-m ediated oxidative pathw ays in
the developm ent o f  AD.
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All general reagents were purchased from Sigm a-A ldrich w ith the following 
exceptions. Am m onium  hydroxide (N H 4 OH), diethylene triam ine pentaacetic acid 
(DTPA), m onoclonal 6E10 and biotinylated 6E10 (AbCam), Streptavidin Europium , 
Enhancer solution and DELFIA Europium -labelled Streptavidin (Perkin Elm er, 
Buckingham shire), glacial acetic acid and acetone (AnalaR), ethanol (F isher 
Scientific), glycine (M elford), 30%  acrylam ide/bis 37.5:1 (NBS Biologicals, 
Cam bridgeshire), Instant Blue (AM S B iotechnology Ltd, Oxon), M ark 12 unstained 
protein standards (Invtrogen), m ulticoloured protein m arkers (N EN Life sciences), 10- 
acetyl-3,7-dihydroxyphenoxazine (AD HP) (Cam bridge B ioscience), OR inhibitors 
(Cam bridge Peptides), M ica sheets (A gar Scientific Ltd, Essex). M illiQ  w ater 
(M illipore) was used to make up all buffers.
2.1.2. Peptides
Recom binant Ap was purchased from rPeptide, Georgia. Synthetic Ap peptides and 
short custom  peptides were purchased from  A m erican Peptide C om pany (APC), 
California. Ap42-1 (reverse Ap42) was purchased from California Peptide Research 







The developm ent o f  the preparation protocol o f  deseeding Ap is explained in chapter
3. The optimal m ethod found for deseeding Ap was found in this chapter to be using 
TFA. Nevertheless, its use had been problem atic until late in the research. For this 
reason m any experim ents were carried out using non-TFA  treated Ap, although all 
key experim ents were repeated using TFA -treated Ap.
All Ap peptides were kept frozen at -20°C until prepared for use. Throughout its 
preparation the peptide was kept on ice to prevent any aggregation. Each vial o f  
lyophilised Ap was initially dissolved in 0.01%  N H 4 OH, pFI 10.6, to 0.5 m g/ml. The 
vials were then vortexed for 6  secs every 10 m ins for 1 hr and then sonicated for 4 x 
30 secs or until com pletely dissolved. For non-TFA treated sam ples the solution was 
then aliquoted into appropriate sized portions for the experim ent pending and the 
solvent evaporated o ff by benchtop speedvac. All peptides were subsequently treated 
with 1,1,1,3,3,3-hexafluoroisopropanol (HFIP) by adding the solvent to the peptide at 
0.5mg/m l, vortexed and sonicated for 4 x 30 secs, and the HFIP rem oved by 
evaporation in the speedvac. The peptide was then HFIP treated once again ju st 
before solubilisation into buffer for use.
W here Ap has been TFA treated, during the N H 4 OH treatm ent the vial was split into 
3 - 5  w orking portions into glass vials and the solvent evaporated using a benchtop 
speedvac. TFA with 4.5%  thioanisol was then added to the vials one at a tim e to a 
concentration o f  1 mg/ml, vortexed and sonicated for 30 secs, and then placed under a 
stream o f nitrogen (N 2 ) gas until all the liquid had evaporated. Unless otherw ise
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stated, HFIP was then added to 0.5 m g/ml, vortexed and sonicated for 4 x 30 secs and 
the HFIP rem oved by evaporation in the speedvac.
In all cases 10 mM  phosphate buffer (PB), pH 7.4, was then added to the peptide to 
the required concentration, vortexed and sonicated for 4 x 30 secs or until dissolved 
and ready for aggregation sampling. W ith each batch, especially when TFA used, the 
pH was checked (to be at pH 7.4) using pH test strips. This m ethod for preparation 
was used in all experim ents except where stated otherwise.
W here test substances were added, such as m etal ions, ethylenediam inetetraacetic acid 
(EDTA), ascorbic acid and OR aggregation inhibitors, these were m ade up at the 
appropriate concentration in 10 m M  PB and then used to solubilise the peptide, 
vortexed and sonicated as above.
2.2.2. Determination of Ap concentration
Caution was taken when trying to ascertain Ap concentration. Copper based 
concentration assays were avoided due to the copper binding properties o f  Ap. 
C oncentration was determ ined by UV absorbance. Ap solutions were prepared and 50 
pi added to a UVette (a UV transparent cuvette). This was then placed in a desktop 
UV spec and the absorbance read at A.270 nm with the extinction coefficient o f  1480. 
The extinction coefficient is based on the existence o f  one tyrosine residue in the 
prim ary Ap sequence. Chemical treatm ents and aggregation m ay m odify this residue 
as it is susceptible to oxidation and im plicated in the A p-A p interactions required for 
aggregation. For these reasons, this technique was not used to com pare results where 
different treatm ents have been applied or w here aggregation is believed to have 
proceeded.
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2.2.3. Thioflavin T
Thioflavin T  was dissolved in M illiQ  w ater to a stock concentration o f  1 mM . This 
stock solution was kept w rapped in foil to prevent exposure to light. 100 m M  glycine 
was prepared also in M illiQ  water, and 2.5 M  sodium  hydroxide (NaOH ) added to pH 
8.5. The 100 mM  glycine-N aOH  buffer was then used to m ake up a w orking solution 
o f  15 pM  thioflavin T in 50 m M  glycine-N aO H  buffer. This was kept at 4°C in the 
dark, and used for up to a week. For use, the 15pM thioflavin T was allow ed to come 
to room  tem perature for 30 m ins and then used to prim e the Synergy 2 m ultilabel plate 
reader. A t each tim e point 3 x 5 pi 100 pM  Ap or 10 pi <100 pM  Ap w as aliquoted in 
triplicate into a N unc 96 well black m icrotitre plate. The sam ples were then injected 
with 50 pi 15 pM  thioflavin T, m ixed and read 10 tim es over 2 m ins w ith the 
p latereader at Ex A450nm and Em A482nm (LeVine, 1993). A verage fluorescence 
was calculated over the course o f  the 2  m ins together w ith standards deviations and 
plotted as relative fluorescence units (RFU).
2.2.4. Oligomeric immunoassay
Ap sam ples were diluted 1:125 in assay buffer, 0.5%  y-globulin, 0.05%  Tween 20, 50 
mM tris-HCl, 150 mM  NaCl, pH 7.6, vortexed and frozen at -80°C until use. C lear 96 
well M axisorb microtitre plates were coated with 100 pi, 1 pg/m l m onoclonal 
antibody (m Ab) 6E10 in 10 mM phosphate buffered saline (PBS), covered w ith a 
plate seal and left at 4°C overnight. Plates were then blocked w ith 150 pi assay buffer 
with 1% gelatine from fish skin added to a final concentration o f  0.022% . This was 
then incubated for 1 hr at 37°C and then washed with 4 x 300 pi PBS Tween (PBST) 
using a platewasher. Excess liquid was tapped out o f  the plate and 100 pi o f  the 
peptide samples aliquoted into the wells in quadruplicate. The plate w as then
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incubated for 1 hr at 37°C and subsequently washed w ith 4 x 300 pi PBST. Excess 
liquid was once again tapped out o f  the plate and 100 pi biotinylated m Ab 6E10 in 
assay buffer was added to the wells at a concentration o f  1 pg/ml. Follow ing a further 
incubation for 1 hr at 37°C and 4 x 300pl PBST wash, lOOpl 1:500 dilution o f  
Europium -labelled streptavidin in 0.05%  y-globulin, 0.5% bovine serum  album in 
(BSA), 20pM  DTPA, 10 m M  tris, 150 m M  NaCl, pH  7.4, was added to each well. 
This was then shaken for 10 mins on a V ictor 2 plate reader, covered in foil and 
placed on a rocking table for a further 50 mins. Enhancer solution was allow ed to 
com e to room  tem perature, and after washing w ith 4 x 300 pi PBST, 100 pi o f  
Enhancer was added to each well. Plates w ere shaken again for 10 m ins and then read 
using the V ictor 2 m icroplate reader using the tim e-resolved D ELFIA  system. 
Averages and standard deviations were plotted in relative fluorescence units (RFU).
2.2.5. Amplex red
A stock solution o f  10 mM  AD HP (A m plex red) in dimethyl sulphoxide (DM SO) was 
aliquoted into 50 pi portions. Each aliquot had 10 secs o f  N 2 (g) introduced into it and 
then frozen in N 2 (i) and stored at -80°C. 1 KU/ml stock solution o f  horseradish
peroxidase (HRP) in 10 mM PB, pH 7.4, was prepared and aliquoted into 15 pi 
portions. 1 0  secs o f  N 2(g) was introduced into the aliquots and then they were frozen 
in N 2 (i) and stored at -80°C. The HRP was then diluted to 10 U/ml and split into 100 
pi aliquots w hich can then be used to make up the Am plex red w orking solution. 5 
mis A m plex red w orking solution was made for each experim ent using 50 pi 10 mM  
Am plex red stock solution and 100 pi 10 U/ml HRP in 10 m M  PB. The resultant 
working solution was 100 pM  Am plex red, 200 m M /ml HRP. For fluorescence 
m easurem ents, 15 pi o f  the test solution or H 2 O 2  concentration (for concentration
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curve) was pipetted in triplicate into the w ells o f  a N unc 384 w ell black plate. 15 pi 
Am plex red w orking solution was then added to  each w ell and the plate shaken and 
fluorescence read on the V ictor 2 m icroplate reader at Ex A,563nm and Em  A,587nm 
(Zhou et al., 1997). Averages and standard deviations were converted to 
concentration o f H 2 O 2 and plotted.
2.2.6. Atomic force microscopy
2pl 25 pM  Ap in 10 mM  PB was diluted by either 1:10 or 1:100 in M illiQ  w ater was 
pipetted onto a piece o f  cleaved mica. This was allow ed to dry and then im aged using 
a Digital instrum ents m ultim ode Scanning Probe M icroscope (SPM ) using tapping 
m ode w ith an AppNano ACT, alum inium  (reflex) coated probe w ith spring constant 
o f  40 N /m  (nanoScience Instrum ents Inc). At least 3 x 1 0  pm im age scans o f  each 
sam ple were perform ed followed by 5, 2 and 1 pm scans.
2.2.7. Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE)
Tris-glycine buffered SDS-PAGE gels were m ade using Biorad M ini gel kit, using 
glass plates separated by 0.75 mm spacers. Gels were m ade using a tw o layered 
system with a resolving gel for protein separation and then a stacking gel. The 
percentage gel required was obtained by altering the am ount o f  acrylam ide in the 
resolving gel recipe. Table 1.1 shows the recipe for 2 x 16.5% gels.
The resolving gel was pipetted between the cleaned glass plates to ~15 m m  below  the 
top o f  the glass. 2  drops o f  butanol were then pipetted onto the top o f  the resolving 
gel and the gel given time to polym erise. The butanol w as then washed out from 
between the plates with M illiQ water, the stacking gel poured on top and a com b
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inserted to create wells. Gels were given further tim e for polym erisation, then either 
used or w rapped in saran w rap and kept at 4°C until their use, w ithin 24 hrs.
Solution 16.5% Resolving gel (mis) Stacking gel (mis)
MilliQ water 1.8 5.6
1.5M Tris-HCl, pH 8.8 2.5 -
0.5M Tris-HCl, pH 6.8 - 2.5
30% Acrylamide/Bis mix 5.5 1.7





Figure 2.1. Recipes for resolving and stacking gel to make 16.5% SDS tris- 
glycine gels.
Ingredients added in the order shown.
Sam ples for gel electrophoresis had equi-volum e SDS Sam ple buffer (0.125 M  Tris- 
HC1, pH 6 .8 , 2%  SDS, 10% glycerol, 0.01%  brom ophenol blue, 0.1 M  dithiothreitol 
(DTT)) added to them , and then heated to 98°C for 3 mins. Samples along w ith either 
M ark 12 unstained protein m arkers or m ulticoloured protein m arkers were loaded into 
the wells o f  the gel and then electrophoresed at a constant voltage o f  180 V, for 60 
mins, in Tris-glycine running buffer (25 mM  tris, 0.192 M glycine, 1% SDS).
2.2.8. Instant Blue
Following electrophoresis o f  gels they were put into Instant Blue protein stain 
overnight on a rocking table. The stain was then rem oved and replaced w ith M illiQ  
w ater to destain.
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2.2.9. Ap detection by western blot
Blotting was perform ed using a sem i-dry blotting system. For each blot to be 
perform ed 1 piece o f  0.45 pm Im m obilon-p polyvinylidene fluoride (PVDF) paper 
was soaked for 30 secs in m ethanol. The nitrocellulose and 6  pieces o f  blotting paper 
were then soaked in sem i-dry blotting buffer for at least 30 m ins. Once the gel has 
finished running, 3 x pre-soaked blotting papers were layered in the blotting tank, 
following by the nitrocellulose, then the gel, and lastly 3 m ore pre-soaked blotting 
papers. The stack was then rolled to elim inate air bubbles and the lid to the tank put 
on with extra w eight applied to the top. The blots were run at constant am ps o f  0.06 
am ps per blot for 2  hrs.
Once run, the blots were either put straight into block (2%  dried m ilk powder, 10 m M  
PBST) for 1 hr, or dried to be stained later. If  the blot was dried, the blot went into 
100% methanol for 30 secs, M illiQ water for 2 mins, then 10 mM  PBS for 1 min, 
prior to going into the blocking solution. Subsequently the blots were incubated with 
1:10000 dilution o f  mAb 6E10 in blocking solution for 90 mins, w ashed w ith PBST 
for 4 x 5 mins, then incubated with 1:10000 dilution o f  polyclonal anti-m ouse-H RP in 
block for 90 mins. Finally, the blots were washed w ith PBST for 4 x 5 m inutes and 
left in PBST for developing the blot by ECL Kit to visualise the bands.
2.2.10. Photo-induced cross-linking of unmodified proteins (PICUP)
18 pi 25 pM  Ap or control peptide samples were used for PICUP reactions w hich 
were perform ed com pletely in the dark. To the peptide sam ple, 1 pi 20 mM  APS was 
added, followed by 1 pi 1 mM  tris(2 ,2’-bipyridyl) dichlororuthenium (II). This 
m ixture was mixed briefly and placed in the cross-linking apparatus. This utilised the 
tim ed shutter from a cam era to perm it source o f  light to pass to the sample for a
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controlled length o f  time, during w hich the light dependent reaction could take place. 
The sam ples were exposed to light for the required length o f  tim e (betw een 0-1 secs). 
F inally 10 pi 10% p-m ercaptoethanol in 10 m M  PB was added to each sam ple to 
quench the cross-linking reaction (Bitan et al., 2003a). 30 pi SDS gel loading buffer 
was then added to each sample ready for gel electrophoresis.
2.2.11. Formation of SDS-stable oligomers
N on-PICU P cross-linking o f  Ap was investigated using H 2 O 2 and HRP, and, H 2 O2  
w ith CuCl2. 30 pi reaction m ixtures were m ade up o f  25 pM  Ap with 100 pM , 10 pM  
or 1 pM  H 2 O 2 and either HRP (100, 10 or 1 U/ml) or Q 1CI2 (1.33, 0.133 or 0.013 
mM ). The reaction m ixtures were m ixed and incubated at 37°C for 1 hr or 24 hrs. 
Samples had 30 pi SDS gel loading buffer added to them  following the incubation 
tim e to quench the reaction and prepare them  for gel electrophoresis. W hen being 
m ade for im m obilisation experim ents, reaction m ixtures were kept at the same 
concentrations but volum es were increased according to the im m obilisation procedure 
requirem ents. SDS gel loading buffer was not added follow ing the cross-linking 
incubation but instead mAb 6E10 was added as set out in im m obilisation protocol.
2.2.12. Development of immobilisation of Ap to assess H2O2 generation
This protocol was developed over the course o f  experim ents and is still being 
finalised. In early experim ents 25 or 50 pM  Ap was aggregated over a range o f  tim e 
periods in 10 m M  PB, pH 7.4 at 37°C. Sam ples o f  the Ap solution were taken for 
thioflavin T, im munoassay and Am plex red in addition to 50-100 pi sam ple which 
was then incubated at 37°C for 60 mins on a surface pre-coated with mAb 6E10 (test 
surfaces included a range o f  microtitre plates, nitrocellulose m em brane, dynabeads
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and 0.6 ml Greiner PCR tubes). The surface was then w ashed 3 tim es w ith 10 m M  PB 
and then 10 mM  PB added to the im m obilised Ap and incubated for 24 or 48 hrs at 
37°C. The buffer was then assessed for its H 2 O 2  concentration by A m plex red.
The m ost recent protocol does not use a surface for the im m obilisation o f  Ap samples 
but instead uses ultracentrifugation o f  the 6E10-bound Ap. R ecovery o f  the antibody 
was tested using a range o f  biotinylated 6E10 dilutions m ade in 10 m M  PB. These 
were then centrifuged for 1 or 2 hrs at 16,110 x g and also for 1 hr in the airfuge at 
approx. 136,000 x g. 3 x 100 pi sam ples were taken before and after centrifuge steps 
and coated onto a clear 96 well M axisorb m icrotitre plate. The level o f  antibody 
present in the sam ple was then detected using streptavidin-Europium  detection used 
for the oligom eric immunoassay.
When testing Ap sam ples 25 or 50 pM  Ap42 was aggregated in 10 mM  PB at 37°C 
for various lengths o f  tim e to test different aggregation time points. Sam ples were 
taken for thioflavin T, im munoassay and Am plex red fluorescence determ ination. To 
the rem aining Ap solution, the mAb 6E10 was then added to a final concentration o f 
1-4 pg/m l and incubated for 2 hrs at 37°C to allow  antibody binding. This was then 
placed in the airfuge and spun at approx 136,000 x g for 90-180 mins. Thioflavin T 
and im munoassay sam ples were taken from the supernatant and from control PB 
sam ples. Following immobilisation on mAb 6E10, ultra-centrifugation and 
supernatant removal, each tube had either 100 pi 10 mM  PB added or 1 pM  H 2 O 2 and 
were gently mixed. Thioflavin T sam ples were taken to gauge recovery o f  Ap. The 
immobilised Ap samples were then incubated at 37°C for 48 hrs and then placed in the 
airfuge for a further 90-180 mins. The supernatant from each sam ple was then tested 
for its H 2 O 2 concentration using the Am plex red assay.
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W here cross-linked sam ples were tested, the H RP/H 2 O 2 cross-linking procedure was 
followed, except using scaled up volum es o f  each reagent to have a reaction mixture 
o f  total volum e 180 pi. 75 pM  o f each Ap peptide was prepared in 10 m M  PB and 
split into 2 samples, 1 to be cross-linked, the other as a non-cross-linked control. To 
the cross-linked sam ple HRP and H 2 O 2 was added to the Ap to final concentrations o f 
100 U/ml, 100 pM  and 25 pM  respectively in 10 mM  PB. To the non cross-linked 
sam ples 10 mM  PB was added to the peptide to bring it to 25 pM . All sam ples were 
incubated at 37°C for 1 hr at w hich point sam ples were taken for thioflavin T and 
A m plex red fluorescence determ ination. 6E10 was then added at 10 pg/m l and 
incubated for a further 2 hrs at 37°C and then placed in the airfuge for 2 hrs at approx 
136,000 x g. Supernatants were rem oved and tested for their fluorescence in the 
thioflavin T  and A m plex red assays. 100 pi lOmM PB was added to each 
im m obilised sample and gently mixed. These were then incubated at 37°C for 24 hrs, 
placed in the airfuge for 2 hrs at approx. 136,000 x g. The supernatants were rem oved 
and tested for their H 2 O 2 concentration using the Am plex red fluorescence assay.
2.2.13. Statistical Analyses
For the large m ajority o f  the data produced m ultiple com parisons were required. For 
these, ANOVAs were perform ed followed by planned pairw ise com parisons o f  m eans 
using Tukey HSD. The ANOVA reports a p value (Prob > F) w hich reports w hether 
or not at least one pair o f  means is statistically different. However, it does not report 
which groups differ from each other. The Tukey HSD is essentially a t-test that 
corrects for experim ent-wide error rate when there are m ultiple com parisons. 
Pearson’s correlation coefficients have also been used when appropriate.
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Increasing evidence implicates the early soluble oligom ers o f  Ap to be the prim ary 
toxic species causing AD (Chrom y et al., 2003; Kayed et al., 2003; K im  et al., 2003; 
W alsh et al., 1999). For this reason, studies o f  the early aggregation and toxicity o f  
p-amyloid are critically dependant on the starting m aterial o f  the peptide being tested. 
Yet, the inherent predisposition o f  Ap for tim e-dependent aggregation in aqueous 
solution plagues its investigation (Teplow, 1998). This fact has led to m anufacturers 
o f  synthetic and recom binant Ap using a range o f  solvents and processes to prevent its 
aggregation during production, some more successful than others. As a consequence 
there is m uch variability in the peptide state received from different com panies. This 
can be com pounded with lot-to-lot variability from the same com pany (M ay et al., 
1992). M ost, if  not all, com m ercially available peptides contain some proportion o f  
pre-aggregated material that “seeds” the aggregation process, especially w here AP42 
is concerned. There are many published “deseeding” techniques using a range o f 
solvents designed to disaggregate the peptide to create a m onom eric starting m aterial, 
such as using DM SO, HFIP (Dahlgren et al., 2002; W alsh et al., 1999), N aO H  and 
NH 4 OH (for high pH) (Fezoui et al., 2000), TFA (Arim on et al., 2005; Jao et al., 
1997; Zagorski et al., 1999), in com bination with sonication and filtering (H uang et 
al., 1997). Each claims to be the optimal m ethod to produce seed-free Ap.
For our investigations into H 2 O 2 generation, a process believed to occur at the very 
early stages o f  aggregation (Tabner et al., 2005), it was vital for us to have a
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consistent and highly deseeded starting m aterial. For this reason, detailed 
investigation into where to source our peptide, its production m ethod, solvent use and 
pre-experim ent deseeding techniques w ere perform ed. For this we prim arily utilised 3 
techniques to ascertain the level o f  pre-aggregated m aterial in the samples: thioflavin 
T, oligom eric im m unoassay and AFM.
3.1.1. Thioflavin T
Thioflavin T is a fluorescent dye com m only used to m onitor aggregation o f  
am yloidogenic proteins. Aggregation is accom panied by an increase in the P-sheet 
content o f  the protein. W hen thioflavin T  binds to p-sheet, its structure changes, 
shifting its excitation and em ission wavelengths from  Ex A3 85nm EmA445nm to 
ExA450nm and EmA482nm. This m eans that it can be used as a m easure o f  the 
aggregation state o f  the peptide (LeVine, 1993, 1999).
Figure 3.1. The structure of thioflavin T 
3.1.2. Oligomeric immunoassay
The monoclonal antibody 6E10 binds specifically to the first 17 residues o f  the Ap 
peptide. Each Ap subunit can only bind one o f  these antibodies therefore, when the 
same antibody is used for capture and detection, only aggregated Ap should be 
detected. A lthough this can give no inform ation on the size o f  the aggregates, a 
negative signal can signify a m onom eric preparation o f  Ap as no detection antibody 
can bind to a captured monomer. Also notable is that once Ap has aggregated fully to
Cl c h 3
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m ature fibrils, the im m unoassay signal, although still raised in com parison to control 
sam ples, is reduced com pared to m axim um  fluorescence. This is presum ably due to 
detection antibody binding sites being obscured due to the quaternary structure o f  the 
fibrils, or, due to them  being w ashed o ff  the capture antibody because o f  their size.
3.1.3. Atomic force microscopy
AFM  has some m ajor advantages over other m ethods o f  im aging Ap aggregates. 
Sam ples do not need to be conductive or sem i-conductive as needed w ith STM. 
Sam ple preparation is very simple in com parison to Electron M icroscopy, EM , and by 
using interm ittent contact m ode, or tapping mode, the soft biological sam ples can be 
im aged in a more natural state. It works via a cantilever tapping across the surface o f  
the sample w ith a laser focused on the back o f  the tip  reflecting o ff  the tip and into a 
photodetector. This m easures the position o f  the beam, and the com puter program  can 
interpret this data. Because the beam is tapping over the surface, this form  o f  A FM  
can image, not only the topography o f  the surface, but also the interaction o f  the tip 
with the sample. This is called the phase and effectively gives a m easure o f  the 
“elasticity” o f  the sample on the surface.
Position
Detector
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3.2.1. Selection of recombinant peptide
Prelim inary studies had identified that in general recom binantly m ade Ap contained 
less seeds than synthetically m ade, although all key experim ents were also perform ed 
with a synthetically produced Ap to corroborate results. In addition, rPeptide had 
been identified as the m ost consistent producer o f  recom binant Ap. They provided a 
choice o f  4 solvents for the peptide to be prepared in: HFIP, N aO H  and the acids HC1 
and TFA (referred to as rAp42-HFIP, rA p42-N aO H , rAp42-HCl and rA p42-TFA  
respectively). W e initially com pared these 4 pre-treatm ents for their Ap42 seed 
content and subsequent aggregation properties by thioflavin T  and oligom eric 
im m unoassay (figure 3.3).
W here the peptide had been prepared in the acids, rAp42-HCl and rAp42-TFA , no 
significant increases in thioflavin T fluorescence w ere observed upon incubation at 
100 pM , in 10 mM  PBS at 37°C over 72 hrs. The high thioflavin T  fluorescence 
throughout the 72 hr incubation suggests that the sam ples were already highly 
aggregated. Sim ilarly, the im munoassay results indicated these peptides were highly 
aggregated at T=0. In fact Pearon’s correlation coefficients were significantly 
negatively correlated (HC1: r = -0.601, TFA: r = -0.802, p < 0.002, n = 24) im plying 
the samples contained a high proportion o f m ature fibrils upon w etting the peptide.
The rAp42-NaOH sample at 100 pM  started at approxim ately h a lf the starting 
thioflavin T fluorescence o f  the HC1 and TFA treated sam ples and this fluorescence 
showed significant increases over the course o f  the 72 hrs (r = +0.800, p < 0.000, n = 
18). The im munoassay started at a higher fluorescence than the HC1 and TFA treated 
samples, but, as w ith the TFA treated sample, this decreased over tim e (r = -0.89, p <
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0.000, n = 24). A lthough this sample appeared to start in a less aggregated state than 
the HC1 and TFA treated samples, it was still largely aggregated upon wetting.
The rA(342-HFIP sam ple started lowest in its thioflavin T fluorescence and this 
increased steadily over the 72 hr period (r =  +0.864, p < 0.000). In addition, the 
im m unoassay showed increasing fluorescence over the first 24 hrs, at which it 
plateaued then started to drop. This indicated that this was the best peptide for further 
study. However, the im munoassay clearly showed that this peptide contained 
aggregates upon wetting and therefore still required deseeding for investigation into 
the early aggregation process.
T h ioflav in  T
HC1 TFA NaOH
AP42 pre-treatment

























F ig u re  3.3. A ggregation  o f Ap42 m easu red  by th ioflav in  T  an d  o ligom eric 
im m unoassay
Recombinant AP42 prepared by the manufacturer with HC1, TFA, N aOH  or HFIP, were dissolved in 
0.001%  NHjOH, pH 10.04 and buffered to pH 7.4 by addition o f  5 x PBS to a final concentration o f  
100 pM AP42 in 10 mM PBS. Samples were aggregated at 37°C over 72 hrs with samples being taken 
for thioflavin T (A) and oligomeric immunoassay (B) at given tim e intervals. Results are means ± S.D. 
(Thioflavin T: n=3, Immunoassay: n=4)
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3.2.2. T he  effect o f bu fferin g  o u t N H 4O H  on agg reg atio n
Using N H 4 OH or NaOH at a pH greater than 10 is thought to prevent aggregation and 
also assist in initial solubilisation o f  the Ap (G uilloreau et al., 2007; Streltsov et al., 
2008). The peptide should not aggregate prior to buffering the solution down to pH 
7.4. This was tested using N H 4 OH (see figure 3.4). The treatm ent m ade no difference 
to either the starting thioflavin T fluorescence or the aggregation properties o f  both 
100 pM Ap40 and Ap42. The im m unoassay indicated that Ap40 was near m onom eric 
upon solubilisation (data not shown) but Ap42 required effective deseeding. 
A lthough this process did not aid any deseeding o f  Ap42, it did show that N H 4 OH 
treatm ent did not have a detrim ental effect on the peptide and its aggregation. This 
identified it as a useful solvent for pre-experim ental m anipulation o f  the peptides, as 
















Time point - hrs
6 24 48
Time point - hrs
. - 1 i'
72
72
1 AP40 No 
N H 4 0 H  
AP40 
N H 40H  
1 PBS No 
N H 40H  
PBS 
N H 40H
1 Ap42 No 
N H 40H  
Ap42 
N H 40H  
1 PBS No 
N H 40H  
PBS 
N H 40H
F ig u re  3.4. T he effect o f b u ffering  ou t NH4OH on aggreg atio n  o f A p40 an d  Ap42
100 pM AP40 and AP42 prepared by either dissolving straight into 10 mM PBS, or, solubilising into 
0.01%  NH4OH, pH 10.6, first and then buffering this out to a final concentration o f  10 mM PBS, pH 
7.4. Thioflavin T fluorescence was then assessed over 72 hrs (A = AP40, B = AP42). Results are means 
± S .D .(n=3)
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3.2.3. T h e  effect o f N H 4 O H  as a deseeding tre a tm e n t
In 3.2.2. the Ap was only in the N H 4OH for enough tim e to solubilise the peptide and 
then buffered out. We also tested if  incubating the peptide in NH 4 OH for longer time 
periods followed by removal o f  the solvent was able to deseed AP42. This was 
unsuccessful as both im m unoassay and thioflavin T data showed no decrease in 
fluorescence with increased incubation time (see figure 3.5). In fact, there appeared to 
be a small increase in the fluorescence o f  50 pM  Ap42 over tim e, indicating the 
NH 4 OH m ay not fully prevent the propensity o f  AP42 to aggregate. For these reasons 
NH 4 OH treatm ent was not used to deseed Ap42 and was only used for short time 
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F ig u re  3.5. T he  effect o f p ro longed  NH4OH trea tm e n t.
Ap42 was solubilised in 0.01%  N H 4OH, pH 10.6, and incubated at 4°C for 6, 24 and 48 hrs. The 
solvent was then evaporated o ff  in a centrifugal concentrator. The samples were then dissolved into 10 
mM PB to a final peptide concentration o f  50 pM and then were assessed by thioflavin T and 
immunoassay. Results are means ± S.D. (Thioflavin T: n=3, Immunoassay: n=4)
3.2.4. T he  effect o f H F IP  tre a tm e n t an d  sonication
HFIP treatm ent is com m on am ong Ap preparation techniques as it is believed to aid
solubility into the aggregation buffer. Some groups even claim that this treatm ent
removes all Ap42 seeds from the sample creating a m onom eric solution (Shelat et al.,
2008). Sonication, likewise, is believed to be needed to not only lift the peptide into
solution, but also aid deseeding o f the peptide (Evans et al., 1995; Huang et al., 1997).
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We found HFIP treatm ent to be useful for reducing the initial fluorescence from the 
recom binant Ap42 solubilised at 25 pM  in 10 mM  PB, in both thioflavin T and the 
im munoassay (see figure 3.6.). However, it was clear from the im m unoassay results, 
that even with the HFIP treatm ent the fluorescence was above the fluorescence from 
PB, indicating a fully deseeded peptide had not been obtained.
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F ig u re  3.6. T he effect o f H F IP  and  son ication  on deseeding.
Ap42 was split in 0.01% N H 4OH, pH 10.6, incubated at 4°C for 30 mins. Samples were then prepared 
with and without sonication in the NH4OH, with and without HFIP treatment and with and w ithout 
sonication in the 10 mM PB. Ap42 was prepared at 25 pM in the 10 mM PB and assessed by thioflavin 
T (A) and Immunoassay (B). Results are means ± S.D. (Thioflavin T: n=3, Immunoassay: n=4)
Sonication was performed at both the NH 4OH and solubilisation into the PB steps. 
Where HFIP treatm ent was not performed, sonication appeared to have limited 
effectiveness. However, where the HFIP treatm ent was perform ed both sonications
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appeared to be useful in reducing thioflavin T fluorescence yet only the sonication in 
PB showed a sm all decrease in the oligom eric im m unoassay fluorescence. This 
identified both HFIP treatm ent and sonication as useful deseeding techniques. 
N evertheless further deseeding o f  A042 w ould be preferable for investigation o f  early 
Ap oligom erisation.
3.2.5. The effect of NaOH as a deseeding treatment
We also investigated N aO H  treatm ent follow ed by buffering out the high pH  w ith 10 
m M  PB to see if  this was more advantageous than NH 4 O H  treatm ent. Follow ing the 
m ethod in Smith et al (2006) with a few changes, this was tried w ith both the 
recom binant Ap42 and also synthetically m ade Ap42 (Sm ith et al., 2006).
The solubilisation o f  Ap42 in 2mM  NaOH, pH 11.3, at 1 mg/ml prior to buffering 
with PB appeared to have no beneficial effect on the starting m aterial o f  the peptide 
(see Figure 3.7). In fact, the NaOH treatm ent increased the starting fluorescence o f  
both the recom binant and synthetic peptide when buffered down to pH 7.4 w ith 10 
mM  PB to a final concentration o f  50 pM  Ap. Treating the peptide for longer (2 hrs) 
am plified this effect. Centrifuging the sam ples and taking the supernatant did rescue 
the peptides som ewhat, with a small reduction in fluorescence observed in both cases. 
However, it was clear that NaOH treatm ent did not improve the starting m aterial o f  
the peptide from the double HFIP treated samples. In fact, when these sam ples were 
allow ed to aggregate over 24 hrs, the NaOH treatm ent had detrim ental effects on their 
aggregation properties. The NaOH treated recom binant peptide showed reduced 
aggregation related fluorescence and the synthetic N aO H  Ap42 did not appear to show 
any aggregation related fluorescence increases (data not shown).
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F ig u re  3.7. T he  effect o f N aO H  on deseeding.
Recombinant and synthetic AP42 was split in 0.01%  N H 4OH, pH 10.6, followed by 2 x HFIP 
treatm ents. To appropriate tubes, 2mM  NaOH, pH 11.3 was added to the Ap42 at 1 mg/ml, vortexed 
and sonicated with or without 2 hour incubation at 4°C, with or w ithout centrifugation for 10 mins at 
16,110 x g. The NaOH treated samples and supernatants were then buffered out with 10 mM PB to a 
final AP42 concentration o f  50 pM and oligom eric content assessed by immunoassay. Results are 
means ± S.D. (n=4)
3.2.7. F ilte rin g
Filtering appears to be a logical strategy for rem oving the larger seeds o f Ap from the 
solution. This technique is em ployed by several research groups (Balcells et al., 2008; 
Evans et al., 1995; Huang et al., 1997). We initially investigated the deseeding ability 
o f  lOkDa and 30kDa m olecular weight cut o ff filters (Vivaspin) as, in theory, they 
should filter out anything larger than dimers and hexam ers respectively.
Filtering was perform ed following HFIP treatm ent o f  the peptides, at 50 pM  Ap in 10 
mM PB. As Ap40 appears to contain less seeds than Ap42 upon solubilisation, it was 
hypothesised that the filters would remove a larger proportion o f  the peptide from the 
Ap42 than the AP40 sample. This was not the case as the filters removed a sim ilar 
and substantial quantity o f  peptide from both samples (see Figure 3.8.A) alluding to 
the idea that the “stickiness” o f Ap was going to cause a large loss o f  protein on the 
filter. The immunoassay results from 50 pM Ap40 were as expected, with the sample 
prior to filtering giving a fluorescence only m arginally raised com pared to PB
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controls. The filtering process brought the fluorescence even closer to PB (101%  ± 
5% o f  PB fluorescence). Even with the concentration increased 5 fold the 
im m unoassay fluorescence did not increase, im plying the Ap40 was largely 
m onom eric (data not shown). The A(342 results showed filtering the sam ple brought 
about a huge reduction in fluorescence in the im munoassay, from nearly 20 x the PB 
fluorescence to less than 2 x the PB fluorescence. Increasing the concentration 5 fold 
caused a m inor increase in the fluorescence (data not shown) indicating a large 
proportion o f  the oligomeric content had been removed by the filtering process, 
although it was not as close to m onom eric as the filtered A p40 sample.
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F ig u re  3.8. F ilte rin g  Ap40 an d  Ap42 in lO m M  PB
HFIP treated Ap40 and Ap42 was solubilised into 10 mM PB to a concentration o f  50 pM, and samples 
vortexed and sonicated. These were then assessed for protein concentration by UV absorption at 
270nm (extinction coefficient = 1490) and samples taken for immunoassay. The rest o f  the Ap was put 
through either a 10 or 30 kDa MWCO filter by centrifugation for 30 mins at 4000g at 4°C. The filtrate 
was then also assessed for its protein concentration (A) and by immunoassay (B). Results are means ± 
S.D. (Concentration: n=3, Immunoassay: n=4)
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Filtering the peptides w ith these filters did aid the deseeding o f  A|342 yet w ith the cost 
o f  a huge loss o f  protein content on the filter. This large loss o f  peptide was 
considered an unacceptable cost. Furtherm ore, subsequent investigations w ith filters 
identified an incom patibility w ith the A m plex red assay (which w ould be used for 
assessing H 2 O 2 generation by Ap), as the filters are coated w ith glycerol. W hen PB 
was assessed by Am plex red before and after filtering through these filters the 
fluorescence generated was substantially increased in the filtered sample. W e believe 
this was due to a small am ount o f  this glycerol, a known incom patible substance in the 
Am plex red, w ashing o ff  the filter into the sam ple producing a false positive result for 
H 2 O 2 generation. Subsequent experim ents to rem ove this glycerol were lim ited in 
their success hence filtering was discounted as a deseeding m ethod for our purposes.
3.2.8. Airfuge
Another, non-chem ical strategy for rem oving larger Ap42 seeds was via 
sedim entation by centrifugation. Here an airfuge was used to spin the sam ples at 
-136 ,000  x g for increasing tim e periods and sam ples taken to assess protein 
concentration and oligomeric immunoassay. The results obtained showed that the 
airfuge was not going to be useful for deseeding 50 pM  Ap42 in 10 mM  PB (see 
figure 3.9). Increasing length o f  time in the airfuge reduced the protein concentration 
o f  the sam ple, indicating sedim entation o f  the peptide had occurred. However, the 
oligom eric im munoassay showed that over this time there was in an increase in 
fluorescence, signifying an increase in oligomeric content. As the sam ple could not 
be chilled in the airfuge, this increase may be due to the norm al aggregation that 
would happen over this time period at this tem perature. However, aggregation o f  
Af342 at this concentration and tem perature indicated that the aggregation observed
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was much more than would be expected within this tim e period. The centrifugal 
forces may be concentrating the peptide tow ards the bottom o f  the sam ple, driving a 
small am ount o f  aggregation o f  the peptide, rather than simply sedim enting larger 
aggregates. N evertheless, the process did not aid deseeding o f  A(342 and therefore all 
centrifugal steps were avoided once the peptide was solubilised into PB.
A. C o n cen tra tio n
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F ig u re  3.9. T he effect of cen trifu g a l sed im en tation  o f the  sam ple
HFIP treated A042 was solubilised at 50 pM in 10 mM PB, vortexed and sonicated, and the initial 
protein concentration and immunoassay samples taken. The A(342 was then spun in the airfuge for up 
to 90 minutes at 87,000 rpm (approx. 136,000 x g), with sam ples taken for immunoassay and assessing 
protein concentration every 15 mins. Protein concentration expressed as a percentage o f  the initial 
protein concentration (A). Immunoassay expressed by the ratio o f  the sample fluorescence to PB 
fluorescence (B). Results are means ± S.D. (Concentration: n=3, Immunoassay: n=4)
3.2.9. T F A  tre a tm e n t o f Ap42
The treatm ent o f  Ap with TFA has been considered a deseeding technique by several 
groups as its low pH prom otes the random coil conform ation o f  Ap encouraging 
disaggregation (Arimon et al., 2005; Jao et al., 1997; Zagorski et al., 1999).
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Treatm ent o f  the peptide with neat TFA (Jao et al., 1997) was infrequently successful, 
quite often appearing to com pletely denature the peptide, rendering it aggregation 
incom petent. We believe this to be at least partially due to oxidation o f  the 
m ethionine residue (M et35) w hich has been shown to reduce fibrillisation rate 
(Butterfield and Bush, 2004). M anzoni et al reported that the addition o f  4.5% 
thioanisol to the TFA prevents this oxidation, perm itting efficient deseeding o f  the Ap 
w hilst protecting the peptide from denaturation (M anzoni et al., 2009). This was 
tested in along with centrifugation and subsequent HFIP treatm ent (See figure 3.10).
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F ig u re  3.10. T he effect o f T F A  tre a tm e n t on Ap
NH4OH treated AP40 and Ap42 were subsequently treated with TFA, 4.5%  thioanisol, vortexed and 
sonicated for 30 secs. H alf the samples were then centrifuged for 15 minutes at 16110 x g and then all 
samples dried under N 2(g). One centrifuged and one non-centrifuged tube from each set o f  samples 
were then HFIP treated 2 times as described earlier. All samples were then solubilised in 10 mM PB, 
pH 7.4, to a final concentration o f  25 pM, vortexed and sonicated for 4 x 30 secs. Sam ples were then 
analysed for thioflavin T (A) and Oligom eric immunoassay (B) starting fluorescence. Results are means 
± S.D. (Thioflavin T: n=3, Immunoassay: n=4)
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The thioflavin T and oligom eric im m unoassay data supported this claim bringing the 
fluorescence o f  25 pM A(342 in both assays right back to PB levels, indicating an 
alm ost m onom eric solution in the oligom eric immunoassay. This was observed in 
both the centrifuged and non-centrifuged sam ples showing the centrifugation did not 
provide any additional deseeding to the samples. In the Ap40 sam ples the TFA 
treatm ent retained more thioflavin T fluorescence than the Ap42 indicating the P-sheet 
content was affected less than the Ap42, yet it also appeared to be m onom eric from 
the im munoassay. Deseeding o f the AP42 sam ple was confirm ed by AFM , where 




F ig u re  3.11. A FM  of T F A  deseeded A(342
TFA deseeded Ap42 was solubilised at 25 pM into 10 mM PB, pH 7.4, vortexed and sonicated, then 
diluted 10 fold into MilliQ water. 2 pi was then dotted onto cleaved mica and imaged using a Digital 
Instruments SPM in tapping mode. Left-hand image is height, right-hand image is phase contrast. 
Images are AP42 (A and C) and PB control (B). Bar represents 2pm in A and B, and 200 nm in C.
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Subsequent treatm ent o f  the samples with HFIP provided no additional deseeding and 
actually increased the fluorescence observed from all samples in both assays. Thus 
we can conclude that although HFIP aids deseeding o f  more aggregated sam ples, it 
som ewhat permits early aggregation, perhaps prom oting certain oligom eric species. 
Unfortunately, due to the preparation requirem ents o f  using TFA, one HFIP treatm ent 
had to be incorporated into the final deseeding strategy to perm it transfer from the 
glass vials used for the TFA to the 0.6 ml PCR tubes used for solubilising the peptide.
O f im portance here is the ability o f  the TFA treated peptides to subsequently 
aggregate. The addition o f  4.5%  thioanisol during the TFA deseeding appeared to 
protect the peptides from TFA-m ediated oxidation o f  M et35; subsequent sam pling at 
later time points showed increased thioflavin T and im m unoassay fluorescence, 
indicating aggregation had occurred (this can be seen in Chapter 4).
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F ig u re  3.12. T he  effect o f T F A  tre a tm e n t on Ap pep tides
NH4OH treated Ap peptides were subsequently treated with TFA, 4.5%  thioanisol, vortexed and 
sonicated for 30 secs. Non TFA treated and TFA treated samples were then solubilised in 10 mM PB, 
pH 7.4, to a final concentration o f  25 pM, vortexed and sonicated for 4 x 3 0  seconds. Samples were 
then analysed for thioflavin T fluorescence. Results are means ± S.D. (n=3)
This technique was also tested in a range o f  Ap peptides to see if  it was appropriate to 
treat all the peptides in the same manner to provide a sim ilar starting point for 
com parison o f their properties (Ap40, Ap42 and Ap42 substituted peptides Y10A,
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H 6 A, H13A, H14A  and M 35N) (See figure 3.12). It was also tested on the 
synthetically produced peptide (data not shown). The thioflavin T  data show ed a clear 
reduction in the thioflavin T  fluorescence in all the Ap sam ples tested.
3.3. Discussion
The inherent predisposition o f  Ap for aggregation m eans that it invariably contains a 
large proportion o f  pre-aggregated “seeds” that prom ote further aggregation and 
severely ham per the investigation o f  the early aggregation o f  the Ap peptide. As 
Ap42 has a greater tendency for aggregation it is afflicted by this issue m ore so than 
Ap40. Yet, perhaps for this very reason, evidence im plicates Ap42 as being 
responsible for neurotoxicity in AD. To be able to investigate early aggregation and 
the properties o f  early oligomers, published m ethods for deseeding Ap were 
investigated, with the aim to create a seed-free, preferably m onom eric solution o f  Ap 
at T=0 that retained aggregation properties on solubilisation. This was also hoped to 
reduce lot-to-lot variability (M ay et al., 1992) and produce a peptide preparation 
procedure that reproducibly produced Ap that generated consistent results. 
Treatm ents tested included HFIP (Dahlgren et al., 2002; W alsh et al., 1999), N aO H 
and NH 4 OH (for high pH) (Fezoui et al., 2000), TFA (Arim on et al., 2005; Jao et al., 
1997; Zagorski et al., 1999), sonication and filtering (Huang et al., 1997). DM SO w as 
discounted as a potential deseeding treatm ent as it interferes with the A m plex red 
reagent used for determ ination o f  H2 O 2  generation by Ap.
Initial experim ents were designed to select the best supplier preparation o f  Ap. It had 
been found that many suppliers o f  Ap could not guarantee the aggregation state o f  the 
peptide. Sometim es it was far less aggregated than others when it would arrive alm ost
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com pletely aggregated. Previous unpublished w ork in our laboratory by Dr. Susan 
M oore (Lancaster University) had identified a supplier o f  recom binant A(3 that had 
proved to be far m ore consistent than others in the quality o f  peptide delivered 
(rPeptide). rPeptide provided 4 solvent options for the lyophilisation o f  Ap: HC1, 
TFA, HFIP and N aOH. W ithout any subsequent treatm ent, the Ap42 sam ple 
lyophilised in HFIP (Ap42-HFIP) w as the only peptide to show aggregation 
associated fluorescence increases in the thioflavin T and oligom eric im m unoassay and 
so was selected for further study. How ever, it still showed a large proportion o f  p re ­
aggregated m aterial; it needed further treatm ent for the study o f  early oligom eric 
species. The other treatm ents however, did provide us w ith our first insight into their 
usefulness as a subsequent deseeding technique.
The acid treatm ents AP42-HC1 and AP42-TFA in particular showed no aggregation 
associated fluorescence changes. The drying o f  the peptide at acid pH, should 
prom ote protonation o f E22 and D23 and consequently the a-helical Ap structure 
(Coles et al., 1998). However the subsequent solubilisation at neutral pH  showed 
large P-sheet associated fluorescence in the thioflavin T. This was suggested to be 
due to any rem aining solvent forcing the peptide through its pi o f  5.5 (Fezoui et al., 
2000). This could have had potentially irreversible consequences on the aggregation 
state o f  the peptides. For this reason subsequent testing o f  deseeding techniques was 
done with consideration o f  this possibility.
On the other hand, the use o f  NaOH as the lyophilisation solvent should avoid the pi 
upon solubilisation. However it did not appear to promote an aggregate free starting 
m aterial. In fact, experim ents with N H 4 OH to keep the Ap aw ay from its p i at pH s 
greater than 10, showed that it could prevent further aggregation o f  the Ap but did not 
act to deseed the peptide. In fact, incubation o f  the peptide at 4°C for 48 hrs in 0.01%
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NH 4 OH perm itted aggregation associated increases in fluorescence in both thioflavin 
T  and im munoassay; tim e dependent aggregation proceeded yet at a far reduced rate. 
Unlike observations by Fezoui and colleagues using N aOH, we found no advantage to 
the aggregation state o f  the peptide (Fezoui et al., 2000), yet we found no 
disadvantage for using it for short periods w hich would enable easier handling o f  the 
peptide. N aO H  treatm ent was also tested, follow ing a later m ethod by Sm ith et al 
(Sm ith et al., 2006). Yet this also confirm ed earlier observations that the high pH did 
not aid the deseeding process. In fact the im m unoassay showed clear increases in 
fluorescence in both recom binant and synthetic Ap42 when N aO H  was incubated with 
the Ap for 2 hrs at 4°C com pared to non-incubated samples showing a tim e-dependent 
effect o f  N aOH  on aggregation state.
HFIP treatm ent was the only solvent treatm ent that had reproducibly reduced 
fluorescence m easured at T=0 in both thioflavin T and oligom eric im munoassay. 
Together w ith sonication during N H 4 OH, HFIP and PB solubilisation steps, this 
com prised the basis for the deseeding o f Ap for the m ajority o f  the length o f  this 
research. O ther techniques investigated including filtering and ultracentrifugation, 
were hoped to be useful as no chemical m odification o f  the Ap would be induced. 
However, these proved unsuccessful for several reasons. Filtering resulted in costly 
loses o f  Ap due to both the removal o f  a large proportion o f  higher order aggregates 
and lower order Ap “sticking” to the filter, along w ith the incom patibility w ith the 
A m plex red reagent. U ltracentrifugation, was intended to sedim ent larger aggregated 
Ap such as protofibrils. Increasing time in the airfuge reduced the concentration o f  
Ap in the supernatant yet this was in conjunction w ith increases in im munoassay 
fluorescence; AP was not deseeded.
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The deseeding o f  Ap w ith TFA had always proven to be problem atic, despite evidence 
that this strong acid prom oted the random  coil conform ation o f  Ap, prom oting its 
disaggregation (Arim on et al., 2005; Jao et al., 1997; Zagorski et al., 1999). 
Treatm ent o f  Ap with 100% TFA often rendered it unable to aggregate, possibly due 
to the oxidation o f  M et35 by TFA (shown to reduce fibrillisation rate) (Butterfield and 
Bush, 2004). TFA has been shown to induce peptide oxidation (Shen et al., 1994). 
U nfortunately late in this research, we becam e aw are o f  research by M anzoni et al that 
used 4.5%  thioanisol added to the TFA. The use o f  thioanisol as an antioxidant during 
peptide exposure to TFA reportedly protects the peptide from M et35 oxidation w hilst 
the TFA prom otes deseeding o f  Ap (M anzoni et al., 2009). W hen this was tested 
effective deseeding o f  Ap42 was achieved, together w ith other Ap42 am ino acid 
substituted peptides, some o f  which were highly aggregated upon arrival. Great care 
had to be taken during deseeding by this process due to the reactivity o f  TFA, 
requiring careful handling and consideration o f  its incom patibilities w ith certain 
laboratory equipm ent. This meant a further HFIP treatm ent had to be perform ed to 
transfer the samples to the tubes used for aggregating Ap. This also ensured all traces 
o f  the TFA had been removed by the stream o f  nitrogen gas, w hich could low er the 
pH o f  the PB used to solubilise the peptide. A small reduction in the pH used for 
aggregation o f  the peptide may alter its aggregation properties. R educing the pH  low 
enough allows protonation o f  E22 and D23, stabilising the a-helical structure, thus 
slowing aggregation (Coles et al., 1998). However, the treatm ent o f  Ap w ith TFA had 
now becom e a viable deseeding m ethod that would hopefully aid the investigation o f  
the early aggregation properties o f  Ap.
Unfortunately, this method o f  deseeding was only brought to our attention late in the 
project. For this reason, much o f  the following w ork was perform ed on Ap40 and
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Ap42 that had received no TFA deseeding, but had been HFIP treated tw ice with 
sonication as this had produced the best preparation o f  peptide at this time. Key 
experim ents were repeated w ith the peptides being deseeded using the TFA method.
3.4. Conclusions
•  The optimal deseeding conditions for Ap peptides were found to be treating 
the peptide w ith TFA containing 4.5%  thioanisol, in a glass vial, vortexing and 
sonicating on ice, followed by evaporation under a stream o f  nitrogen.
•  This m ay be attributable to the low pH o f  the TFA prom oting the a-helical Ap 
structure, yet the thioanisol protecting the M et35 from  oxidation.
• High pH  could prevent aggregation for short tim e periods, yet it does not act to 
deseed the peptide
•  Sonication always appeared to be beneficial in deseeding Ap
• Prior to the use o f  TFA to deseed Ap, HFIP treatm ent was the best deseeding 
m ethod available. This was the protocol used throughout m uch o f  this 
research. However, key experim ents were repeated w ith TFA  deseeded Ap
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Chapter 4 
Hydrogen peroxide generation by (3-amyloid
4.1. Introduction
In 1956 Harm an first proposed that aging is the result o f  cum ulative dam age to cells 
directly caused by free radical m ediated dam age and oxidative stress (Harm an, 1956). 
Since aging is the greatest risk factor for AD this has generated the hypothesis that 
oxidative stress may be a m ajor factor in Ap production and deposition. AD brains 
exhibit m any signs o f  extensive oxidative stress w ith the products o f  oxidation 
reactions being detected in the CSF and plasm a o f  patients. M any aspects o f  AD m ay 
contribute to this oxidative stress, including soluble and fibrillar Ap, brain m etals, 
NFT, glial activation, abnormalities o f  the m itochondria and aging (C hauhan and 
Chauhan, 2006).
Oxidative stress is caused when the production o f  ROS overcom es the cellular defence 
m echanism s to detoxify it (Lynch et al., 2000). ROS are reactive m olecules that 
contribute to a dam aging oxidative environm ent. These include H 2 O 2 , peroxynitrite, 
and free radicals. Free radicals are particularly harmful as their unpaired electrons 
make them  very unstable and highly reactive as they try to pair up their electrons. 
Free radicals generated in the body are toxic and have to be neutralised or rem oved. I f  
not, they will react with many different types o f  m olecules in an attem pt to gain an 
electron. N evertheless, once an electron is obtained the donor m olecule finds itself 
w ith an unpaired electron thus becom es a free radical. Therefore it is vital that the 
body has m echanism s o f  detoxifying these radicals (Chauhan and Chauhan, 2006).
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The high reactivity o f  free radicals m eans that they can only exert effects locally, 
being only able to diffuse over short, nanom etre distances. H 2 O 2 on the other hand is 
a freely perm eable oxidising agent. A lthough not as toxic as free radicals, it is still 
cytotoxic and pro-apoptotic, yet its effects can extend beyond its site o f  generation and 
are perhaps m ore likely to be responsible for the global increases in oxidative dam age 
observed in AD (Lynch et al., 2000). The Fenton reaction can utilise this H 2 O 2 to 
later generate the more harmful hydroxyl radical w ith the aid o f  redox-active metals. 
M ultivalent redox active metals are fundamental to the concept o f  redox chem istry as 
they enable electron transfer to occur. The ability o f  redox active m etals to occupy 
different valence states perm its redox cycling, a property utilised by m any biological 
enzymes. However, if  unregulated, ROS can be produced in an inappropriate and 
excessive m anner causing dam age (Sm ith et al., 2007a). The degree o f  ROS-m ediated 
dam age in neurons indicates a state o f  oxidative stress. In response to oxidative stress 
a living system can dynam ically regulate its defences to respond to insults. A  cell that 
fails to sufficiently defend against oxidative im balance will inevitably enter into 
apoptotic cell death (M oreira et al., 2006).
It is critical that oxidative balance is rigorously controlled in the brain. A lthough only 
com prising 2 %  o f body m ass it consum es 2 0 % o f the body’s oxygen uptake due to its 
high m etabolic rate (Smith et al., 2007a). Hence an environm ent is created in w hich 
there is a heightened potential for oxidative stress. To com bat this environm ent the 
brain is abundant in antioxidant enzymes to a far greater extent than any other organ. 
However, considering the potential for oxidative injury this is still at a relatively low 
level. Com bined with the accum ulation o f  m etals that is observed w ith aging, the 
environm ent is ideal for redox and Fenton chemistry, generating ROS (Sm ith et al., 
2007a). Neuronal cells are highly concentrated with unsaturated fatty acids, prim e
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targets for oxidative dam age, and their low m itotic index m eans cells that succum b to 
apoptotic signals cannot be regenerated (Lynch et al., 2000). N eurodegeneration 
follows leading to the clinical features o f  AD. In fact, oxidative stress is considered to 
be one o f  the earliest features o f  brain pathology in AD, occurring prior to signs o f  
neurodegeneration and senile plaque form ation, long before symptom presentation 
(N unom ura et al., 2010). It has been hypothesized that these features are 
com pensatory responses to ensure neurons do not yield to oxidative insults. I f  the 
source o f  the oxidative stress is directly from oligom eric Ap (as discussed in 1.4.3), 
then perhaps, the plaques form a mechanism  o f  sequestering aw ay this toxic species.
The early stages o f  the Ap aggregation process have been im plicated in neuronal 
oxidative stress by various indirect mechanisms. These include hypotheses such as 
adverse metal binding (Huang et al., 2004), pore form ation (Lashuel et al., 2002), 
m em brane perm eabilisation (Kayed et al., 2004), ion leakage (W alsh et al., 2002) and 
loss o f  antioxidant activity (Smith et al., 2007a). Evidence that Ap m ay actually be 
directly responsible for this oxidative stress via the generation o f  H 2 O 2 and free 
radicals was first reported by Huang and colleagues (Huang et al., 1999a) yet it was 
m uch earlier that H2 O 2 was suggested to m ediate the toxicity o f  Ap (Behl et al., 1994). 
Research in our laboratory has observed this generation o f  H 2 O 2 , not only from  Ap but 
also from aggregating proteins implicated in other neurodegenerative diseases, such as 
a-synuclein (Parkinson’s disease), ABri (British dem entia), and fragm ents o f  the prion 
protein (prion disease) (Tabner et al., 2001; Tabner et al., 2002; Turnbull et al., 2003a, 
b; Turnbull et al., 2001a). As a consequence o f  this evidence we have speculated that 
this H2 O 2 generation may be a com m on toxic m echanism  exhibited by these peptides, 
causing neuronal cell death (Allsop et al., 2008; Tabner et al., 2002).
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The m echanism  by w hich these peptides generate H 2 O 2  is thought to involve the redox 
cycling o f  m etal ions (Huang et al., 1999a) w ith subsequent Fenton chem istry 
generating free radicals. Ap was originally thought to be able to generate these 
radicals w ithout the presence o f  metals. However, it was later shown that only trace 
m etals were needed to perm it the reaction and these were already present in the 
buffers used (Butterfield, 2002; D ikalov et al., 2004; G uilloreau et al., 2007; Turnbull 
et al., 2001b). In this chapter, the generation o f  H 2 O 2  was investigated w ith no added 
m etal ions, and so was reliant on those at trace levels w ithin the buffer (C hapter 7 
addresses the m etal ion dependency o f  this reaction). Furtherm ore, experim ents were 
carried out to ascertain how H 2 O2 is generated by Ap; is there a particular type o f  
early oligom er that structurally forms an enzym atic active site for its generation? Or 
do our observations support another m anner o f  H 2 O 2 form ation by Ap, either as a by­
product o f  early aggregation or in fact a characteristic o f  Ap m onom ers.
4.2. Results
4.2.1 H2O2 generation by Ap42
The principle m ethod utilised to measure H 2 O 2 generation from Ap solutions was 
A m plex red. This has been used to investigate H 2 O 2  generation by am yloidogenic 
peptides previously by our research group (Allsop et al., 2008; M asad et al., 2007) and 
also by others (Deraeve et al., 2006). The published assay required an excessive and 
costly quantity o f  sam ple to be used for the determ ination o f  H 2 O2 concentration. We 
needed to reduce this quantity but m aintain accuracy and the linear relationship 
between H 2 O 2 concentration and fluorescence at sub-m icrom olar concentrations. This 
was achieved by using reduced volum es o f  the A m plex red w orking solution and the
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sam ple in a 384 well m icrotitre plate (see figure 4.1). We also confirm ed that the 
assay detected low concentrations o f  H 2 O 2 generated by an enzym atic system. Here 
L-amino acid oxidase (L-AAO) was incubated with varying am ounts o f  an L-am ino 
acid substrate (L-AA, leucine in this case). D-AAO was used as a control. As can be 
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F ig u re  4.1. H 2 O 2 co n cen tra tio n  cu rve
A series o f  H20 2 concentrations were made in 10 mM PB. 15 pi o f  the H 20 2 concentration was plated 
into a black 384 well plate in triplicate, followed by 15 pi Amplex red working solution. The 
fluorescence was read on the V ictor 2 microplate reader at Ex L563 nm and Em L587 nm. Results are 
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F ig u re  4.2. H 2 O 2 g eneration  by L-A A O
A series o f  L and D-AAO concentrations were made in 10 mM PB. L-Leucine was added to each and 
incubated at 37°C for 20 mins. 15 pi o f  the reaction mixtures was plated into a black 384 well plate in 
triplicate, followed by 15 pi Amplex red working solution. The fluorescence was read on the V ictor 2 
microplate reader at Ex X563nm and Em A.587nm. Results are means ±  S.D (n=3).
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We then verified H 2 O 2 production from aggregating solutions o f  AJ342 w ith no added 
metal ions or reducing agent (see figure 4.3). The aggregation o f  A(342 at 37°C  was 
m easured using the thioflavin T  and oligom eric im munoassay. Both confirm ed 
aggregation associated increases in fluorescence over the 48 hr period. D uring this 
tim e over 600 nM  H 2 O 2 was generated from this solution. As several com pounds 
have been shown to generate false positive results in the A m plex red assay, it was 
im portant to verify that the positive signal generated in the A m plex red assay was 
from H 2 O 2 generation and not an adverse reaction. This was confirm ed using catalase 
to degrade the H 2 O 2 , w hich duly reduced the fluorescence observed. O f note is that 
catalase itself, at high enough concentrations generates a false positive signal in the 
assay. We used catalase at 10 U/ml (and lower) routinely, to verify H 2 O 2  generation 
at the end o f  an experim ent: 30 m ins incubation at 37°C was sufficient for catalase to 
elim inate the H 2 O 2 generated. However, in figure 4.4, Ap42 was aggregated w ith and 
w ithout 10 U/ml catalase present throughout the 48 hr incubation period. The 
presence o f  catalase in the solution significantly reduced the am ount o f  H 2 O 2 detected 
(One way ANOVA, p < 0.000). Both the thioflavin T and oligom eric im m unoassay 
showed no significant differences suggesting that the presence o f  the catalase m ade no 
difference to the aggregation o f  the peptide.
Another concern was that the H2 O 2 may be being generated from an im purity present 
in the solution. To test for this A|342 was depleted from the solution using a series o f  
incubations with mAb 6E10. The solutions pre and post depletion were then tested for 
their ability to generate H 2 O 2 (see figure 4.3). Over 48 hrs incubation at 37°C the 
solution before depletion o f  A042 generated nearly 1 pM  H 2 O 2 . Yet, following one 
incubation with 6E10 this had been reduced to less than 100 nM. A fter 3 incubations
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with 6E10 no H2 O2 was made, presum ably due to all o f  the Ap42 being selectively 
removed from the solution. This supported Ap as the likely source o f  the H2 O2 .
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F ig u re  4.3. T he effect o f ca ta lase  on aggregation  an d  H 2 O 2 g en era tio n
HFIP treated AP42 was solubilised at 25 pM  into 10 mM PB, pH 7.4, with and w ithout the presence o f  
10 U/ml catalase. These were incubated at 37°C and samples taken at various time intervals for 
thioflavin T (A) and Immunoassay (B) to assess aggregation state and Amplex red (C) to measure H 20 2 
concentration. Results are means ± S.D (Thioflavin T and Amplex Red: n=3, Immunoassay: n=4, * 
indicates ANOVA p < 0.000).
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F ig u re  4.4. D epletion o f Ap42 from  so lu tion  p rec lu d es H 2 O 2 g en era tio n
HFIP treated AP42 was solubilised at 50 pM  into 10 mM PB. This was then incubated for 48 hrs at 
37°C following consecutive incubations with 6E10 coated wells in a 96 well M axisorb plate to deplete 
the AP42 from the solution. The original AP42 solution and depleted solutions were then assayed for 
their H20 2 concentration by Amplex red. Results are means ± S.D (n=3)
4.2.2. Is H 2 O 2 g en e ra ted  from  a specific fo rm  o f A p?
Next, we attem pted to resolve the issue o f  how Ap generates H 2 O2 and, in particular, 
if  a specific oligom eric species is responsible. Initial experim ents supported the idea 
that H2O 2 is generated from a specific type o f Ap oligomer. Figure 4.5A  shows 
results obtained from different concentrations o f  Ap42 aggregating over 48 hrs in the 
oligom eric im munoassay to mature fibrils. A ggregation was confirm ed by AFM  at 24 
and 48 hrs (see figure 4.6). However using AFM  to actually identify a form o f  Ap 
responsible for the H2O 2 generation was troublesom e due to the heterogeneity o f  Ap 
aggregating solutions.
The images from the 25 pM sample o f Ap clearly show fibrils being form ed from 
smaller, undetermined Ap species at 24 hrs, which were fully sequestered into mature, 
super-coiled fibrils at 48 hrs. These events coincided with the slowing down o f  H2 O2 
generation supporting evidence that mature fibrils are inert in this respect.
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Importantly, despite the different concentrations o f A|3, the concentration o f  H 2 O 2 
generated by 48 hrs is the same (although at 5 pM Ap it has taken longer). In fact, per 
m olecule o f  Ap42, the 5 pM  solution actually m ade 10 x more H 2 O 2 in 48 hrs than the 
50 pM  solution. This can best be explained as a direct consequence o f  the solution 
aggregating at a slower rate, thus preserving the longevity o f  the H 2 O 2 generating 
species.
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F ig u re  4.5. T he effect o f co n cen tra tio n  on aggreg atio n  an d  H 2 O 2 g en era tio n
5, 25 and 50 pM HFIP treated AP42 was aggregated in 10 mM PB, pH 7.4 at 37°C and samples taken 
for immunoassay (A) and Amplex red (B) analysis at various time points over 48 hrs. Results are means 
± S.D. (Immunoassay: n=4, Amplex red: n=3)
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F ig u re  4.6. A F M  im ages of Ap42 a t  24 an d  48 h rs
25 pM Ap42 aggregated in 10 mM PB, pH 7.4 for 24 and 48hrs at 37°C was diluted 10 fold into MilliQ 
water and 2 pi spotted into the centre o f  a piece o f  cleaved mica. This was then imaged using a Digital 
Instruments SPM using tapping mode. Left hand image shows the height o f  objects, right hand image is 
phase contrast. A, B and C are at 24 hrs, D E and F are at 48 hrs. Bar represents 2 pm in A, 400 nm in 
B and D and 200 nm in C, E and F.
Figure 4.7 shows the results o f a similar experim ent, except the param eter tested was 
tem perature (the concentration o f Ap was kept constant). At lowered tem peratures 
the Ap42 aggregated more slowly. However, at 20°C despite aggregating to the same 
end point (m ature fibrils), considerably less H 2O 2 was generated. W hen the Ap42 was 
aggregated at 4°C, it took nearly 96 hrs to aggregate fully (data only shown until 48 
hrs in figure 4.7). N evertheless, the concentration o f  H2 O 2 m easured in the solution 
never rose above 20%  o f that generated from the solution at 37°C. The relationship 
between tem perature and enzymatic activity offers further support to the idea that a 
particular oligomeric species o f  Ap generates H 2O 2 through a catalytic m echanism.
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A. Im m unoassay































F ig u re  4.7. T he  effect o f te m p e ra tu re  on aggreg atio n  an d  H 2 O 2 g en e ra tio n
50 pM HFIP treated Ap42 was aggregated in 10 mM PB, pH 7.4 at 37, 20 and 4°C and samples taken 
for immunoassay (A) and Amplex red (B) analysis at various time points over 48 hrs. Results are means 
± S.D. (Immunoassay: n=4, Amplex red: n=3)
4.2.2.1. Do Ap fibrils d eg rad e  H 2 C>2 ?
The generation o f  H2 O2 appears to be relatively rapid in the early stages o f  
aggregation, and then slows as mature fibrils are formed. This raised the question o f  
w hether these fibrils were inert in H2 O 2 generation, or w hether fibrils play a role in 
degradation o f the H2 O2 . To test this 25 pM Ap42 was aggregated for 48 hrs in 10 
mM PB at 37°C to form mature fibrils such as those seen in figure 4.6. Following 
this, the solution was put in the airfuge to pellet the fibrillar material. The pellet had
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fresh 1 pM  H2C>2 in 10 mM PB added to it, m ixed and then incubated for a further 48 
hrs at 37°C. Thioflavin T and Am plex red data can be seen in figure 4.8. Thioflavin T 
fluorescence from the sample before and after ultracentrifugation in the airfuge 
confirm ed that the large m ajority o f  the fibrillar m aterial had been sedim ented by this 
step, leaving very little fluorescence rem aining in the supernatant. The subsequent 
incubation for 48 hrs at 37°C the fibrils generated a reduced fluorescence in the 
Am plex red assay com pared to the control w ith no Ap42 fibrils present. Fibrils 
appeared to som ewhat aid H2 O2 degradation.
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F ig u re  4.8. Ap42 fib rils  d eg rad e  H 2 O 2
25 pM A f42 in 10 mM PB was incubated at 37°C for 48 hrs to form fibrils. The solution was then 
placed in the airfuge for 3 hrs at 87,000 rpm (-136,000 x g), at which point the buffer was rem oved and 
sampled for thioflavin T fluorescence (A). To the pellet and control 1 pM H 20 2 in 10 mM PB was 
added, gently mixed and transferred to 0.6 ml Greiner PCR tubes, which were then incubated at 37°C 
for a further 48 hrs. The solutions were then tested using the Amplex red assay for H 20 2 (B). Results 
are means ± S.D (n=3)
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4.2.3. H2O2 generation and aggregation from Ap peptides
To investigate the dependence o f  both H 2 O 2 form ation and aggregation o f  Ap on 
particular residues im plicated in its metal binding and aggregation, a range o f  different 
Ap peptides were tested. These included Ap40 and Ap42 substituted peptides Y10A, 
H 6 A, H13A, H14A, M 35N and also the reverse peptide Ap42-1. These Ap peptides 
were TFA treated to prom ote deseeding o f  the sam ples, then aggregated at 25 pM , in 
10 mM  PB over 48 hrs at 37°C and tested in the thioflavin T  assay, oligom eric 
im m unoassay and A m plex red assay over 48 hrs. A ggregation was then expressed as 
a percentage o f  the m axim um  fluorescence obtained from Ap42 to enable direct 
com parison o f  the results.
4.2.3.I. Ap40 and Ap42
Firstly, w t Ap40 and Ap42, different only in respect o f  2 extra am ino acid residues at 
the C-term inus, were compared. This sam ple o f  Ap42 generated a m axim um  
concentration o f  slightly greater than 500 nM  o f  H 2 O 2  during the 48 hr period with, as 
previously observed, a steep increase early in the tim e course w hich plateaued during 
the latter stages o f  aggregation (see figure 4.9A). This m ay be due to the form ation o f  
a H2 O2  generating oligom er followed by the sequestration o f  this species into fibrils 
halting further H 2 O 2 generation. Ap40 exhibited reduced propensity for aggregation 
as m easured by both thioflavin T and immunoassay, with only a small increase in 
fluorescence observed over the 48 hrs (see figure 4.9B). Ap40 im m unoassay 
fluorescence at T=0 is equivalent to PB controls, indicating an alm ost m onom eric 
solution was obtained. Although small, the increase in fluorescence observed in the 
oligom eric im munoassay signified the solution contained aggregates. Despite the 
reduced aggregation o f  Ap40, over the 48 hrs Ap40 appeared to generate alm ost as
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much H2 O 2 as Ap42 (nearly 400 nM). However, over the following 24 hrs this H 2 O2 
generation ceased and actually decreased suggesting opposing processes m ay be at 


































F ig u re  4.9. T h e  aggregation  an d  H 2 O 2 g en e ra tio n  from  Ap42 an d  Ap40
TFA deseeded Ap40 and A f42 were solubilised to 25 pM in 10 mM PB, pH 7.4. Samples were then 
taken for thioflavin T (ThT), oligomeric immunoassay (Imm) and Amplex red (H 20 2) at 0, 24 and 48 
hrs. Aggregation is expressed as a percentage o f  the maximum fluorescence attained by AP42 during 
its aggregation in each assay (left hand vertical axis) and Amplex red fluorescence has been converted 
to concentration o f  H20 2 (right hand vertical axis). Results are means ± S.D (Thioflavin T and Amplex 
red: n=3, Immunoassay: n=4)
4.2.3.2. AP42-Y10A
The substituted AP42 Y10A, despite its inability to form di-tyrosine dimers, 
aggregated over the 48 hr period albeit at a reduced rate com pared to AP42 (see figure 
4.10). It also generated H2O 2 , again, at a reduced rate, reaching ju st 300 nM 
corresponding with the early stages o f its aggregation, and then it plateaued.
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F ig u re  4.10. T h e  aggregation  an d  H 2O 2 g en e ra tio n  from  Ap42 Y 10A
TFA deseeded Ap42 Y10A was solubilised to 25 pM in 10 mM PB, pH 7.4. Samples were then taken 
for thioflavin T (ThT), oligomeric immunoassay (Imm) and A m plex red (H 20 2) at 0, 24 and 48 hrs. 
Aggregation is expressed as a percentage o f  the maximum fluorescence attained by AP42 during its 
aggregation in each assay (left hand vertical axis) and Amplex red fluorescence has been converted to 
concentration o f  H 20 2 (right hand vertical axis). Results are means ± S.D (Thioflavin T and Amplex 
red: n=3, Immunoassay: n=4)
4.2.3.3. AP42 H 6A , H 13A  an d  H 14A
The 3 histidine substituted peptides AP42 H 6 A, H I3A and H14A, were tested to 
investigate how these copper binding residues may affect aggregation and H 2 O2 
generation (see figure 4.11). Ap42-H6A showed reduced aggregation associated 
increases in fluorescence by thioflavin T together with very low im m unoassay 
fluorescence, yet this was more likely due to a loss o f  affinity for the antibody. A 
small positive signal was detected so some binding did occur yet H is6  lies within the 
binding epitope for 6E10 and may be involved in AP-6E10 binding. Concurrently, 
generation o f  H2 O 2 by this peptide was -5 0 %  o f  AP42 by 48 hrs. In com parison, 
H13A and H14A Ap42 exhibited greater aggregation associated increases in 
fluorescence in respect o f  the thioflavin T assay, where they surpassed that o f  Ap42. 
The oligom eric immunoassay showed slightly reduced aggregation associated 
fluorescence for both peptides. The concentration o f  H 2O 2 generated by these 
peptides was again reduced com pared to wt A042, at -4 0 0  nM.
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F ig u re  4.11. T he aggregation  an d  H 2 0 2 g en era tio n  from  Ap42 H 6 A, H 13A  an d  
H 14A
TFA deseeded AP42 H6A, H13A and H14A was solubilised to 25 pM  in lOmM PB, pH 7.4. Samples 
were taken for thioflavin T (ThT), oligomeric immunoassay (Imm) and Amplex red (H 20 2) at 0, 24 and 
48 hrs. Aggregation is expressed as a percentage o f  the maximum fluorescence attained by AP42 
during its aggregation in each assay (left hand vertical axis) and Amplex red fluorescence has been 
converted to concentration o f  H20 2 (right hand vertical axis). Results are means ±  S.D (Thioflavin T 
and Amplex red: n=3, Immunoassay: n=4)
8 0
C h ap te r 4 H ydrogen  perox ide  genera tion  by A(3
4.2.3.4. Ap42 M 35N
The m ethionine residue at positive 35 (M et35) o f Ap is widely im plicated in the redox 
chem istry o f Ap due to its metal reducing capacity. Substitution o f  the m ethionine 
with norleucine rem oves the sulphur atom and therefore the potential for the sulphur 
to donate an electron to the metal ion. This would theoretically preclude H 2 O 2 
generation. This was found not to be the case as this peptide again generated 
approxim ately h a lf the concentration o f  H2 O2 com pared to wt Ap42 (see figure 4.12). 
This peptide concurrently exhibited reduced aggregation com pared to Ap42.
Ap42 M 35N
H 202
0 10 20 30 40 50
Time - hrs
F ig u re  4.12. T he aggregation  an d  H 2 O 2 g en e ra tio n  from  Ap42 M 35N
TFA deseeded A f42  M35N was solubilised to 25 pM  in 10 mM PB, pH 7.4. Samples were then taken 
for thioflavin T (ThT), oligomeric immunoassay (Imm) and Amplex red (H 20 2) at 0, 24 and 48 hrs. 
Aggregation is expressed as a percentage o f  the maximum fluorescence attained by AP42 during its 
aggregation in each assay (left hand vertical axis) and Amplex red fluorescence has been converted to 
concentration o f  H20 2 (right hand vertical axis). Results are means ± S.D (Thioflavin T and Amplex 
red: n=3, Immunoassay: n=4)
4.2.3.5. S u m m ary  o f Ap peptides
Com paring the increase in aggregation associated fluorescence from the peptides at 48 
hrs and the H2O 2 generation from each peptide over this time clearly shows that the 
am ount o f  aggregation does not directly correlate with the concentration o f  H 2 O 2 
generated (see figure 4.13). All the peptides exhibited reduced generation o f  H 2 0 2
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com pared to wt Ap42. H13A and H14A dem onstrated increased aggregation 
associated fluorescence in the thioflavin T assay, w hilst H6 A, M 35N and Y10A 
displayed reduced thioflavin T fluorescence.
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F ig u re  4.13. A ggregation  an d  H 2 O 2 g en e ra tio n  from  Ap pep tides by 48 h rs
TFA deseeded Ap peptides were aggregated at 37°C for 48 hrs at 25 pM in lOmM PB, pH 7.4. 
Aggregation was assessed by thioflavin T fluorescence (A), Immunoassay fluorescence (B) and H 20 2 
generation by Amplex red fluorescence (C). Results are means ± S.D (Thioflavin T and A m plex red: 
n=3, Immunoassay: n=4)
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4.2.4. T he  effect o f asco rb ic  acid  on H 2 O 2 g en e ra tio n
Ascorbic acid (Vitam in C) is utilised in conjunction with copper ions by several 
research groups to investigate ROS generation by Ap (D ikalov et al., 2004; Guilloreau 
et al., 2007; M urray et al., 2005; Nadal et al., 2008). This is because it is an electron 
donor, able to reduce Cu(II) to Cu(I), initiating redox cycling and Ap m ediated H 2 O 2 
generation consequently increasing the levels o f  H 2 O2 m easured. A scobate is found at 
high concentrations within neurons, on average estim ated at 10 mM  (Rice, 2000), so it 
has the potential to take part in A P-m ediated ROS generating reactions. As I have 
found Ap to generate H2 O 2 w ithout the addition o f  exogenous copper, a range o f  
ascorbic acid concentrations was tested with Ap42 to observe its effect on aggregation 
but also to see if  H2 O 2 generation was elevated from Ap with no added copper.
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F ig u re  4.14. A scorbic acid  co n cen tra tio n  d ep en d en t effects in th io flav in  T  an d  
A m plex red
A concentration range from 0.025 to 250 pM ascorbic acid was made in 10 mM PB and tested in the 
thioflavin T assay (A) and Amplex red assay (B). The samples were then incubated for 24 hrs at 37°C 
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Controls with no Ap were initially tested for in the thioflavin T and Am plex red 
assays (see figure 4.14). No concentration dependent effect was observed in the 
thioflavin T assay. However in the Am plex red assay, at 25 and 250 pM  ascorbic acid 
significantly increased fluorescence was detected (Tukey HSD test, p < 0.000, n=3). 
The sam ples were then incubated at 37°C for 24 hrs and tested again in the A m plex 
red assay which showed further increases in fluorescence at these concentrations. 
This indicated that the presence o f  these higher levels o f  ascorbic acid generated 
H2 C>2 . The generation o f  such a strong positive signal is indicative o f  ascorbic acid 
acting as a pro-oxidant, reacting with the free Cu(II) ions in the buffer solution.
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F ig u re  4.15. T he effect o f ascorb ic acid  on th e  agg reg atio n  o f Ap42
25 pM AP42 was solubilised into a range o f  ascorbic acid concentrations in 10 mM PB and incubated at 
37°C. Samples were taken and tested for thioflavin T fluorescence (A) and in the oligomeric 
immunoassay (B) at various time points over 48 hrs. Results are means ± S.D (Thioflavin T: n=3, 
Immunoassay: n=4), Tukey HSD * indicates p = 0.005.
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These concentrations o f  ascorbic acid were incubated with A|342 and aggregation o f  
the peptide at 37°C m onitored over 48 hrs by thioflavin T and im m unoassay (see 
figure 4.15). At 6  hrs the thioflavin T assay showed no significant difference in the 
fluorescence m easured from the samples. H owever, the im m unoassay detected small, 
significant increases in fluorescence at 25 and 250 pM  ascorbic acid (Tukey HSD p = 
0.005); increasing ascorbic acid concentration appeared to prom ote oligom er 
form ation. At 24 hrs aggregation both thioflavin T and im m unoassay showed a 
concentration dependant effect but with decreased fluorescence m easured with 
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F ig u re  4.16. T he  effect o f ascorb ic  acid  on A m plex  red  fluorescence from  
ag g reg a tin g  Ap42 and  PB contro ls
25 pM A f42 was solubilised into a range o f  ascorbic acid concentrations in 10 mM PB and incubated at 
37°C. Samples were taken and tested for Amplex red fluorescence at various time points over 48 hrs. 
Legend refers to the ratio o f  A f to ascorbic acid in the sample. Results are means ± S.D (n=3)
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Am plex red fluorescence was m onitored over the 48 hrs in both the Ap sam ples and 
controls (see figure 4.16). The increases in fluorescence observed in controls 
containing 25 and 250 pM  ascorbic acid (1:1 and 10:1) at 24 hrs m irror those 
previously observed. However, at 48 hrs the level o f  fluorescence from these controls 
dropped. The high levels o f  H 2 O 2 generated by these controls m eant the level o f  H 2 O 2 
generated from the corresponding Ap42 sam ples could not be calculated, yet it can be 
considered to be less than that o f  the ascorbic acid alone.
H2 O 2 generation by Ap42 was calculated over the time course for the lower
concentrations o f  ascorbic acid (see figure 4.17). A lthough the differences between
the 4 concentrations shown are small, at 6 hrs incubation there appears to be a
concentration dependant effect, with the greater concentrations o f  ascorbic acid
generating more H2O 2 . This correlates w ith the increase in oligom er associated
fluorescence in the immunoassay. Despite this initial increase in H 2 O 2 generation the
final concentration m easured over the 48 hrs was not raised com pared to the sam ple
with no added ascorbic acid.
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F ig u re  4.17. T he effect o f ascorb ic acid on H 2 C>2 g en e ra tio n  from  ag g reg a tin g  
AP42
25 pM AP42 was solubilised into a range o f  ascorbic acid concentrations in 10 mM PB and incubated at 
37°C. Samples were taken and tested o f  Amplex red fluorescence at various time points over 48 hrs. 
Appropriate PB control fluorescence values have been subtracted and fluorescence converted to 
concentration o f  H2C>2. Results are means ± S.D (n=3)
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To check that the signals in the Am plex red, especially those from the controls with 
the highest ascorbic acid concentrations, were from H 2 O2 generation, sam ples were 
diluted 4:1 v/v with 50 U/ml catalase or w ith 10 mM PB (see figure 4.18). These 
were incubated at 37°C for 30 mins and then A m plex red fluorescence m easured. 
This brought all fluorescence readings down to below  PB control levels indicating 
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F ig u re  4.18. T h e  effect o f ca ta lase  on A m plex red  fluorescence on asco rb ic  acid  
sam ples
25 pM A f42  was solubilised into a range o f  ascorbic acid concentrations in 10 mM PB and incubated at 
37°C for 48 hrs. Catalase in 10 mM PB was then added to the samples to a final concentration o f  10 
U/ml catalase and 20 pM A f42. These were then incubated for 30 mins at 37°C and then sampled, 
together with controls with no added catalase, for their fluorescence in the Amplex red assay. Results 
are means ± S.D (n=3)
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4.3. Discussion
One o f  the earliest features o f  AD brain pathology is the detection o f  m arkers o f  
oxidative dam age. Huang and colleagues first reported the possibility that Ap m ay be 
directly responsible for this oxidative dam age via the generation o f  H 2 O 2  (H uang et 
al., 1999a). M onom eric Ap appears an unlikely candidate for the generation o f  H 2 O 2  
as the reduction o f  2 Cu(II) ions is now the favoured m echanism  o f  H 2 O 2  generation. 
This suggests two or more Ap subunits in close vicinity would be required for the 
donation o f  these 2  electrons for the initiation o f  the redox reactions generating H 2 O2  
(Hureau and Faller, 2009). Previous work has also suggested that a lag phase before 
ROS is generated from Ap, corresponding to the period in w hich oligom ers m ay be 
generated (Tabner et al., 2005). M uch evidence now  im plicates H 2 O 2 as being m ade 
by a particular subtype o f  early oligom er, the structure o f  w hich facilitates the 
generation o f  H 2 O2 in an enzymatic m anner. The experim ents perform ed were done 
so as to test this hypothesis with the ultim ate aim o f  elucidating the Ap species that 
generates H 2 O 2 . The less favoured alternative hypothesis was that the H 2 O 2 is 
generated as a by-product o f  the process o f  early aggregation.
4.3.1 Ap generates H2O2
The A m plex red assay was developed and used to measure the low concentrations o f  
H2 O2 generated from Ap. Experim ents were focused on Ap42, this being the species 
that exhibits greater toxicity and also generates m ore H 2 O 2 than Ap40. Control 
experim ents were initially perform ed to confirm  that the positive A m plex red signal 
generated by Ap was from H 2 O 2  (by the addition o f  catalase) and that the A p was the 
source o f  the H 2 O 2 (by depletion o f  AP).
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H 2 O2  was found to be made from A p42, the signal for w hich was elim inated by the 
addition o f  catalase. O f interest, when Ap42 was aggregated for 48 hrs w ith and 
w ithout the presence o f  10 U/ml catalase, although H2 O 2 was elim inated, the 
thioflavin T  and im m unoassay fluorescence data suggested that the presence o f  
catalase m ade no difference to the aggregation o f  the peptide. This appears to 
contradict reports that Ap the self-oxidation o f  key residues drives aggregation o f  the 
peptide; w hether it be through oxidation o f TyrlO to form dityrosine dim ers (B am ham  
et al., 2004; Smith et al., 2007a), or o f  M et35 (Bitan et al., 2003b). On the other hand, 
it is possible that Ap oxidation proceeds preferentially to H 2 O 2  degradation by 
catalase, or that sufficient oxidation occurs despite the presence o f  the catalase. 
A nother explanation may be the presence o f  some pre-aggregated A p42 upon wetting, 
seeding its aggregation (p-sheet folded Ap triggers the m is-folding o f  m ore Ap (Jarrett 
et al., 1993)), thus oxidation may not be required to initiate it.
The depletion o f  Ap42 from solution by successive incubations w ith the m A b 6E10, 
found that removing the Ap42 from the solution rendered the solution increasingly 
less capable o f  generating H 2 O2 . This indicated that the likely source o f  the H 2 O 2 was 
the Ap and not a contam inant dissolved in the buffer. The requirem ent o f  oxygen as a 
substrate for H 2 O 2 generation by Ap was tested. However efforts to reduce the supply 
o f  oxygen for H 2 O 2 generation by the creation o f  a nitrogen atm osphere for the AP to 
aggregate were unsuccessful (data not shown).
4.3.2. H2O2 may be generated by a specific form of Ap
The heterogeneous and dynamic nature o f  Ap aggregating solutions plagues attem pts 
to attribute any specific characteristic, including toxicity o f  Ap, to any discrete species 
(Bharadwaj et al., 2009). Evidence suggests that a specific form o f  pre-fibrillar A p is
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responsible for the neuronal toxicity observed in AD, yet identification o f  this species 
is yet to be achieved due to the properties o f  this problem atic peptide. Investigation o f  
w hether the generation o f  H 2 O 2  is an enzym atic property o f  a specific type o f  early Ap 
species due to the redox cycling o f  m etal ions, required significant consideration o f  
these problem s. If  a key pathogenic event in the developm ent o f  AD is the generation 
o f  H 2 O 2  by Ap then targeting this process m ay be a valid approach for developing 
disease-course altering therapeutics. However, the w ay in w hich the A p generates 
H 2 O 2 m ay also be o f  importance when considering other AD drug developm ent 
strategies. For exam ple, inhibition o f  aggregation: if  H 2 O 2 generation is m ade by a 
specific early oligom er, and an inhibitor only inhibits aggregation after the form ation 
o f  this oligom er, then the outcom e may be an increase in the levels o f  the H 2 O 2  
generating oligom er, thus exacerbating the toxicity.
Initial experim ents testing how concentration and tem perature affected Ap 
aggregation and its generation o f  H 2 O 2 suggested H 2 O 2 was in fact m ade by a specific 
early form o f  Ap. The effect o f  lowering the concentration slowed the aggregation o f  
the peptide. However, the concentration o f H2 O 2 generated was not determ ined by the 
concentration o f Ap present. If the generation o f  H 2 O 2 was m ade as a by-product o f  
aggregation, it may be expected that tenfold less peptide present w ould generate 
substantially less H2 O 2 . This was not the case. In actuality, slowing the aggregation 
by reducing Ap concentration increased the H 2 O 2 generation per m olecule o f  Ap 
present. This clearly supports the idea that the lifespan o f  a specific form o f  A p  in 
solution is a determ inant o f  the level o f  H2 O 2 generated. It was subsequently 
hypothesised that slowing aggregation o f  Ap42 using tem perature may also prolong 
the longevity o f  the H2 O 2 generating Ap species. This too could generate m ore H 2 O 2 , 
but also, the lower tem perature may protect the H 2 0 2 from naturally degrading in
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solution. In com plete contrast, lowering tem perature greatly reduced the generation o f  
H2 O 2  by A(342. Despite contradicting the hypothesised effect, the best explanation for 
these results still supports the generation o f  H 2 O 2  being due to a specific form  o f  Ap; 
if  H2 O 2 was m ade as a by-product, equal concentrations o f  Ap aggregating from  the 
same starting point, to m ature fibrils, should generate sim ilar quantities o f  H 2 O 2 . This 
was not the result observed. Furtherm ore, tem perature is linked to the enzym atic 
activity o f  proteins. R educing tem perature m ay decrease H 2 O 2 generation due to the 
reduction o f  enzym atic activity o f  the specific H 2 O 2 generating form  o f  Ap despite the 
potential for the lowered tem perature to increase the longevity o f  this Ap species. 
This evidence appears to support the hypothesis that H 2 O 2 generation is dependent on 
the presence and longevity o f  particular H 2 O 2  generating oligom eric species.
Calculation o f  the rate o f  H 2 O 2 generation at different stages o f  Ap aggregation would 
be m ore appropriate to com pare the ability o f  Ap species to generate H2 O 2 , rather than 
absolute H2 O 2 concentrations. However, as relatively few  m easurem ents could be 
perform ed during Ap aggregation, often due to sam pling time constraints and the large 
consum ption o f  samples for A m plex red testing, rates could not be reasonably 
calculated. In future experiments, a greater num ber o f  sam ples should be taken to 
allow  rates o f  H2 O 2 generation to be com pared at different stages o f  aggregation and 
between different Ap peptides. W ithout calculation o f  rates, the H2 O 2 m ade by A p42 
appears to be largely generated during the early stages but then slows as Ap is 
sequestered into fibrillar material.
There is evidence that Ap may generate ROS at one stage o f  aggregation but actually 
scavenge it at another (Hureau and Faller, 2009; Naylor et al., 2008). Unlike other Ap 
aggregation species, fibrils can be sedim ented by centrifugation and so could be easily 
tested to see if  they play a role in the degradation o f  H 2 0 2. W hen 1 pM  H 2 0 2 was
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added to the Ap42 fibrils and incubated for 48 hrs there was -2 0 %  decrease in the 
H2 O 2 detected com pared to control sam ples im plying that fibrils aid the 
decom position o f  H 2 O 2 . This m ay be due to a specific characteristic o f  the fibrils, or 
they m erely provide an easy substrate for oxidation by H 2 O 2 . However, this does 
m ean that where heterogeneous solutions o f  Ap42 are concerned, the concentration o f  
H 2 O2 m easured m ay actually be the net effect o f  2  opposing actions: those generating 
H 2 O 2 and those degrading it. Ap aggregation interm ediates m ay also degrade H 2 O 2 . 
However, these could not be tested in this respect as the airfuge is ineffective for 
sedim entation o f  earlier Ap species. Additionally we found the airfuge m ay actually  
induce som e aggregation whilst investigating it as a potential deseeding technique 
(figure 3.9). However, oxidation o f  early Ap by H 2 O 2 (albeit at a far increased 
concentration) has been observed w hilst investigating cross-linking o f  the peptide (see 
chapter 5).
4.3.3. The aggregation and H2O2 generation from Ap peptides
4.3.3.1. Wild type Ap
Ap40 lacks 2 hydrophobic residues at the C -term inus o f  the peptide, Ile41 and Ala42. 
These 2 amino acids are responsible for the increased aggregation and toxicity 
observed by Ap42 com pared to Ap40. The reduced aggregation o f  AP40 could be 
clearly seen in the thioflavin T and im munoassay results. H 2 O 2  was also reduced in 
com parison to AP42, being generated over the first 24 hrs but follow ed by a decrease 
in H 2 O 2  detected at 48 hrs. As Ap40 is very m uch m onom eric upon wetting, it m ay be 
that this represents the formation o f  the H 2 O 2 generating species, w hich consequently 
becom es oxidised permitting its fibrillisation. This also suggests that the H 2 O 2 
generating Ap species is formed very early during the aggregation process. M aybe
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with Ap42 this species is m ore stable, persisting in solution despite the tendency for 
fibrillisation. This m ay support the idea that som e oligom ers are form ed “o f f 5 the 
fibrillisation pathway. There certainly appear to be tw o processes at play w ith A|340, 
one generating H 2 O 2 , the other rem oving it from  solution, m aybe by com peting 
species in the heterogeneous aggregating solution. This effect has been observed 
repeatedly during this work and has been suggested by other researchers (Hureau and 
Faller, 2009; N aylor et al., 2008). Once the im m obilisation technique is finalised 
(described in chapter 6 ), it would be o f  interest to test Ap40 for both H 2 O 2  generation 
and degradation, as it was often observed that AJ340 appears to quench H 2 O 2  generated 
during an experim ent, more so than any other Ap peptide. This supports evidence on 
the redox properties o f  Ap that supports a role as both pro- and antioxidant, dependent 
on the m icroenvironm ent. Concentration and oxidation state may be m ajor factors in 
controlling a gain in toxicity (Sm ith et al., 2007a).
4.3.3.2. Ap42-Y10A
Ap42-Y10A, despite its inability to form dityrosine dim ers, was aggregation and H 2 O 2 
generation com petent, albeit both at a reduced rate to w t Ap42, generating -3 0 0  nM  
H2 O 2 com pared to 500 nM by Ap42. This supports other research that suggests A p42- 
Y10A generates H 2 O2 at ha lf the rate o f  the w t Ap42 (Barnham  et al., 2004). This 
does elim inate dityrosine dim ers as both a pre-requisite for aggregation and as the sole 
H2 0 2 generating Ap species. On the other hand, the reduced aggregation and 
production o f  H 2 O 2 by Ap42 Y 10A does indicate this residue as playing a prom inent 
role in Ap aggregation and its redox chem istry o f  Ap generating H2 0 2. It m ay be that 
di-tyrosine dim ers are a stabilising influence on oligom er generation. This would help 
explain both decreased aggregation and H 2 O2  generation. I f  the tyrosine plays a role
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in copper co-ordination by the peptide (Sm ith et al., 2007a), then perhaps this 
substitution reduces the binding o f  copper to the peptide, thus decreasing the metal - 
catalysed generation o f  H 2 O 2 . Soluble dityrosine dim ers m ay be a key species in A0- 
m ediated toxicity, as these stable, covalently bonded species are found in the brains o f  
AD patients. O ther research has found Ap-Y IO A to form oligom eric species. 
However, w here the w t peptide was toxic to cell cultures, A p-Y IO A  was not 
(Bam ham  et al., 2004). This implicates the role that this tyrosine residue has in 
form ing dityrosine bonded Ap, prom oting early aggregation interactions as being 
relevant to the neurotoxicity o f  Ap in AD. W hether this is related to oxidative 
m echanism s is yet to be determ ined. Interestingly though, one o f  the 3 am ino acids 
different in rat Ap is TyrlO (a phenylalanine in rat Ap). This peptide has reduced 
aggregation potential, neurotoxicity to cell cultures and also reduced AD oxidative 
neuropathology com pared to hum an Ap (H uang et al., 1999b).
4.3.3.3. Histidine substituted Ap42
The histidine substituted Ap42s showed 2 different effects; H 6A -A p42 showed 
decreased aggregation yet H I3A and H 14A-Ap42 showed increased aggregation 
com pared to w t Ap42 in the thioflavin T assay yet reduced in the oligom eric 
immunoassay. The assays m easure different aspects o f  the aggregation process; the 
thioflavin T assay appears to m easure fibrillar content preferentially w hereas the 
oligom eric im munoassay is m ore sensitive to the early oligom eric changes. This 
would imply that these 2 m utants are more fibrillogenic than the native Ap42, w ith 
early oligom eric species being sequestered rapidly into fibrils. All three showed H 2 O 2  
generation albeit significantly reduced in com parison to w t Ap42 (Tukey HSD p < 
0.001 at 24 and 48 hrs) with H6A-Ap42 reduced more so than H13A and H14A -
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Ap42. Consequently, not one o f  these histidine residues is critical for the coordination 
o f  trace levels o f  redox active m etals to perm it H 2 O 2 generation by the peptide. It m ay 
be that the substitution o f  ju s t one o f  these histidines reduces the affinity o f  copper for 
binding Ap. This m ay have dual effects to decrease the level o f  H 2 O 2 generated: 
reducing the redox potential o f  Ap oligom ers and increasing sequestration o f  Ap into 
fibrils decreasing oligom er longevity. If the copper binding site in H 2 O 2 generating 
oligom ers is a hybrid betw een 2 (or more) Ap m olecules then not all the histidines in 
one m olecule would be essential. If  this was the case then it m ay be predicted that, 
due to their proxim ity His 13 and His 14 m ay be alm ost interchangeable for copper 
coordination, whereas His6  m ay o f  greater im portance. These results support this 
w ith H 6 A  Ap42 exhibiting reduced aggregation and H 2 O 2  generation com pared to 
both H I3A and H14A, which are m ore equivalent to each other. A  triple histidine 
m utant would be interesting to investigate to confirm  that loss o f  this m etal binding 
site ablates H 2 O 2 generation.
4.3.3.4. Ap42-M35N
This Ap substituted peptide also showed reduced aggregation and H 2 O 2  generation 
com pared to w t AP42. M et35 is w idely im plicated in the redox properties o f  A p. 
This am ino acid, a thio ether, is thought to be critical to Ap redox chem istry as its side 
chain is highly susceptible to oxidation, due to its sulphur atom having the potential to 
donate electrons for the reduction o f  metal ions (Vogt, 1995). There is evidence that 
w ith Ap40, substitution o f Met35 with norleucine, rem oving the sulphur atom , causes 
it to become non-oxidative and non-neurotoxic (Varadarajan et al., 1999). However, 
in our experim ents M35N Ap42 retained some o f  the H2 O 2 generating capability o f  
the wt Ap42. This suggests that although M et35 maybe the prim ary source for metal
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reduction, another source o f  electrons m ust also capable o f  initiating the metal 
catalysed redox reactions (maybe TyrlO). A dditionally, its reduced propensity for 
aggregation indicates that M et35 has a role in m itigating the aggregation o f  Ap42. Ap 
w ith M et35 pre-oxidised has been found to aggregate slow er (Butterfield and Bush, 
2004). This may be linked to decreased ability to reduce copper w hich hypothetically 
initiates redox cycling, thus linking aggregation and redox processes. It m ay be that 
the reduced H 2 O 2 generated by M 35N Ap42 caused less oxidation o f  Ap residues, 
such as TyrlO, to take place. The form ation o f  dityrosine dim ers from oxidised TyrlO  
o f  Ap m ay help drive early aggregation perhaps stabilising early interactions.
The biochem istry behind how  the M et35 in Ap m ay be capable o f  facilitating redox 
reactions by A p/m etal com plexes, where other m ethionine containing proteins do not, 
has been suggested to be due to Aps structural properties. The C-term inus o f  Ap42 is 
helical in nature, with each residue interacting with the am ino acid 4 units away. This 
brings M et35 to within van der W aals distance o f  the backbone carbonyl o f  Iso31 
(Shao et al., 1999). This isoleucine may be able to prim e the lone pair o f  electrons o f  
the sulphur atom o f  Met35 for oxidation m aking it easier for electron abstraction. 
This is supported experim entally using Iso31Pro which reportedly disrupts the helical 
structure o f  the C-term inus rendering the peptide non-oxidative and non-toxic, due to 
the loss o f  electron priming (Butterfield and Bush, 2004; Kanski et al., 2002b). 
Following electron priming, Met35 then has to com e within ~14A  o f  the m etal ion for 
transfer o f  the electron to take place (Page et al., 1999). As M et35 is at the C- 
term inus and the metal ion bound towards the N -term inus, folding o f  the peptide 
would need to facilitate this interaction, the alternative being via binding o f  two or 
m ore peptide molecules as when the peptide oligomerises. In this case the m etal- 
bound N -term inus may become stacked against the M et35 in the C-term inus o f  the
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adjacent Ap unit (Sm ith et al., 2007a). This m ay perm it copper-m ediated 
radicalisation o f  M et35 provoking the form ation o f  a stable carbon centred radical on 
the peptide backbone, with ensuing aberrant oxidative chem istry (R auk et al., 2000).
O ligom erisation may be the process that perm its the interaction o f  M et35 o f  Ap w ith 
the bound metal ion. Consequently, it would seem reasonable to expect that some 
form s o f  oligom eric species may be m uch m ore efficient in this respect than others. 
The lack o f  the m ethionine residue with this norleucine substituted peptide m eans that 
another source o f  electrons is available for the reduction o f  Cu(II) to initiate redox 
cycling yet this source does not appear to be as efficient as M et35.
4.3.4. Ascorbic Acid
Ascorbic acid is an antioxidant used by several research groups w hen investigating Ap 
redox capabilities and the generation o f  ROS. This is due to its ability to reduce 
Cu(II) to Cu(I) initiating the redox reactions o f  the Ap/copper com plex. A scorbic acid 
is usually considered an antioxidant due to its ability to donate electrons, capable o f  
detoxifying oxidising agents such as H 2 O2 . The effect o f  ascorbic acid is not fully 
concentration dependant; in vitro it is observed that at high enough concentrations 
ascorbic acid becomes a pro-oxidant, able to initiate Fenton chem istry w hich uses free 
metal ions to convert H2 O 2 to hydroxyl radicals.
A  range o f  ascorbic acid concentrations were tested for their effects on Ap42
aggregation and H2 O 2  generation. The controls for these reactions indicated that the 2
highest concentrations o f  ascorbic acid showed tim e dependant generation o f  H 2 O 2
which was eliminated by the addition o f  catalase. This suggests that the ascorbic acid
at these concentrations is able to reduce the endogenous Cu(II) in the buffer solution
to generate H 2 O2 . By 48 hrs the level o f  FI2 O 2 detected in these 2 controls decreased
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significantly (Tukey HSD, p < 0.000). This m ay be due to the level o f  H 2 O 2  generated 
causing the ascorbic acid to becom e itself oxidised to dehydroascorbate, depleting the 
H 2 O 2 from the solution but also decreasing the concentration o f  ascorbic acid so it no 
longer generates H 2 O 2 . Interestingly, these high levels o f  fluorescence are not present 
in the A(342 containing counterparts. In fact, fluorescence m easured from  these 
sam ples is reduced in com parison to the lower concentrations o f  ascorbic acid, 
implying the Ap may be rem oving the H 2 O 2 generated by the ascorbic acid from  the 
solution. However, a more likely explanation is that the Cu(II) ions are no longer free 
in solution but instead bound to Ap: at high ascorbic acid levels this data supports 
evidence that ascorbic acid plus free copper generates m ore H 2 O2  than ascorbic acid 
plus Ap-Cu(II) (Guilloreau et al., 2007; N adal et al., 2008). Ascorbic acid can be 
considered a better electron donor than A p so these results m ay be expected. Taking 
this viewpoint, it is possible to consider Ap binding copper as an anti-oxidant 
m echanism . However, even though ascorbate levels in the brain can be high, free 
copper is kept at a m inim um  to prevent detrim ental redox reactions. Consequently, 
the fact that ascorbic acid and free copper generates m ore H 2 O 2 has little biological 
relevance. Also, with no copper added to Ap, incubation w ith these higher levels o f  
ascorbic acid generates less H 2 O 2 than AP alone. This suggests that w here Cu(II) 
levels are minim al and most likely A p-bound, greater generation o f  H 2 O 2  results from 
Ap reduction o f  Cu(II) than when high levels o f  ascorbic acid were present.
The presence o f  lower levels o f  ascorbic acid appeared to cause a small increase early 
oligom erisation o f  Ap42 (im m unoassay at 6  hrs). H 2 0 2 generation from  the Ap42 
sam ples at 6  hrs was som ewhat correlated with this, providing support that an 
oligom eric species o f  Ap is responsible for H 2 O 2 generation. These effects in this first 
6  hrs may be directly due to increased reduction o f  Cu(II) to Cu(I) by the presence o f
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ascorbic acid. The early increase in H 2 O 2 generation w ith ascorbic acid may have 
caused increased oligom erisation o f  Ap due to oxidative m odification o f  Ap (m aybe 
in a sim ilar m anner to the cross-linked Ap generated in chapter 5). Despite this, by 48 
hrs, the addition o f  ascorbic acid, even at the highest concentration did not increase 
H2 O 2 generation by the Ap42 com pared to that w ith no added ascorbic acid. This 
appears to contradict other evidence that a reductant such as ascorbic acid elevates 
H 2 O 2 generation (Bam ham  et al., 2004; D ikalov et al., 2004; G uilloreau et al., 2007; 
M urray et al., 2005; Nadal et al., 2008). Im portantly though, is that in this experim ent 
no copper was added to the samples relying on the copper naturally occurring in the 
buffer solutions. This was done as metal ions are found to have varying effects on the 
aggregation and H 2 O 2 generation at different concentrations (investigated in chapter 
7). It m ay be that adding copper and ascorbic acid elevates the H 2 O 2 generated by Ap 
for longer w hich m ay reflect age-dependent metal accum ulation.
4.3.5. Is Ap generated ROS directly responsible for neuronal cell death?
A theory that carries a lot o f  support is that m em brane insertion o f  Ap m ay direct 
oxidative stress at m embrane lipids increasing m em brane permeability. It has been 
suggested that a transient sulphuramyl free radical, formed by the reaction o f  M et35 
with the m etal ion, could abstract a proton from nearby unsaturated bonds in 
phospholipid acyl chains. This would create a carbon centred radical on the lipid that 
readily reacts with m olecular oxygen forming the peroxyl free radical. Subsequently a 
cascade o f  reactions could be initiated, am plifying the original Ap peptide free radical 
(Butterfield and Bush, 2004). The products o f  lipid peroxidation, such as HNE, w ould 
be form ed from the systematic breakdown o f  m em brane lipids by free radical attack 
altering m em brane permeability. Following the abstraction o f  a proton the m ethionine
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becom es positively charged. This SH+ group is an acid with a pK A o f  -5 m eaning any 
close by base, such as water, would except this proton instantaneously. M et35 is 
reform ed and capable o f  reaction with the m etal ion all over again creating a catalytic 
cycle (Butterfield and Bush, 2004; Smith et al., 2007a; V aradarajan et al., 2001). 
Supporting this hypothesis is evidence that reports lipid oxidation is increased with 
Cu-Ap com pared to free copper. Furtherm ore, it has been reported that catalase could 
not protect against the Cu-Ap induced oxidation, illustrating the danger o f  free- 
radicals generated w ithin the m em brane (M urray et al., 2005).
For lipid peroxidation to take place it would seem fundamental for M et35 to be within 
the bilayer. Even if  Ap does not insert fully into the m em brane as some hypothesise, 
the C-term inus o f  Ap has a putative TM  dom ain placing M et35 w ithin the lipid 
bilayer (Sm ith et al., 2007a). Gly37Asp substitution on Ap w as hypothesised to alter 
the position o f  M et35 placing it outside o f  the lipid m em brane. This substituted 
peptide showed no oxidative stress or neurotoxicity, consistent w ith M et35 being 
required within the bilayer (Kanski et al., 2002a).
As evidence suggests the small soluble aggregates o f  Ap are the toxic species, the idea 
that these species may be able to insert into the m em brane, placing them  for reaction 
with lipids, has gained standing. On the other hand it may be that this H 2 O 2  
generation is o f  little consequence to the toxicity o f  the peptide and the early species 
o f  Ap42 exert their toxicity via another m echanism . However, evidence that oxidative 
stress is an early event in the pathogenesis o f  AD and that early A p species generate 
ROS w hich causes oxidative stress cannot be ignored as a possible key pathogenic 
event in the developm ent o f  AD.
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4.4. Conclusions
•  Increasing evidence suggests that small soluble oligom eric A p is responsible 
for neurotoxicity in AD
• Ap generates H2 C>2 during the early stages o f  its aggregation possibly 
im plicating an early oligom eric species as being responsible for its form ation
• Ap42 has been found to generate m ore H 2 O 2 than Ap40, corresponding to the 
increased toxicity attributed to Ap42
•  Ap42 substituted peptides im plicated in m etal binding (H 6 A, H13A, H 14A  
and possibly Y10A), redox cycling (M 35N) and dim erisation (Y10A) 
generated less H 2 O 2 than w t Ap42
•  These peptides retained some ability to generate H 2 O 2 , therefore none o f  these 
residues was absolutely critical for this process
•  The histidine substituted Ap42 m ay have som ewhat reduced affinity for m etal 
binding therefore the metal ion is reduced by M et35 at a decreased rate
•  Substitution o f  Met35 showed that another residue, possibly TyrlO is also able 
to donate an electron to the metal ion, although at a reduced rate
•  Substitution o f  TyrlO dem onstrated that dityrosine dim ers are not a p re ­
requisite for fibrillisation o f  Ap, or the sole source o f  H2 O 2 . H ow ever it 
appears that the formation o f  the Ap species that generates H 2 0 2 was reduced
•  Ap plus ascorbic acid with no added metals showed low levels o f  this anti- 
oxidant to elevate early H2 0 2 generation by Ap but also appeared to prom ote 
AP oligom erisation in a concentration dependant manner.
•  There is evidence that H2 0 2 generation by Ap m ay be targeted in vivo at lipid 
m em branes and that this may be accountable, at least in part, for the oxidative 
stress observed in the AD brain and potentially the pathogenesis o f  AD
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Strong evidence suggests that a form  o f  oligom eric Ap is responsible for neurotoxicity 
in AD. The generation o f  H 2 O 2  by Ap occurs during the early  stages o f  Ap 
aggregation possibly im plicating oligom eric Ap in H 2 O 2 form ation and providing a 
potential source o f  oligom er m ediated toxicity. H ow ever the transient and dynam ic 
nature o f  Ap in solution plagues identification o f  the species responsible. Here, 
several m ethods o f  cross-linking have been tested in an attem pt to create fixed yet 
natural oligom eric Ap. The Ap species created m ay then be tested for their ability to 
generate H 2 O 2 . The cross-linking m ethods tested were photo-induced cross-linking o f  
unm odified proteins (PICUP) and 2 m ethods inducing oxidation o f  Ap using copper 
or HRP w ith H 2 O 2 . The results o f  these experim ents were visualised by SDS-PA GE.
5.1.1. Photo-induced cross-linking of unmodified proteins (PICUP)
PICUP was originally designed to aid elucidation o f  protein-protein interactions in
large, m ulti-protein, com plexes (Fancy and Kodadek, 1999). This m ethod utilises the
photolysation o f  Ru(II)bpy by a persulphate generating Ru(III), and a sulphate radical
(see Figure 5.1.). Ru(III) is a powerful oxidant, able to abstract an electron from
tyrosine’s arom atic ring, forming an electrophilic tyrosine interm ediate. This can
form cross-linked proteins by two m echanisms dependant on the residue targeted. I f
another tyrosine is nearby, a di-tyrosine cross-link would be form ed through arene
coupling. Alternatively, a nucleophilic lysine or cysteine is attacked by the tyrosine
radical, w ith the final protein com plex being linked from tyrosine to cysteine/lysine.
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Figure 5.1. Proposed mechanism of PICUP
The structure o f  Ru(II)bpy is shown in A. Exposure to light causes oxidation o f  R u(II)bpy by a 
persulphate forming Ru(III) (B). This then oxidises tyrosine residues forming a tyrosine radical 
interm ediate within a peptide chain, PI (C). This radical can then undergo reaction w ith another 
tyrosine residue (D) in a second protein chain, P2, or, react with a nucleophilic residue (E) in a second 
protein chain, P2. Adapted from Fancy and Kodadek (Fancy and Kodadek, 1999).
Ap contains one tyrosine residue (Y10) providing the substrate for Ru(III) to abstract 
an electron from. This can then react w ith a second Ap Y10 or w ith nucleophilic 
residues in the Ap sequence, such as the two lysine residues (K16 and K28). This 
technique has been developed by Teplow  and colleagues to investigate early Ap 
aggregation (Bitan et al., 2001). By analysing the range o f  cross-linking oligom ers 
generated by PICUP, they obtained evidence suggesting that Ap40 and Ap42 
aggregate via different pathways. This theory is based on the prem ise that Ap
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subunits that are closer to each other, such as in an oligomer, are m ore likely to be 
cross-linked than peptide chains that are further away. This leads to the idea that the 
spectrum  o f  bands observed upon gel electrophoresis is m ade up o f  both natural and 
unnatural oligomers. However, PICUP o f  Ap is critically dependant on the 
availability o f  key residues. O ligom erisation o f  the peptide m ay obscure, or require 
TyrlO, lim iting Ap cross-linking rather than prom oting it. Indeed, dityrosine cross- 
linked Ap has been im plicated as playing a central role in A p-m ediated toxicity and is 
a com m on oxidative stress-related protein m odification (Sm ith et al., 2007a). It is 
therefore likely, that a proportion o f  PICUP generated cross-linked Ap are the same as 
naturally form ed oligomers.
5.1.2. Cross-linking of Ap via oxidation
The transient nature o f  the oligomeric species confines analysis by PICUP to relying 
on a “snapshot” o f  the oligomer population at a given point in the aggregation process. 
The PICUP technique also contains an inherent issue when trying to use it for 
assessing oligom eric properties; only a proportion o f  the oligom ers form ed may be 
considered “natural” . This makes investigation o f  their characteristics problem atic. 
To bypass these issues cross-linking via oxidation o f  Ap attem pts to turn the problem  
on its head, prom oting oligomerisation o f  the peptide and consequently increasing 
natural oligom er concentration, which can subsequently be tested for their H 2C>2 
generation. Such oxidative mechanisms have long been im plicated in Ap aggregation 
as well as its mechanism o f  toxicity. Two m ethods have been investigated here both 
utilising H20 2 as the oxidising agent. The first uses Cu(II) as a catalyst, as its ability 
to utilise two oxidation states permits redox cycling. This has been shown to generate 
SDS stable Ap including dityrosine dimers (Atwood et al., 2004). The second
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em ploys the enzyme horseradish peroxidase (HRP) to catalyse the oxidation o f  Ap by 
the H2 O 2 w hich has also been shown to form Ap dim ers (Galeazzi et al., 1999).
The AD brain is in a highly oxidative state, having increased brain m etals and a 
reduced capacity to detoxify oxidation events w ith aging. In addition, evidence from 
our laboratory and others indicate Ap is itself able to generate H 2 O 2 (H uang et al., 
1999a; Tabner et al., 2005; Tabner et al., 2002). This infers that utilising HRP and 
Cu(II) to form early SDS-stable oligom ers m ay generate natural oligom ers 
preferentially. The initial oxidation events could occur on the residues m ost liable to 
attack rather than TyrlO solely (as w ith PICUP).
5.1.3. The purpose of cross-linking
The heterogeneous and dynamic nature o f solutions o f  Ap m akes characterisation o f 
the oligom eric species highly problem atic. Evidence suggests that these oligom eric 
species are responsible for neuronal toxicity in AD yet identification o f  the particular 
oligom er culpable remains a contentious issue. Potential offenders include the 
dityrosine dim er (Barnham et al., 2004; Smith et al., 2007a), tetram ers (Ono et al., 
2009) up to hexam ers (Butterfield and Bush, 2004), 12-mers that are able to bind 
receptors inducing toxicity (Lambert et al., 1998), and a 56 kDa Ap species (A p*56) 
that induces m em ory deficits in transgenic mice (Lesne et al., 2006).
Generation o f  cross-linked Ap serves to “fix” oligomers and prevent further 
aggregation. This would enable the AP species generated to be tested, prim arily  for 





Cross-linking o f  Ap
5.2.1. PICUP of AP40
All o f  our evidence suggested that, even w ithout TFA treatm ent, H FIP-treated rAp40- 
HFIP was largely m onom eric upon wetting. This m ade it an obvious starting point for 
developing cross-linking techniques for identifying toxic oligom ers. The m ore toxic 
A|342 inevitably contains a portion o f  pre-aggregated m aterial, w hich com plicates 
interpretation o f  results. As can be seen in figure 5.2, with non cross-linked Aj340 (no 
light exposure) only the m onom eric species is observed at all three tim e-points despite 
aggregation being observed over this tim e period. Following cross-linking o f  the 
Ap40 sam ples SDS-stable oligomers were observed up to a tetram er in size (see figure
5.2. at 0 hrs aggregation, 1/30 sec light exposure). The distribution o f  these oligom ers 
for all aggregation tim e points follows the pattern outlined by Teplow  and colleagues 
for random  association o f  m onom eric species (Bitan et al., 2001). This assum es that 
the probability o f  a m onom er cross-linking with another m onom er is tw ice as likely as 
a m onom er cross-linking to a cross-linked dim er, and so on and so forth. As light 
exposure increases, the more m onom ers get consum ed into dim ers, and dim ers into 
trim ers and tetram ers. With this in mind, the presence o f  natural, low order oligom ers 
in pre-aggregated solutions should generate more, higher order PICUP cross-linked 
A(340 species. Conversely, the opposite was observed to be the case, w ith the p re­
aggregated Ap40 generating fewer trim ers and tetram ers than freshly w etted A p40.
It was observed that despite increased cross-linking, the level o f  m onom er present did 
not appear to decrease accordingly. This may be partially due to cross-linked species 
having more antibody binding sites, m isrepresenting the level o f  cross-linked Ap.
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F ig u re  5.2. P IC U P  of A04O
25 pM TFA treated Ap40 was aggregated in 10 mM PB at 37°C over 24 hrs with samples taken for 
cross-linking and immunoassay at 0, 4 and 24 hrs. These samples were then subm itted to PICUP cross- 
linking with light exposures o f  0, 1/90 or 1/30 seconds. Samples o f  PICUP cross-linked Ap40 
containing final concentration o f  15 pM AP40, 0.67 mM APS, 33.3 pM Ru(II)bpy and 3.3%  P- 
m ercaptoethanol were diluted 1:1 with SDS gel loading buffer. 15 pi (for Instant blue staining) and 5 
pi (for western blot) o f  these samples were then run on 16.5% SDS Tris-Glycine gels and stained both 
Instant Blue (A) and by western blot probed with mAb 6E10 (B). Immunoassay results are shown in C 
(means ± S.D, n=4)
5.2.2. P IC U P  of AP42
This method was subsequently tested on A|342 (see figure 5.3). When the samples 
were not exposed to light, preventing any cross-linking from occurring, a single band 
was observed representing the monomeric form o f  the peptide. The size o f  this band 
was considerably reduced when the A(342 had been pre-aggregated for 24 hrs, yet no
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oligom eric forms o f the peptide were observed at any tim e point. However, 
im m unoassay data suggested that Ap42 had oligom eric content from the point o f 
being wetted. There was no evidence to suggest that seeds for aggregation were too 
large to enter the gel: loading o f  protofibrillar/fibrillar Ap onto gels shows antibody 
binding on blots corresponding to the position o f  the bottom o f  the w ells on the gel. 
This was not present hence protofibril/fibrillar content is unlikely (also supported by 
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F ig u re  5.3. P IC U P  of Ap42
25 pM TFA treated Ap42 was aggregated in 10 mM PB at 37°C over 24 hrs with samples taken for 
cross-linking and immunoassay at 0, 4 and 24 hrs. These samples were then subm itted to PICUP cross- 
linking for 0, 1/90 or 1/30 seconds. Samples o f  PICUP cross-linked A(342 containing final 
concentration o f  15 pM A(342, 0.67 mM APS, 33.3 pM Ru(II)bpy and 3.3%  P-m ercaptoethanol were 
diluted 1:1 with SDS gel loading buffer. 15 pi (for Instant blue staining) and 5 pi (for western blot) o f  
these sam ples were then run on 16.5% SDS Tris-Glycine gels and stained both Instant Blue (A) and by 
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C ross-linking o f  the Ap42 sam ples, interestingly, did not follow  the typical band 
distribution observed w ith Ap40. Firstly, for freshly w etted Ap42, w hen exposed to 
light for 1/90 sec few  trim ers were observed, yet a larger band o f  tetram ers appeared. 
If  the sam ple was purely m onom eric, trim ers would be tw ice m ore likely to be 
generated than tetram ers suggesting that pre-PICU P, the sam ple contains dim ers 
w hich are subsequently cross-linked to tetram ers. This m ay go some w ay to 
explaining the oligom eric content observed in the oligom eric im m unoassay at T=0. 
W hen the T=0 sample was cross-linked for 1/30 sec, again there appeared to be m ore 
tetram ers, along w ith pentam ers and hexamers, than trim ers generated, supporting the 
idea that dim ers were pre-existing in solution.
W hen the T=4 hrs sample was cross-linked for 1/90 sec, pentam ers w ere also 
observed, which were not seen at T=0. Increasing the tim e for the PICUP reaction to 
1/30 sec showed darker staining for tetram ers and pentam ers than 1/90 sec, 
nonetheless, cross-linked Ap larger than pentam ers were not observed. Following 
pre-aggregation for 24 hrs, PICUP o f  the Ap42 sam ple revealed only a m onom eric 
band suggesting a large portion o f  the peptide had been sequestered into fibrils.
5.2.3. Cross-linking Ap40 using copper and H20 2
As PICUP appeared not to generate natural oligomers w hich could be used for 
subsequent characterisation, other methods were tested to try to form  stable oligom ers. 
C opper and H2 0 2 were tested to try to induce cross-linked Ap40. Incubation o f  these 
w ith Ap40 for 1 hr generated no cross-linked species (data not shown). However, 
when incubated for 24 hrs SDS-stable oligomers up to tetram ers were generated at the 
highest concentrations o f H2 0 2 (see figure 5.4). The level o f  copper ions present 
appeared to have only a small effect on the cross-linked Ap40 made, albeit its
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presence was needed. Later investigations with copper showed it to have its greatest 
effect on A(3 aggregation at sub-equim olar concentrations (see chapter 7). However, 











H20 2 - pM 100 10 1 100 10 1 100 10 1 X  100 X
CuCl2-m M  1.67 0 .167  0 .017  X  X  1.67
F ig u re  5.4. C ross-link ing  A p40 w ith  co p p er an d  H 2C>2 fo r 24 h rs.
25 pM  A(340 in 10 mM PB, pH 7.4, was incubated for 24 hrs at 37°C with various concentrations o f  
H20 2 and copper (II) chloride. Samples were then diluted 1:1 with SDS gel loading buffer. 15 pi (for 
Instant blue staining) and 5 pi (for western blot) o f  these samples were then run on 16.5% SDS Tris- 
Glycine gels and stained both Instant Blue (A) and by western blot probed with mAb 6E10 (B).
5.2.4. C ross-link ing  Ap42 using co p p e r an d  H 2O 2
W hen Ap42 was incubated with copper and H 2 0 2, cross-linking o f  Ap42 again 







H20 2 - pM 100 10 1 100 10 1 100 10 1 X 100 X
CuC12- iuM 1.67 0.167 0.017 X X  1 67
F ig u re  5.5. C ross-link ing  Ap42 w ith  copper an d  H 20 2 fo r 24 hrs.
25 pM A(342 in 10 mM PB, pH 7.4, was incubated for 24 hrs at 37°C with various concentrations o f  
H20 2 and copper (II) chloride. Samples were then diluted 1:1 with SDS gel loading buffer. 15 pi (for
Instant blue staining) and 5 pi (for western blot) o f  these samples were then run on 16.5% SDS Tris-
Glycine gels and stained both Instant Blue (A) and by western blot probed with mAb 6E10 (B).
•  § Multimers
Monomer
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Here, few distinct oligom eric bands were observed, but rather, at the highest H 2 O 2 
concentrations, a large sm ear ranging from  dim er to approxim ately heptam er. At 
lower ^ ( V c o p p e r  concentrations a band o f -1 8  kDa in size was produced, implying 
preferential generation o f tetram ers from cross-linking via this method. It can also be 
seen that incubation with copper alone generated some small oligom ers (dim er/trim er) 
and incubating the Ap42 for 24 hrs alone generated a small proportion o f  dimers.
5.2.5. C ross-link ing  Ap40 using H R P  an d  H 2 O 2
HRP is com m only used to catalyse the oxidation o f  a substrate by H 2 O 2 . This 
appeared to be a far more efficient m echanism  o f  oxidising the Ap40 than using 
copper (II) chloride as observed (see figure 5.6). Incubation o f  the A(340 w ith HRP 
and H2 O2 for only 1 hour at 37°C generated not only dim ers to tetram ers, but also 














HRP -  U/111I 100 1 0 X 100 X
F ig u re  5.6. C ross-link ing  Ap40 w ith  H R P an d  H 2 O 2 fo r 1 h r.
25 pM Ap40 in 10 mM PB, pH 7.4, was incubated for lh r at 37°C with various concentrations o f  H 20 2 
and HRP. Samples were diluted 1:1 with SDS gel loading buffer. 15 pi (for Instant blue staining) and 
5 pi (for western blot) o f  these samples were then run on 16.5% SDS Tris-Glycine gels and stained both 
Instant Blue (A) and by western blot probed with mAb 6E10 (B. Overexposed, C. Normal exposure).
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Bands at ~ 8 -m er and 10-mer Ap40 appeared to be specifically generated by the 
reaction o f  HRP and H 2 O2 . This suggests that these oligom ers are not ju st being made 
from random  association o f m onom ers as w ith PICUP o f  Ap40, as this would predict 
a 7-m er band being larger than an 8 -m er band, and yet a 7-m er band is not present.
Extending the incubation period to 24 hrs generated a strong band at ~45kD a when 
100 pM  H2 O2 and 100 U/ml HRP were used (see figure 5.7). This corresponds to a 
dodecam er (10-mer). A spectrum  o f  other low-order, SDS-stable species were also 
observed. Both HRP and H2 O2 were required for these species to be form ed and over 











H20 2-  pM 100 10 1 100 10 1 100 10 1 X X 100
HRP -  TJ/111I 100 10 1 X 100 X
F ig u re  5.7. C ross-link ing  A04O w ith  H R P  an d  H 2 O 2 fo r 24 h rs.
25 pM AP40 in 10 mM PB, pH 7.4, was incubated for 24 hrs at 37°C with various concentrations o f  
H20 2 and HRP. Samples were then diluted 1:1 with SDS gel loading buffer. 15 pi (for Instant blue 
staining) and 5 pi (for western blot) o f  these samples were then run on 16.5% SDS Tris-G lycine gels 
and stained both Instant Blue (A) and by western blot probed with mAb 6E10 (B).
5.2.6. C ross-link ing  Ap42 using H R P  an d  H 2 O 2
The cross-linking o f Ap42 using HRP generated notably more cross-linked species 
than when performed on A(340. When incubated for only 1 hr at 37°C strong bands 
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In addition, at the highest concentration o f  HRP and H 2 O2 , a relatively strong band 
was visible at -4 5  kDa, presum ably representing a 10-mer, together with a lighter 








H20 2- jiM 100 10 1 100 10 1 100 10 1 X X  100
H R P -U /m l 100 10 1 X 100 X
F ig u re  5.8. C ross-link ing  Ap42 w ith  H R P  an d  H 2 O 2 fo r 1 h r.
25 pM Ap42 in 10 mM PB, pH 7.4, was incubated for 1 hr at 37°C with various concentrations o f H 20 2 
and HRP. Samples were then diluted 1:1 with SDS gel loading buffer. 15 pi (for Instant blue staining) 
and 5 pi (for western blot) o f  these samples were then run on 16.5% SDS Tris-Glycine gels and stained 
both Instant Blue (A) and by western blot probed with mAb 6E10 (B).
Once again, the incubation period was extended to 24 hrs to see if  this effect could be 
am plified. As shown in figure 5.3, incubation o f  25 pM  AP42 for 24 hrs at 37°C 
allow ed aggregation to progress to the point at which the m ajority o f  the Ap has been 
consum ed into fibrils with only a small proportion o f  m onom er rem aining visible on 
the western blot. At the highest HRP concentration, this effect was again observed 
(see figure 5.9), although over exposure o f  the blot did present a 45 kDa band 
rem aining at the highest H2O 2 concentration (data not shown). Despite the propensity 
o f  Ap42 to form fibrils, at the lower concentrations o f  HRP, bands up to hexam er 


























H R P-U /m l 100 10 X 100 X
F ig u re  5.9. C ross-link ing  Ap42 w ith  H R P  an d  H 2 O 2 fo r 24 hours.
25pM  AJ342 in 10 mM PB, pH 7.4, was incubated for 24 hrs at 37°C with various concentrations o f  
H20 2 and HRP. Samples were then diluted 1:1 with SDS gel loading buffer. 15 pi (for Instant blue 
staining) and 5 pi (for western blot) o f  these samples were then run on 16.5% SDS Tris-Glycine gels 
and stained both Instant Blue (A) and by western blot probed with mAb 6E10 (B).
5.2.7. C ross-link ing  Ap m u tan t p ro te ins using H R P  an d  H 2 O 2
Having observed the generation o f  SDS-stable cross-linking o f  both AP40 and AP42 
using HRP and H2 O 2 , functional Ap42 m utants implicated in Ap metal binding (H 6 A, 
H13A and H14A), redox chemistry (M 35N), and dim erisation (Y10A) were 
subsequently investigated. These were anticipated to give some insight into the 
residues and processes involved in the formation o f  these oligomers.
Ap40 and Ap42 presented with a sim ilar banding pattern as observed previously, w ith 
Ap42 showing a greater proportion o f  larger m olecular weight protein bands (see 
figure 5.10). In com parison the Y10A-AP42 shows one band at w hat appears to be 
m onom er in size, clearly im plicating this tyrosine as being critical for the cross- 
linking reaction. H6A-Ap42 has greatly reduced binding affinity for the mAb 6E10,
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as only a small band is observed in the control sample and no bands are observed 
follow ing cross-linking. Similarly, the other two histidine substituted peptides, H13A 
and H14A show far lighter banding than the other peptides. All these sites are within 






F ig u re  5.10. C ross-link ing  o f Ap pep tides w ith  H R P  an d  H 2 C>2 fo r 1 h r.
Freshly wetted 30 pM Ap in 10 mM PB, pH 7.4, was incubated for 1 hr at 37°C w ith 100 pM  H20 2 and 
100 U/ml HRP. Samples were then diluted 1:1 with SDS gel loading buffer. 5 pi o f  these samples 
were then run on 16.5% SDS Tris-Glycine gels and stained by western blot probed with mAb 6E10. A 
= Non cross-linked samples, B = cross-linked samples.
H13A presents a small am ount o f monomer, yet the m ajority o f  the peptide appears to 
be between pentam er and 12-er in size, with particular staining at the 45 kDa species 
(10-mer). The H14A substituted peptide interestingly, presents only one band, also at 
this size. This is particularly interesting as the control blot showed no bands for H14A 
even following over-exposure. This was initially thought to be due to reduced binding 
affinity for the antibody. However TFA deseeding showed this not to be the case (see 
figure 5.11); H14A was too aggregated to enter the gel matrix. Yet, follow ing cross- 
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kDa band, the final peptide tested, M 35N, showed particularly strong staining for 
bands between pentam er and heptam er species.
This initial investigation o f  cross-linking these substituted Ap peptides was perform ed 
on non-TFA deseeded peptides with only HFIP treatm ent. Even though control blots 
indicated no oligomeric species in any o f  the non cross-linked sam ples, this was 
considered to be an artefact o f  the reducing conditions and SD S-instability o f  the 
species; previous work identified some o f  these am ino acid substituted peptides to 
contain high levels o f  pre-aggregated m aterial w ithout TFA deseeding (see figure 
3.10). When these Ap peptides were TFA deseeding prior to their cross-linking 
(figure 5.11) the results obtained were quite different.
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F ig u re  5.11. C ross-link ing  of T FA  deseeded Ap pep tides w ith  H R P  an d  H 2 0 2 fo r 
1  h r.
Freshly wetted 30 pM TFA treated Ap in 10 mM PB, pH 7.4, was incubated for 1 hr at 37°C with 
lOOpM H20 2 and 100 U/ml HRP. Samples were then diluted 1:1 with SDS gel loading buffer. 15 pi 
(for Instant blue staining) and 5 pi (for western blot) o f  these samples were then run on 16.5% SDS 
Tris-Glycine gels and stained both Instant Blue and by western blot probed with mAb 6E10 Non-cross- 
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The TFA deseeded A|3s generated far few er o f  the larger m ultim ers, across all 
peptides. A p42 appeared to retain its tendency for generation o f  higher cross-linked 
species, w ith the 45 kD a species rem aining a preferred species. A|340 on the other 
hand loses this band and shows cross-linked oligom ers up to tetram er in size. Y10A 
rem ained m onom eric, unaffected by the cross-linking process and H 6 A lacks 
reactivity for the mAb 6E10 as only a very faint band was ever observed w ith this 
peptide. TFA deseeded HI 3A only presented cross-linked species at dim er and light 
bands at tetram er/pentam er in size. This was em ulated by H14A, except this peptide 
had a band at tetram er in size in the TFA -deseed control suggesting the deseeding 
process was not as effective on the H14A substituted peptide. The TFA deseeded 
M 35N also generated only a light band at tetram er in size following cross-linking.
5.3. Discussion
The investigation o f  the properties o f  early Ap oligom eric species is plagued by the 
innate tendency o f  Ap for further aggregation. A solution o f  Ap is dynam ic and 
heterogeneous m aking identification o f  a specific Ap species responsible for an 
observed effect problematic. The cross-linking o f  Ap presents a possible solution to 
this problem , “fixing” the oligomer population and enabling characterisation o f  their 
properties such as the ability to generate H2 O2 .
C ross-linking o f  Ap would also be beneficial in circum venting the issues o f  SDS- 
stability o f  Ap species which further hinders identification o f  the toxic Ap species. It 
has long been observed that many oligomeric species appear to be SDS-labile. Ap40 
has been found to migrate as a single band, representing the m onom eric form, and 
Ap42 up to five bands, regardless o f the aggregation state o f  the peptides (W alsh et
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al., 1997). This indicates that Ap40 aggregates are all disaggregated by SDS, w hereas 
Ap42 m ay have several SDS-stable species, but these may be form ed from the 
dissociation o f  fibrils or protofibrils, or from SDS prom oting Ap se lf association.
Under the reducing conditions used here, with no cross-linking perform ed, both Ap40 
and Ap42 m igrated as a single m onom eric band, at all tim e points tested during its 
aggregation. This is presum ably due to a com bination o f  factors: the dynam ic and 
transient nature o f  the interm ediates, together w ith SDS-instability. Follow ing 24 hrs 
aggregation the band representing the m onom er becom es considerably sm aller in 
Ap42 but not the Ap40 sample, indicating the A p42 has been sequestered into larger, 
fibrillar aggregates and that Ap42 has a greater inclination for this. The fact that p re­
aggregation o f  the sample generated no visible oligom ers supports the hypothesised 
m echanism s observed for Ap aggregation: Ap is sequestered into fibrillar species via 
a series o f  transient and highly dynam ic oligom eric intermediates.
5.3.1. PICUP cross-linking
The first technique investigated to achieve cross-linked, stable, Ap was PICUP. This 
technique is based on the idea that self-associating Ap m olecules (oligom ers) are 
closer together, and more likely to becom e cross-linked than those not self­
associating.
W hen this technique was used to compare cross-linking o f  Ap40 pre-aggregated for
different lengths o f  time, no evidence for the presence o f  oligom eric Ap40 was
observed. The banding observed followed the pattern set out in B itan et al, for the
random association o f m onomers (Bitan et al., 2001). This suggests that the Ap40
present at these time points is not self-associating in small, low-order oligom ers. If
self-association is occurring only a very small population o f  Ap40 is partaking at any
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one time. In fact, instead o f  an increase in cross-linked A(340 banding as aggregation 
proceeded, the reverse was observed. This does not m ean that small A p40 oligomers 
do not exist, but supports low  order oligom eric A|340 being a short-lived entity, 
directly sequestered into fibrils. The alternative would be A|340 form ing fibrils 
w ithout oligom eric interm ediates. This would infer early aggregation com m encing 
via linear association o f m onom ers, with subsequent m onom ers jo in ing  the end o f  the 
grow ing chain. This hypothesis is less favoured as evidence im plicating other 
oligom eric Ap playing a role in the m echanism  o f  toxicity is strong (Chrom y et al., 
2003; Kayed et al., 2003; Kim et al., 2003; Lam bert et al., 1998). However, there is 
evidence that Ap40 and Ap42 m ay aggregate via different pathw ays (Bitan et al., 
2003a) . Perhaps the longevity o f  these species in the brain is critical to w hy Ap42 is 
considered m ore toxic than Ap40.
PICUP cross-linking o f  Ap42 suggested that low order, self-interacting Ap42 were 
present prior to cross-linking, in particular dimers. This was the case at 0 and 4 hrs 
aggregation time. This supports evidence that the Ap dim er may be an im portant 
interm ediate species during the aggregation o f  Ap42 as it appears to be som ewhat 
conserved during the process o f  aggregation. Dityrosine dim ers have been im plicated 
as playing a critical role in AD pathogenesis and in H 2 C>2 generation by the peptide 
(Barnham  et al., 2004; Smith et al., 2007a). In addition, when the sam ples were 
cross-linked for 1/90 sec pentam ers were observed at 4 hrs which were not seen at 0 
hrs. This suggests an increase in stable, low-order Ap42 species had occurred over the 
4 hr aggregation time, which PICUP had then cross-linked.
W hen the Ap42 was aggregated for 24 hrs prior to the PICUP cross-linking reaction 
the only band observed was for the m onom er at any cross-linking reaction time. The 
sequestration o f  Ap42 into fibrils by 24 hrs would result in the concentration o f  low-
119
Chapter 5 Cross-linking o f  Ap
order AJ342 being notably reduced in the solution. The likelihood o f  these becom ing 
cross-linked by the PICUP reagents w ould be severely com prom ised and only 
m onom eric A p42 is observed.
The fact rem ains that, despite dim ers appearing to be a significant interm ediate during 
the aggregation o f  Ap42 initiated by its self-association, they were not observed when 
PICUP cross-linking reaction was not perm itted due to the lack o f  light exposure. 
This m eans that these dim ers may not be the dityrosine dim ers that have been 
im plicated in AD pathogenesis (Bam ham  et al., 2004; Smith et al., 2007a). D ityrosine 
cross-linked Ap42 would be SDS-stable, like the PICUP cross-linked Ap42. E ither 
the dityrosine Ap42 dim er is at such a low concentration to not be detected by w estern 
blot or the d im er-self interactions may be other, w eaker interactions, perhaps in 
dynam ic equilibrium  with other low -order self-interactions, w ith dim er the m ore 
favourable. It may, in fact be a combination o f  the two.
The differences between the PICUP cross-linking observed here w ith Ap40 and AP42, 
do not necessarily suggest different aggregation pathways, despite the differences 
between the banding observed. It certainly appears that Ap42 has a far greater 
tendency to form the low-order self interactions that may initiate the aggregation 
process, or at least these interactions are less transient in nature than those o f  Ap40 
(described in figure 5.12). The increased hydrophobicity o f  Ap42 com pared to Ap40 
may provide Ap42 with a greater tendency to self-associate into oligom ers and a 
reduced propensity to disaggregate back to m onomers (hence the difficulties with 
deseeding the peptide). O ligomeric self-interactions are transient in nature for both 
Ap40 and Ap42, but those for Ap42 appear to be longer-lived, in particular dimers. 
This supports evidence by Walsh and colleagues who detected only 3 stable Ap 
species: dim ers, protofibrils and mature fibrils (W alsh et al., 1997).
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F ig u re  5.12. T h e  tendency  fo r agg regation  o f Ap40 an d  A042
The formation o f  early oligomeric A f is in dynamic equilibrium with monomers and other Ap species. 
The tendency o f  one Ap species for forming another is represented by the thickness o f  the arrow.
Although cross-linked Ap was generated by PICUP, the species visualised as bands on 
the gel, com prised a mixture o f  natural oligomers, cross-linked to becom e SDS-stable 
due to their proxim ity, and unnatural oligomers, those form ed by chance. This 
technique was thoroughly investigated by S. Ma and D. Hou (Lancaster University) to 
attem pt to optim ise the cross-linking o f natural oligomers and reduce that o f  unnatural 
oligomers. However, this was largely unsuccessful and although interesting to use for 
investigation o f  Ap aggregation, these cross-linked species were considered 
inappropriate for isolation and characterisation.
5.3.2. C o p p e r an d  H 2 O 2 cross-linking
It has been observed that Ap binds copper, altering the rate o f  Ap aggregation 
(investigated further in chapter 7) (Atwood et al., 1998). The interaction o f copper 
with TyrlO and histidines o f  Ap has also been reported to be linked to the form ation 
o f dityrosine cross-links and the initiation o f  the aggregation process, with this 
considerably enhanced by the addition o f H2 O 2 (Atwood et al., 2004). Due to this 
evidence, this was initially investigated as a potential way to make dityrosine cross- 
linked Ap, so as to specifically characterise its properties.
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Experim ents showed that copper-dependant oxidation can form low order Ap40 
oligom ers w hich m ay seed aggregation o f  Ap. However, the results obtained clearly 
indicated that larger SDS-stable cross-linked Ap species other than dim ers were also 
m ade. As Ap only contains one tyrosine residue, other residues were clearly also 
cross-linked by the reaction. The redox activity o f  copper utilises H 2 O 2 to oxidise 
susceptible residues in Ap such as TyrlO but perhaps also other nucleophilic residues 
such as L y s l 6  o f  Lys28. The oxidised residues then react w ith another nucleophilic 
residue form ing cross-linked Ap, in m uch the sam e m anner as w ith PICUP. The 
difference being that copper binds Ap in vivo, in the oxidative atm osphere o f  the 
brain, therefore the hope is that this process produces natural oligomers, rather than 
the m ixture o f  natural and unnatural oligomers generated by PICUP.
Both Ap40 and AP42 required 24 hrs to generate cross-linked Ap using copper and 
H 2 O 2  yet form ation o f  cross-linked Ap42 was far more prolific generating a range o f  
m ultim eric species. Comparison o f  these results, suggests that the Ap40 and AP42 
behave quite differently when subjected to oxidative stress. This difference m ay be 
due to several reasons, none o f  which exclusive o f  each other:
1. AP42 is more susceptible to oxidative stress. The nucleophilic residues are 
oxidised easier, thus cross-links are enhanced between Ap molecules.
2. Ap42 binds copper with different strength com pared to Ap40. This causes the 
copper to be more effective in oxidising residues in the Ap prim ary sequence
3. AP42 has a greater propensity for aggregation. Its greater hydrophobic 
interactions mean Ap42 molecules are in closer proxim ity to one another 
prom oting cross-linking.
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Regardless, the fact that the levels o f oligom er generation by this cross-linking 
technique correlates with the aggregation speed o f  the peptides, supports the belief 
that the species being form ed m ay be natural to the aggregation process. Interestingly 
though, w ith A(340, where cross-linking was successful, the cross-linking banding 
pattern appears to follow the banding pattern expected for the random  association o f 
m onom ers set out for PICUP cross-linking. This is in contrast to A p42, w here a 
tetram er appears to be the preferred cross-linked species. This m ay be significant as 
recently Teplow  and colleagues generated synthetic oligom ers up to tetram ers and 
found tetram ers to be the m ost toxic to neuronal cell cultures (Ono et al., 2009). In 
addition, it appears that under these conditions Ap42 but not Ap40 can form  SDS- 
stable dim ers with the addition o f  copper alone, perhaps due to A p-copper binding 
stabilising the dim ers. These differences between the peptides again, m ay be due to 
any or all or the reasons outlined above, yet they reiterate the existence o f  clear 
variation between the way AP40 and AP42 react in an oxidative environm ent.
5.3.3. HRP and H2O2 cross-linking
HRP was a far more efficient method for creating SDS-stable cross-linked Ap w ith 
both Ap40 and Ap42 exhibiting cross-linking following only 1 hr incubation but also 
following 24 hrs incubation, with Ap42 more so than Ap40. In addition this banding 
did not follow  the banding pattern for the random association o f  m onom ers. In 
particular, bands at -4 5  kDa and 56 kDa appear darker than sm aller bands. This 
im plies that the cross-links formed are made because o f  a natural tendency for the 
form ation o f  these bonds rather than the random association o f  m onom ers during the 
incubation time. Natural Ap oligomers may have been generated and stabilised by the 
cross-linking which may be m anipulated to enable the investigation o f  such oligomers.
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Interestingly, when Ap42 was incubated for 24 hrs at the highest HRP concentration, 
only a small m onom er band remains, ju s t as if  Ap42 had been allow ed to aggregate 
norm ally and had been consum ed into fibrils. This supports the cross-linked Ap42 
species m ade by HRP and H 2 O 2 as being natural interm ediates in the aggregation 
process. The reaction has perhaps prolonged the longevity o f  these species, effectively 
increasing their concentration in solution at any given time. O f note, this effect was 
not seen when copper was used to cross-link Ap42 for 24 hrs. However, as seen in 
chapter 7, high concentrations o f  copper such as those used in these experim ents 
inhibit the aggregation o f  Ap, therefore under these conditions the cross-linked 
oligom ers probably do not progress to fibrils.
In contrast, the lower concentrations o f  HRP tested continued to show som e cross- 
linked species, sim ilar to those observed with 1 hr incubation. As the supply o f  H 2 O 2 
for oxidative events would be the limiting factor in generating these cross-links it m ay 
be that, with Ap42, the reaction may have largely gone to com pletion by 1 hr. I f  the 
reaction acts to prolong the longevity o f  the oligomeric species, the stability instilled 
in them  by the cross-linking may som ewhat prevent their sequestration into fibrils. 
This suggests that the hydrophobicity o f Ap which drives initial self-interactions may 
cause the formation o f  highly transient oligom eric species. Yet, in the highly 
oxidative environm ent o f  the brain or due to interaction with metals, in particular 
copper, these transient species may be stabilised into longer lived, cross-linked 
species, such as those observed here. This may go some way towards explaining the 
increased toxicity o f Ap42 as Ap42 has greater susceptibility to these events.
If the cross-linking events observed with Ap42 incubated with HRP and H 2 0 2 are 
representative o f  the key oligomeric species made during aggregation, it is possible to 
track the possible order o f  early oligomerisation through the bands observed.
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A lthough in dynam ic equilibrium  with other species, initially dim ers m ay be form ed, 
follow ed by tetram ers. D im ers and tetram ers persist in solution, w ith pentam ers and 
hexam ers forming, presum ably due to the addition o f  a tetram er to either a m onom er 
or dim er respectively. These pentam ers/hexam ers have been identified previously as 
the possible toxic Ap species (so called paranuclei) (Bitan et al., 2003b). This is 
follow ed by the appearance o f  45 kDa and 56 kDa cross-linked species, perhaps m ade 
by the cross-linking o f  these pentam ers and hexamers. The 56 kD a species is o f  
particular interest as it has been reported by Ashe and colleagues as being critical to 
A lzheim er’s developm ent, being present in the brains o f  transgenic m ice (Tg2576) 
prior to the m anifestation o f  the disease (Lesne et al., 2006).
A selection o f  am ino acid substituted Aps were tested for their generation o f  cross- 
linked species. The key result here was that Y10A-AP42 was incapable o f  form ing 
any cross-linked species indicating that this tyrosine residue is central to the 
HRP/H 2 O 2 cross-linking reaction; the oxidation o f  this tyrosine is the critical event 
that perm its the cross-link to be formed as it has been shown to be for the form ation o f  
di-tyrosine dim ers (Barnham et al., 2004; Smith et al., 2007a). However, this tyrosine 
is not required for thioflavin T fluorescence increases associated w ith Ap fibrillisation 
(figure 4 . 1 0 ) suggesting this may be an oligomer specific event.
The other substituted peptides generated some interesting results largely due to the 
difference observed with and without TFA-deseeding o f  the peptides. In chapter 3 it 
was seen that these substituted peptides were highly aggregated until TFA deseeding 
was perform ed. When cross-linking was perform ed w ithout TFA deseeding prior to 
use, H I3A, H14A and M 35N-Ap42 all presented a band at the 45 kDa position. 
These were not present in controls with no cross-linking or in the TFA-deseeded 
cross-linked samples. This suggests that multimers were present in the Ap solutions
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with no TFA -deseeding which subsequent cross-linking stabilised so they were 
visualised on the blot. Following TFA-deseeding the loss o f  these higher m ultim eric 
bands, in particular the 45 kDa band, show that these substituted peptides have a 
reduced propensity to form this 45 kD a cross-linked species com pared to w t A042. 
This highlights the need for effective deseeding prior to the use o f  Ap peptides for 
results to be suitably comparable. The presence o f  varying proportions o f  p re ­
aggregated m aterial in the non-TFA treated samples falsely overestim ated the 
propensity o f  the Ap42 amino acid substituted peptides for form ation o f  cross-linked 
oligom ers via this method. However, the presence o f  this 45 kD a band in non-TFA  
treated Ap samples, which are effectively partially aggregated, shows that they do 
have some tendency to form this cross-linked Ap species. In addition, the reduction in 
cross-linking o f  these samples com pared to wt Ap42 suggests that His 13A, H is l4 A  
and M et35 influence the cross-linking o f  Ap via oxidation by HRP and H 2 0 2, 
although not critically like TyrlO, possibly due to altered Ap metal binding properties.
Ap42 was the only peptide to retain its tendency to form these cross-linked m ultim ers 
following its deseeding with TFA. This may be connected to the increased toxicity o f  
this peptide com pared to the toxicity observed with the other peptides (Barnham  et al., 
2004; Smith et al., 2010; Varadarajan et al., 1999). The increased HRP/H 2 0 2 
m ediated cross-linking that occurs with Ap42 com pared to the other Ap peptides, 
indicates that Ap42 is more susceptible to oxidative attack that generates cross-linked 
oligom ers. This may be a decisive event in the formation o f  toxic oligomers.
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5.4. Conclusions
•  Three potential m ethods o f  cross-linking have been investigated in an attem pt 
to create stable oligomeric Ap species that could be tested for their ability to 
generate H 2 O 2
•  PICUP appeared to m ainly generate random ly cross-linked Ap random ly 
rather than “fixing” the natural oligomeric species form ed during aggregation
•  W ith copper and H 2 O 2  Ap42 becam e cross-linked w ith preference for 
tetram ers
•  W ith HRP and H2 O2 Ap peptides showed some tendency to form  larger 
m ultim ers at -4 5  and 56 kDa
•  Ap42 showed the greatest propensity o f  all the peptides tested to form  cross- 
linked oligomers
•  A P42-Y10A showed no cross-linked species indicating this tyrosine to be 
critical in the formation o f  covalent A p-A p bonds via this m ethod.
•  The susceptibility o f  the Ap peptides tested to  the oxidative m odifications 
driving the covalent cross-linking m ay be directly linked to their ability to 
form  o f  toxic oligomers.
•  The ability to generate these cross-linked Ap species will hopefully perm it 
their capacity for H2 O2  generation to be tested
•  Further testing and characterization o f  these low-order oligom ers, m ight allow  
identification o f  the particular species responsible for neurotoxicity
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Chapter 6 
Development of a technique to immobilise
AP
6.1. Introduction
The experim ents described within this chapter aim ed to develop a technique to 
prim arily enable quantification o f  H 2 O 2  generation from Ap at different stages o f  its 
aggregation. M uch o f  the evidence thus far supported indications that H 2 O 2  was 
generated in a catalytic m anner by a particular type o f  small oligom eric species. 
N onetheless, the ever-changing quaternary structure o f  Ap in solution makes 
elucidation o f  the AP species responsible for H 2 O 2 generation seem ingly 
unachievable. However, the idea arose that if  a solution o f  Ap was prevented from 
aggregating whilst these H 2 O2 generating species were present, it should still generate 
H 2 O 2 . W ith this in mind, the method o f im mobilising Ap on the m Ab 6E10 was 
developed (depicted in figure 6.1). This antibody binds Ap with strong affinity and 
has been shown to prevent Ap from further aggregation (Taylor et al., 2003). Using it 
to capture Ap at various stages o f  its aggregation was hoped to provide a “snapshot” 
o f  oligom eric species present at any given moment.
This idea was developed through many stages to try to optim ise the protocol. The 
initial results described show some o f that developm ental process. The m ethod has 
not been fully finalised. However, the best m ethod to date has been used to look at 
the ability o f  Ap42 at different stages o f aggregation to generate and also degrade 
H2 0 2. Additionally, this method has been utilised to test Ap42 substituted peptides 
and also the HRP/H 2 0 2 cross-linked Ap generated in chapter 5.
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Ap aggregated over time and monitored by Thioflavin T and Amplex Red
\ V 7 ^V 7 XV 7
Samples taken at specific time points, immobilised on the antibody 6E10,
and incubated for 48 hours
XV 7
Samples of the incubation buffer taken for Amplex red testing
F ig u re  6.1. S chem atic of the m ethod ra tio n a l fo r im m obilisa tion  o f A p fo r 
d e te rm in a tio n  o f H 2 O 2 generation
6.2. Results
6.2.1. In itia l developm ent of im m obilisation o f Ap
The first attem pt at immobilisation o f Ap utilised Iwaki M axisorb 96 well m icrotitre 
plates coated with mAb 6E10. Ap was aggregated for different tim es and then 
incubated on the 6E10 to capture it. Once captured it was washed with 10 mM  PB x 3 
then incubated in more PB for 24 or 48 hrs. The PB was then removed from the wells 
and its H2 O2 concentration determined by Amplex red. This technique proved 
unsuccessful as the plates themselves were designed for m axim um  antibody binding 
and not for the long incubation times we needed. Consequently, the treatm ent on the 
surface o f  the wells generated hugely inflated background fluorescence readings in the 
Amplex red assay. This created problems when trying to decipher a small positive 
signal above the large background fluorescence due to the size o f  the errors. Other 
plates were tested but all carried the same problem. However, throughout this testing,
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there appeared to be a trend for slightly elevated fluorescence from the wells that had 
Ap captured on the antibody, especially from the wells with earlier time points.
From buffer control samples in Ap aggregation experim ents we knew  that the tubes 
used for aggregating Ap in (0.6 ml Greiner PCR tubes) did not generate high 
background fluorescence in the Amplex red when incubated for over 24 hrs. For this 
reason, these tubes were tested to see if  their inner surface could substitute for w ells o f  
a m icrotitre plate. This proved som ewhat more successful (see figure 6.2) as the 
fluorescence from control tubes was brought down to normal levels which m ade the 
positive signals from those tubes with Ap im mobilised inside clearer.
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F ig u re  6.2. H 20 2 generation  from  im m obilised Ap42
25 pM  AP42 was aggregated over 48 hrs in 10 mM PB, pH 7.4 at 37°C. At various time points during 
the aggregation process samples o f  the Ap42 solution was taken and incubated in 0.6 ml tubes, p re­
coated with 6E10 to capture a “snapshot” o f  the oligomeric species present. The tubes were then 
washed with 3 x 1 0  mM PB then incubated for 48 hrs in PB. This buffer was then assessed for its H 20 2 
concentration by Amplex red. A = Thioflavin T fluorescence, B = H 20 2 generated from immobilised 
A 042 from each o f  the time points. Results are means ± S.D (n—3)
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N ot only w ere positive fluorescence signals observed but the earlier tim e points o f  2 
and 4 hrs AJ342 incubation appeared to generate m ore H 2 O 2 than the other tim e points. 
This data supported our hypothesis that early Ap species prevented from  further 
aggregation retained the ability to generate H2 O 2 . However, the concentration o f  
H 2 O 2 generated was very low ( - 1 0 0  nM) and the errors associated w ith the 
experim ental procedure considered too large. The quantity o f  Ap captured by the 
antibody needed optimisation. We tried maxim ising the surface area to volum e ratio 
using dynabeads: small magnetic beads that could be coated w ith 6E10 inside the 
tubes. This was successful to a degree with 0.5 pM  H 2 O 2  generated from  Ap42 aged 
for 1 hr, yet was excessively costly for the samples we w anted to test so developm ent 
o f  Ap im m obilisation required further consideration.
6.2.2. The immobilisation of Ap
The final m ethod decided on to immobilise Ap came from the suggestion that a 
surface m ay not be required to attach the antibody to: the antibody itse lf inhibits 
aggregation o f  Ap and is large enough to be pelleted by centrifugation, w hen A p- 
bound. The level o f  centrifugation required was first tested using biotinylated-6E10 
(see figure 6.3). It was clear from these results that ultracentrifugation in the airfuge 
would be the m ost efficient method for pelleting the antibody. One hr at approx 
136,000 x g was sufficient to remove over 95% o f  the fluorescence signal from  the 
biotinylated 6E10 original signal.
The m ethod was also tested to ensure that following im m obilisation o f  A p on the 
antibody, the Ap was also centrifuged down into a pellet. Ap42 was pre-aggregated 
for 3 hrs, immobilised for 2 hrs then centrifuged in the airfuge for 3 hrs to ensure 
m axim um  recovery o f  AP in the pellet. Thioflavin T results indicated this was
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successful (see figure 6.4) with fluorescence in the supernatant approaching PB levels 
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F ig u re  6.3. T he  cen trifugation  of b io tiny la ted  6E10
A range o f  biotinylated 6E10 dilutions were made in 10 mM PB. These w ere then centrifuged for 1 or 
2 hrs at 16,110 x g and also for 1 hr in the airfuge at approx. 136,000 x g. 3 x 100 pi samples w ere 
taken before and after centrifuge steps and coated onto a clear 96 well M axisorb m icrotitre plate. The 
level o f  antibody present in the sample was then detected using streptavidin-Europium  detection used 
for the oligomeric immunoassay. Results are means ± S.D (n=4)
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F ig u re  6.4. T h e  u ltracen trifu g a tio n  of im m obilised  Ap42
50 pM A f42  was aggregated in 10 mM PB at 37°C for 3 hrs. The mAb 6E10 was then added to the 
solution to a final concentration o f  1 pg/ml and incubated for 2 hrs to allow antibody binding, then 
placed in the airfuge and spun at approx 136,000 x g for 3 hrs. Samples were taken for thioflavin T 
fluorescence determination prior to adding the antibody, from the supernatant and resuspended pellet 
and control PB samples. Results are means ± S.D (n=3)
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Following the 3 hrs centrifugation the sample holder felt warm. To avoid any sam ple 
heating the time for centrifugation was reduced to 90 mins. H owever, this impeded 
recovery o f the immobilised A042 substantially (figure 6.5A). Despite this, the 
subsequent results were still insightful. Af342 was aggregated for various tim es up to 
48 hrs confirm ed by thioflavin T fluorescence. Each o f  these samples were also tested 
for their H 2 O 2  concentration, showing H2 O 2 had been generated in all o f  the sam ples. 
The majority o f  the H2 O 2 generation appeared to have occurred in the initial 3 hrs, 
with the 3 hr sample containing two thirds o f  the H 2 O 2 detected in the 48 hr sample.
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F ig u re  6.5. T he thioflavin T  fluorescence and  H 2 0 2 g en e ra ted  from  Ap42 sam ples 
a t  v a rio u s tim e points over 48 h rs, p rio r  to im m obilisation  o f on m A b 6E10
300 pi o f  25 pM A042 in 10 mM PB was incubated at 37°C for the appropriate length o f  tim e, set o ff  in 
reverse order so they would all be ready for immobilisation at the same time. 100 pi was removed from 
each tube and tested for its fluorescence in both the thioflavin T assay (A) and Amplex red (B). 2 pi 
mAb 6E10 was then added to the remaining 200 pi o f  each sample and incubated for 2 hrs at 37°C to 
allow antibody binding. Samples were then placed in the airfuge and spun for 90 mins at -136 ,000  x g. 
The supernatant was removed and thioflavin T fluorescence determined (A). Results are means ±  S.D 
(n -3 )
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Following im m obilisation o f the peptide and centrifugation in the airfuge this H2 O 2 
was rem oved in the supernatant. Fresh 10 mM PB was added to one set o f  samples, 
and to another set o f  sam ples 1 pM  Ft2 0 2  was added. These were then incubated for 
24 hrs at 37°C. The results obtained from this can be seen in figure 6 .6 .





























F ig u re  6 .6 . T h e  im m obilisation  o f Ap42 on m A b 6E10 a t  v a rio u s tim e points over 
48 h rs , an d  th e ir  ab ility  to g en e ra te  an d  d eg rad e  H 2 O 2
Following im mobilisation on mAb 6E10, ultra-centrifugation and supernatant removal, each tube had 
either 100 pi 10 mM PB added (A) or 1 pM H 20 2 and gently mixed. These were then incubated at 
37°C for 48 hrs and then placed in the airfuge for a further 90 mins. The supernatant from each sample 
was then tested for its H20 2 concentration using the Amplex red assay. Results are means ± S.D (n=3)
Generation o f  H2 O2 into the fresh PB was low, probably a direct consequence o f  the 
lack o f  recovery o f  the im m obilised peptide following centrifugation. The greatest 
Am plex red signal was observed from the sam ple incubated for 6  hrs and
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corresponded to -1 5 0  nM  o f  H 2 O 2 . A lthough this m ethod requires further 
developm ent, the errors associated with the data had been substantially reduced from 
earlier methods.
H2 O 2 was added to the Ap42 sam ples to investigate the idea that Ap m ay not only 
generate H 2 O 2 but also degrade it (figure 6.6B). Interestingly, all tim e points tested 
show ed som e level o f  H 2 O 2 degradation com pared to controls. However, the sample 
pre-aggregated for 48 hrs showed greatly reduced A m plex red fluorescence com pared 
to controls. This corresponded to the sam ple degrading -0 .7  pM  H 2 O 2 . At 48 hrs 
aggregation A p42 w ould be largely fibrillar providing support to earlier evidence that 
fibrils m ay degrade H 2 O 2 .
6.2.3. Immobilisation of HRP/H2O2 cross-linked Ap
Having observed the generation o f  cross-linked Ap oligom eric species (chapter 5) it 
was hoped that these species could be tested for their ability to generate H 2 O 2 . For 
this we tried cross-linking each peptide using the HRP/H 2 O 2 m ethod follow ed by 
im m obilisation on mAb 6E10. A P42-H6A was not tested due to its lack o f  binding 
affinity for the antibody (observed in chapters 4 and 5). N on cross-linked samples 
were also tested as controls. The thioflavin T fluorescence o f  the Ap peptides w ith 
and w ithout cross-linking showed an increase in fluorescence when all the peptides 
were cross-linked (figure 6.7). This indicated that the cross-linking had been 
successful. However, o f  interest was the observation that A p42-Y 10A  showed an 
increase in thioflavin T fluorescence, considering that no stable cross-linked 
m ultim ers were observed on w estern blots from this peptide.
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F ig u re  6.7. T h io flav in  T  o f cross-linked  a n d  non cro ss-lin k ed  A p peptides
75 pM o f  each Ap peptide was prepared in 10 mM  PB and split into 2 samples, 1 to be cross-linked, the 
other as a non-cross-linked control. To the cross-linked sample HRP and H20 2 was added to the Ap to 
final concentrations o f  100 U/ml, 100 pM  and 25 pM  respectively in 10 mM  PB. To the non cross- 
linked sam ples 10 mM PB was added to the peptide to bring it to 25 pM. All samples were incubated 
at 37°C for 1 hr at which point sam ples were taken for thioflavin T fluorescence determination. Graph 
com pares fluorescence obtained from cross-linked (X-link) and non cross-linked (no X-link) before 
immobilisation. Results are means ± S.D (n=3)
Following incubation o f  the Ap peptides in either cross-linking or non-cross-linking 
conditions for 1 hr at 37°C the peptides were im m obilised by addition o f  the antibody 
for 2 hrs and then centrifuged in the airfuge for 2 hrs. Thioflavin T fluorescence was 
m easured prior to im m obilisation and then from the supernatant following 
centrifugation. This again suffered from poor retrieval o f  peptide following 
centrifugation, although the extra 30 m inutes did appear to recover a greater amount 
o f  non cross-linked Ap42 than in the previous experim ent (see figure 6 .8 ). After 24 
hrs incubation at 37°C in fresh 10 mM PB, the H2 O 2 generated from the immobilised, 
non cross-linked sam ples, was m easured (see figure 6.9). The am ount o f  H2 O2 
generated from the Ap42 sample was greatly improved from the previous experiment, 
with over 400 nM H2 O 2 being generated over 24 hrs. This supports the thioflavin T
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data showing that the recovery o f  Ap was som ew hat improved. The other Ap peptides 
were all found to generate significantly less H 2 O 2 than Ap42 (Tukey HSD, p < 0.000).






















F ig u re  6.8. T h ioflav in  T  o f cross-linked  an d  non cross-linked  Ap pep tides before 
an d  a f te r  u ltra c en trifu g a tio n
75 pM o f  each Ap peptide was prepared in 10 mM PB and split into 2 samples, 1 to be cross-linked, the 
other as a non-cross-linked control. To the cross-linked sample HRP and H20 2 was added to the Ap to 
final concentrations o f  100 U/ml, 100 pM and 25 pM respectively in 10 mM PB. To the non cross- 
linked samples 10 mM PB was added to the peptide to bring it to 25 pM. All samples were incubated 
at 37°C for I hr, then 6E10 added at 10 pg/ml and incubated for a further 2 hrs at 37°C and then placed 
in the airfuge for 2 hrs at approx 136,000 x g. Samples were taken for thioflavin T fluorescence 
determination prior to addition o f  the 6E10 and from the supernatant following ultracentrifugation. A = 
Non cross-linked samples, B = Cross-linked samples. Results are means ± S.D (n=3)
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F ig u re  6.9. H 2 O 2 g en e ra tio n  from  non cro ss-lin k ed  A p pep tides
75 pM o f  each Ap peptide was prepared in 10 mM  PB. Additional 10 mM PB was then added to the 
peptides to bring them to 25 pM. All samples were incubated at 37°C for 1 hr, then 6E10 added at 10 
pg/ml, incubated for a further 2 hrs at 37°C and then placed in the airfuge for 2 hrs at approx 136,000 x 
g. Supernatants were removed and 100 pi lOmM PB added to each with gentle mixing. These were 
then incubated at 37°C for 24 hrs, placed in the airfuge for 2 hrs at approx. 136,000 x g. The 
supernatants were removed and tested for their H 20 2 concentration using the A m plex red fluorescence 
assay. Control PB fluorescence has been subtracted and H 20 2 concentration determined. Results are 
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F ig u re  6.10. A m plex red  fluorescence from  co n tro l sam ples b efo re  
im m obilisation
Control sam ples were prepared to contain 10 mM PB, 100 U/ml HRP, 100 pM  H 20 2 and both HRP and 
H20 2, all in 10 mM PB. These were incubated at 37°C for 1 hr and then tested for their fluorescence in 
the Amplex red assay. Results are means ± S.D (n=3), * indicates Tukey HSD, p < 0.000.
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D eterm ining H 2 O 2  generation from  the cross-linked Ap peptides was im peded by the 
presence o f  the HRP used to catalyse the cross-linking reaction. It was hoped that 
follow ing centrifugation o f  the sam ples the HRP w ould rem ain in the supernatant 
along w ith the H 2 O 2 . A ny H RP rem aining in the sam ple would use up any H 2 O 2 
generated as substrate for further oxidation o f  the Ap. Controls showed that following 
incubation o f  the HRP with H 2 O 2 for the 1 hr required for cross-linking to occur 
significantly reduced the fluorescence detected by A m plex red com pared to  the H 2 O2  
alone (Tukey HSD, p < 0.000) (see figure 6.10). This was a drop in H 2 O 2 
concentration from the 100 pM  added to ~1.5 pM  in 1 hr. Furtherm ore, the HRP in 10 
mM  PB after the 1 hr incubation had -3 0 %  o f  the fluorescence from PB alone.
The presence o f  HRP in the Ap sam ples was also be seen in the Am plex red data from 
the pre-im m obilised sam ples but also from the supernatants following centrifugation 
o f  the sam ples (see figure 6.11). This show ed all the Ap sam ples to have negative 
H 2 O 2 readings follow ing cross-linking having used up all o f  the 100 pM  H 2 O 2  during 
the 1 hr cross-linking incubation tim e com pared to the control sample with no peptide, 
which has -1 .5  pM  H2 O 2 rem aining. Interestingly, Y 10A  generated a less negative 
reading than the other peptides following the cross-linking incubation.
Follow ing centrifugation o f  the cross-linked Ap peptides, the Am plex red signal from
the supernatant was below PB controls, indicating the m ajority o f  the HRP was not
centrifuged down with the Ap and was removed in the supernatant. However,
follow ing the 24 hr incubation o f  the im mobilised, cross-linked Ap in fresh 10 mM
PB, the supernatant continued to generate a negative signal in the A m plex red assay.
This indicated that some HRP had remained in the sample. In fact, the signal becomes
m ore negative in both the peptide sam ples and controls. Unfortunately, this means
that attem pts to determ ine w hether cross-linked Ap was able to generate H 2 O 2 were
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unsuccessful. If any had produced any H2 O 2 , it would have been m opped up by the 













/  /  ^  ^  ^  ^  #





Supernatant post 24 
hr incubation
F ig u re  6.11. H 2O 2 g en e ra tio n  from  cro ss-lin k ed  a n d  im m obilised  A p peptides
75 pM  o f  each Ap peptide was prepared in 10 mM  PB. HRP and H 20 2 were added to the Ap to final 
concentrations o f  100 U/ml, 100 pM  and 25 pM  respectively in 10 mM PB. All samples were 
incubated at 37°C for 1 hr, then 6E10 added at 10 pg/ml, incubated for a further 2 hrs at 37°C and then 
placed in the airfuge for 2 hrs at approx 136,000 x g. Supernatants w ere removed and 100 pi lOmM PB 
added to each with gentle mixing. These were then incubated at 37°C for 24 hrs, placed in the airfuge 
for 2 hrs at approx. 136,000 x g. Samples were taken prior to adding 6E10 and from the supernatants 
following both centrifuge steps and tested for their H 20 2 concentration using the Amplex red 
fluorescence assay. Control PB fluorescence has been subtracted and H 20 2 concentration determined. 
Results are means ± S.D (n=3)
6.3. Discussion
To investigate the ability o f  different stages o f  Ap aggregation for H2 O2 generation the 
idea o f  im m obilising Ap was developed. This was based on the hypothesis that if  a 
specific form o f  Ap was responsible for the generation o f  H 2 O2 , then a solution o f Ap 
containing this species would still generate H2 O 2 if  prevented from aggregating. 
C apturing Ap at different times during its aggregation using the mAb 6E10 was 
attem pted in several m anners and the developm ent o f  this technique is still in
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progress. The largest obstacle has been optim ising the am ount o f  Ap captured by the 
antibody and various surfaces were tested to optim ise Ap im m obilisation: m icrotitre 
plates, PCR  tubes, nitrocellulose m em brane and dynabeads. C onsistently during these 
trials, Ap pre-aggregated for shorter lengths o f  tim e appeared to be capable o f  
generating m ore H2 O 2 than those sam ples aggregated for longer times. However, the 
levels o f  H 2 O 2 detected at any tim e point were low often w ith large errors associated.
The final protocol described here, still requires further work. This used 
ultracentrifugation to pellet the antibody, taking the im m obilised Ap w ith it. Test 
experim ents had shown good recovery o f  im m obilised Ap w hen put in the airfuge for 
3 hrs. How ever, because o f  issues w ith possible sam ple heating this centrifugation 
tim e was reduced to 90 m ins for the im m obilisation o f  different aggregation time 
points o f  Ap yet this was detrim ental to sam ple recovery. Recovery was improved by 
increasing the tim e to 2 hrs (see figure 6.5A T=0 com pared to figure 6.8A Ap42) 
nonetheless, this aspect requires im provem ent. A chilled centrifuge was considered. 
H owever, placing the airfuge in the cold room may still allow  the sample holder to 
warm  som ew hat overtim e and condensation w ithin the air pipes should be avoided. A 
chilled centrifuge was tried overnight at -1 6 ,0 0 0  x g but Ap recovery was poor. 
Increasing the concentration o f  6E10 m ay be useful or perhaps using a polyclonal 
antibody for Ap instead o f  6E10. This would allow  more cross-linking o f  the 
antibodies w ith the Ap, m aking larger com plexes that should sedim ent easier.
W hen Ap aggregated for different lengths o f  tim e were im m obilised by this method, 
the recovery o f  peptide was low. In addition, w ithout a reliable m ethod o f  calculating 
the concentration o f  Ap in solution, that isn’t affected by the aggregation state o f  the 
peptide (which would obviously be an issue here) no quantification o f  recovery rate 
can be calculated. A lthough thioflavin T fluorescence was m easured, this serves only
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as a guide as it is dependent on both concentration and aggregation state o f  the 
peptide. It was hoped that the high recovery rate observed in the test conditions would 
be replicated, in which case sam ples at each tim e point could have been directly 
com pared. However, as it stands, the results obtained for H 2 O 2 generation by each 
tim e point im m obilised may reflect the am ount o f  Ap recovered after 
ultracentrifugation rather than differences in the type o f  Ap present and its H 2 O2 
generating ability. H ow ever unsuccessful this experim ent was in som e ways, it is 
very close to becom ing a useful technique. The error bars are far reduced from the 
earlier m anifestations o f  the protocol and the fact that H 2 O 2  generation is still detected 
supports the hypothesis that a specific form o f  early Ap species is responsible for its 
form ation. M uch im provem ent is obviously required but if  a technique such as this 
could help in identifying the oligom er/oligom er population that generates the H 2 O 2 , it 
m ay provide a specific target for potential therapeutics. It could also determ ine 
w hether potential aggregation inhibitors also reduce these earlier potentially toxic 
species. In addition, much aggregation inhibitors/potential therapeutics cannot be 
assessed for their effect on H2 O 2 generation by Ap due to adverse reactions between 
them  and the reagents used. This technique enables this as, theoretically, the test 
agent is washed o ff  w ith only the Ap species remaining.
All AP42 tim e points tested also showed some ability in aiding H2 O 2 degradation 
com pared to controls. This indicates that throughout the aggregation process there are 
A p species present that are susceptible to oxidation by low levels o f  H 2 O 2 . This 
indicates that the H2 O 2 concentration m easured from solutions o f  Ap is the net 
quantity o f  that being generated and degraded, possibly w ith different Ap species 
being responsible for the opposing actions. In fact, if  oxidation o f  Ap is an oligom eric 
stabilising event, as proposed in chapter 5, the reduction o f  H 2 O2  by the immobilised
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Ap m ay have been due to such events. Ap42 aggregated for 48 hrs showed the 
largest difference, w ith over 70%  o f  the H 2 O 2 added degraded. A t this tim e point it 
can be assum ed that the large m ajority o f  the A p42 has been sequestered into fibrils, 
indicating that fibrils m ay be particularly susceptible to oxidative dam age from the 
H 2 O 2 , prom oting its degradation within the solution. There are m any ways in which 
elevated H 2 O 2 m ay induce oxidative m odification o f  Ap. Carbonyl adducts, histidine 
loss and dityrosine cross-links, appear to cause a raised resistance o f  Ap to proteases 
(Lynch et al., 2000). Several other oxidative m odifications o f  tyrosine are possible; 
DOPA, dopam ine and dopam ine quinine adducts have been extracted from AD 
plaques (Ali et al., 2004). O ther m odifications to Ap found w ithin senile plaques 
include M et35 oxidation (discussed in 4.3.3.4) and 2-oxo-histidine (Atwood et al., 
2000a). This m ay point tow ards m ature fibril and plaque form ation being a protective 
m echanism  against oxidative stress, being a “sink” for oxidative m odification.
A lthough im m obilisation o f  Ap has shown H 2 O 2 generation from  Ap prevented from 
further aggregation, the Ap species im m obilised rem ain heterogeneous. This m eans 
that the species responsible for the H2 O 2 generation still cannot be identified. It was 
put forward that m aybe one, or several o f  the cross-linked species generated in chapter 
5 m ay actually be responsible. For this reason Ap peptides were cross-linked with 
HRP and H2 O 2 as described in chapter 5 and im mobilised to try to determ ine H 2 O2  
generation from these species. Interestingly, thioflavin T results from these sam ples 
showed increased fluorescence from all o f the cross-linked sam ples com pared to their 
non cross-linked counterparts, including Ap42-Y10A. This peptide showed no cross- 
linked species on SDS-gels yet this thioflavin T data suggests otherw ise. It is 
therefore posited that cross-links are made by the oxidation o f  AP42-Y10A  by HRP
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and H2 O 2 . H owever, w ithout the tyrosine residue partaking in the cross-link, they are 
unstable in the reducing conditions o f  the SDS-gel.
Recovery o f  the im m obilised Ap was m arginally im proved com pared to the Ap time 
course experim ent due to increasing the time for centrifugation (figures 6.5 and 6.6). 
In support o f  this, results w ith the non cross-linked sam ples showed AP42 to generate 
approxim ately 3 tim es the highest level o f  H 2 O 2 obtained w hen Ap42 had been 
im m obilised at different aggregation time points. A lthough there may have been 
different rates o f  peptide recovery o f  the substituted peptides, it is interesting to note 
that H 2 O 2 generation was detected in all the sam ples, yet all reduced in com parison to 
w t A p42, supporting earlier observations that none o f  the substituted residues tested 
are pre-requisites for H 2 O 2 generation.
Unfortunately, the presence o f  the HRP used to generate the cross-links consequently 
elim inated the ability to determ ine the H 2 O 2 generation from  the cross-linked 
oligom ers. A lthough the m ajority o f  it rem ained in the supernatant following 
ultracentrifugation o f  the samples, enough rem ained to remove any H 2 O 2  potentially 
m ade by the Ap. In fact the presence o f  the HRP brings fluorescence below control 
levels. As HRP is one o f  the com ponents o f  the A m plex red w orking solution, this 
was first thought to be possibly due to altering the reaction dynam ics. However, the 
fact that the negative signal further decreases follow ing the 24 hr incubation indicates 
the HRP rem aining continues to use up all the residual oxidising pow er from the 
buffer. The issues with HRP here may be able to be overcom e if  recovery o f  Ap could 
be im proved sufficiently to perm it the addition o f  an im m obilised-Ap w ashing step 
into the protocol. This would hopefully rem ove any residual HRP thus allow ing H 2 O2 
generation from the cross-linked peptides to be determ ined.
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A nother possibility that has been investigated is the use o f  cerium  chloride to visualise 
H 2 O 2 generation from the cross-linked species separated by gel electrophoresis (Seitz 
et al., 1991). This was investigated using L-A AO supplied with an L-AA in the wash 
solution, and found to generate H 2 O 2 from  w ithin the gel m atrix form ing a band on the 
gel. This was developed to improve its sensitivity for H 2 O 2 as I have found A(3 to 
generate only a very small level o f  H 2 O 2 . However, the experim ents for this are yet to 
be com pleted with Ap and will require careful consideration o f  w hether non-reducing 
conditions should be em ployed and also w hether a sufficient quantity o f  Ap can be 
loaded onto a gel to get a signal from.
A lthough this experim ent was unsuccessful at its objective, the fact that Ap42-Y 10A 
appeared to be less susceptible to oxidative attack by H 2 O 2 is o f  interest. In other 
words, TyrlO  is the prim e target for oxidative m odification o f  Ap42 (supporting other 
research (A twood et al., 2000a)). And, as has been observed, this m odification is 
critical for the generation o f  SD S-stable cross-linked Ap m ultim ers. The oxidative 
nature o f  neuronal cells supports the idea that oxidation o f  this residue m ay be a key 
step in the initiation o f  aggregation o f  the peptide in the brain.
6.4. Conclusions
•  A  protocol was developed to enable im m obilization o f  Ap aggregates for 
determ ination o f  their ability to generate H 2 O 2
•  Testing o f  Ap sam ples taken during its aggregation consistently showed Ap 
im m obilized earlier in its aggregation generated m ore H 2 O 2  than later time 
points
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•  The tim e point corresponding to m ature Ap fibrils show ed increased H 2 O2  
degradation com pared to other tim e points
•  The observation o f  H 2 O 2  degradation as well as generation indicates that the 
m easured concentration o f  H 2 O 2 from  a solution o f  Ap can be considered the 
net concentration, perhaps with different Ap species responsible for its 
generation and degradation
•  W hen im m obilized, A p42 generates m ore H 2 O2 than Ap40 and the other Ap42 
am ino acid substituted peptides (Y10A, H I3A, H14A  and M 35N)
•  A p42-Y 10A  form s cross-links using H RP/H 2 O 2 detectable by thioflavin T 
fluorescence increases yet these are not SDS-stable
•  H 2 O 2  generation could not be determ ined from cross-linked Ap sam ples due to 
a small am ount o f  HRP rem aining in the sample. Im proving peptide recovery 
m ay enable this testing as w ashing o f  the im m obilized Ap m ay be possible
•  TyrlO  was identified as possibly the prim e target for oxidative m odification o f 
Ap42, w hich m ay be key for stabilization o f  early  oligom eric Ap
•  This m ethod still requires further w ork especially in respect o f  peptide 
recovery
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Chapter 7
The effect of metal ions on H20 2 generation
by P-amyloid
7.1. Introduction
M etal ions are a key contributor to pathogenesis o f  AD, having clear involvem ent in 
prom oting Ap aggregation and ROS generation, both o f  w hich are central pathological 
events in disease developm ent. The brain has com plex system s to regulate m etal ion 
m etabolism ; although vital to enzym atic and structural protein functions, their 
potential for redox reactions needs to be tightly controlled to prevent oxidative 
dam age to cellular com ponents (Hureau and Faller, 2009).
7.1.1. Metal ions in AD
The biom etals copper (Cu), iron (Fe) and zinc (Zn) have been w idely im plicated in the 
pathogenesis o f  AD. The brain shows an age-dependant concentration o f  Cu, Fe and 
Zn in the neocortex (H uang et al., 2004) and strong signals for these m etals are 
observed in a typical senile plaque (see figure 7.1) (Liu et al., 2006). Both Ap and its 
precursor APP are m etalloproteins, hence dyshom eostasis o f  metal interactions may 
be linked to AD. The presence o f  m etals prom otes Ap aggregation and conversely, 
m etal chelators are able to dissolve Ap deposits and attenuate am yloid burden in APP 
transgenic m ouse m odels o f  AD. Even trace am ounts o f  these metals can initiate 
auto-aggregation o f  Ap and lead to its neurotoxicity (H uang et al., 2004; Liu et al., 
2006). This evidence supports the idea that the dysregulation o f  cerebral biometals 
and the subsequent redox reactions o f  these metal ions, leading to oxidative stress, 
m ay play a prom inent role in AD developm ent (Huang et al., 2004; Liu et al., 2006).
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F ig u re  7.1. T h e  e lem enta l p ro file  o f a typ ical senile p laq u e
Senile plaques were identified from cryo-sectioned AD brain tissue then stained and analysed for their 
elem ental content. The increased concentration o f  these metal ions can be seen localised within the 
plaque. (Liu et al., 2006)
APP is also im plicated in copper hom eostasis and is believed to modulate copper- 
induced toxicity and oxidative stress in neuronal cultures. This is supported by 
evidence that APP knockout m ice exhibit increased brain copper levels (W hite et al., 
1999) presum ably due to the loss o f  a copper chelation capacity o f  APP (one possible 
biological role). In line with this, overexpression o f  the APP Swedish m utation in 
m ice reduces brain copper levels prior to am yloid plaque form ation (M aynard et al., 
2002). In these m ice, iron and zinc are also dysregulated (Sm ith et al., 2007a).
Further evidence for the role o f  metal ions in AD pathogenesis is the fact that the AD 
brain shows a fourfold decrease in the level o f  gene expression for metal regulatory 
proteins (Colangelo et al., 2002). Consequently, the AD brain has reduced capability 
to deal with the oxidative insults inflicted by increased redox active metal ion activity. 
In fact, cerebral biometal metabolism  may be tightly linked to the processing o f  APP 
as the 5 ’untranslated region (5 ’UTR) o f  APP m RN A has been found to hold a 
functional iron-response elem ent (IRE). Fe and Zn ions can prom ote APP expression 
via this IRE in a dose-dependent m anner w hilst copper can mediate its expression via 
the prom oter region, supporting its role as a redox active m etalloprotein (Liu et al., 
2006; Rogers et al., 2002).
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7.1.2. p-amyloid, metals and redox chemistry
It has long been observed that AP peptides can initiate synaptosom al lipoperoxidation 
and raise levels o f  H2 O 2 inducing neuronal oxidative stress (Behl et al., 1994; 
Butterfield et al., 1994). This m ay be through causing an indirect increase in ROS, 
decreasing antioxidant activity or through m ediating dysfunction o f  m itochondria 
(Chauhan and Chauhan, 2006). The idea that the source o f  this oxidation could 
actually be the peptide itself was not considered at the time. However, in 1999, 
Huang et al reported characteristics o f Ap that lent itself to oxidative abilities; Ap was 
found to be redox active, able to generate H 2 O 2  directly, in a cell free m anner via 
reduction o f  m ultivalent metal ions (Huang et al., 1999a).
It is believed that the high affinity interactions betw een redox active m etal ions and 
Ap through its histidine residues provide a structural environm ent capable o f  
facilitating these redox reactions. Ap has been found to reduce Cu(II), and, albeit to a 
lesser extent, Fe(III). The ensuing reactions generate H2 O 2 and hydroxyl radicals 
(Liu et al., 2006). Both o f  these are potent ROS capable o f  dam aging cellular 
com ponents and may be directly related to the w idespread oxidative dam age observed 
in the AD brain (Sm ith et al., 1996). It is proposed that following redox reactions 
between Ap and the metal ion, the reduced metal ion participates in a Fenton reaction 
with H2 O 2  to m ake the hydroxyl radical. The H aber-W eiss reaction can form  more 
hydroxyl radicals from superoxide and H2 O 2 , catalysed by the metal ion. The reaction 
schem e outlined below has been proposed, where M (n+1)+ is the oxidised metal ion,
and M n+ represents the reduced ion (Huang et al., 1999a; Liu et al., 2006).
1. (AP)2 + M (n+1)+ AP:AP+' + M n+
2. M n+ + 0 2 M (n+1)+ + 0 2" >
3. 0 2" + 0 2" + 2H+ H2 O 2 + O 2
m aking H2 O 2
Redox reactions
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4. M n+ + H20 2 M (n+,)+ + O H ' + O H ‘ Fenton R eaction
5. 0 2‘ + H20 2 O H '+ OH  + 0 2 H aber-W eiss Reaction
M etal ion hom eostasis is altered in AD, accum ulating to 3-5 fold normal 
concentrations. This is thought to create an environm ent prim ed for these A p- 
m ediated redox reactions (Lovell et al., 1998). Cu(I) is far m ore reactive than Fe(II) 
when taking part in hydroxyl radical form ation in the Fenton reaction, corresponding 
w ith the belief that copper is m ore im portant in these reactions in AD. The radicalised 
Ap that is produced m ay react w ith oxygen, reform ing the non-radicalised Ap, the 
conform ational changes induced possibly prom oting its oligom erisation (Huang et al., 
1999b). Vital to these reactions is thought to be the oxidation o f  the sulphur atom o f 
M et35-A p as it acts as a source o f  electrons providing the electrochem ical property 
needed for these reactions (Varadarajan et al., 1999). Oxidised M et35-A p has been 
isolated from AJD am yloid plaques and is copper bound (B utterfield and Bush, 2004; 
Smith et al., 2007a). In addition, the generation o f  H20 2 by A p-m etal com plexes is 
theoretically catalytic in nature, and the subsequent Fenton chem istry generates highly 
reactive hydroxyl radicals thus m aking it a potent source o f  ROS (Butterfield et al., 
2001; Huang et al., 1999a; Tabner et al., 2002).
D ifferent Ap species have varying levels o f  these redox properties correlating with 
their aggregation potential, neurotoxicity to cell cultures and AD oxidative 
neuropathology such that AP42 (hum an) > AP40 (hum an) > AP40 (rat/m ouse) (Huang 
et al., 1999b; Liu et al., 2006). The H20 2 generated by Ap is thought to mediate 
cytotoxicity as addition o f  catalase detoxifies the H20 2 and reduces cell death in vitro 
(Huang et al., 1999b). If the H20 2 generated by Ap is not efficiently degraded or 
detoxified, it is feasible that these interactions are responsible for the oxidative stress
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induced neuronal lesions and, the ensuing loss o f  neurons and intellectual faculties 
(Deraeve et al., 2006). Yet there is conflicting evidence on the aggregation state- 
dependency o f  these reactions. Some have found them  to be independent o f 
aggregation state. H owever, as the presence o f  copper induces Ap auto-aggregation, 
and the process o f  oligom erisation is dynam ic by nature, the exact state o f  Ap is 
nothing but am biguous. In fact, m any believe that the physiochem ical properties o f 
Ap are thought to determ ine w hether the peptide acts as a pro- or anti-oxidant 
indicating, at an absolute m inim um , a partial dependency on its conform ation and 
consequently its aggregation state (A twood et al., 2003; Gaeta and Hider, 2005).
7.1.3. Ap and copper
Copper is the m etal ion largely im plicated in m etal-A p m ediated toxicity due to its 
redox capabilities and binding affinity for Ap. In neuronal cells copper is norm ally 
kept bound to key regulatory proteins to prevent its redox activity and production o f 
dam aging ROS. Extracellular concentrations o f  copper are norm ally m aintained at 
0.2-1.7 pM. Follow ing presynaptic excitation it is released into the synaptic cleft 
where it reaches up to a concentration o f  15 pM . The concentration o f  copper found 
w ithin senile plaques however, is -4 0 0  pM  (Lovell et al., 1998; Smith et al., 2007a). 
This is a grossly inflated local level and is presum ably sequestered there bound to Ap, 
facilitating ROS generation (discussed further in 1.5.2).
Ap itself has been found to bind Cu(II) at sub pM  concentrations and does so w ith an 
unusually strong affinity indicating a role for this binding in vivo (Atwood et al., 1998; 
Atwood et al., 2000b). Even synthetically made Ap contains significant 
concentrations o f  Cu (and Fe) (Turnbull et al., 2001a; Turnbull et al., 2001b). 
Despite this, it is also believed that the m anner in w hich Ap binds copper ions allows
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the ion to m ove into and out o f  the fibril architecture (Karr et al., 2005). It has been 
shown that Cu(II) induces Ap aggregation, w ith this effect being greater w ith Ap42 
and under m ildly acidic conditions (such as the m ild acidosis observed in AD brains) 
(A twood et al., 1998). In addition, Cu(II) bound Ap has altered PM  interactive 
properties w hich m odify its binding and its functional abilities (Karr et al., 2005). 
C opper has two oxidation states, o f  either Cu(I) or Cu(II) perm itting electron transfer 
reactions producing ROS, given an electron donor/acceptor to react with. A p42, as 
well as being tightly linked to AD pathogenesis, has the greatest affinity for metal 
ions. It has been found that theoretically Ap42 can bind up to 2.5 Cu(II) ions per 
peptide unit (A twood et al., 2000b). It has been suggested that the am ount o f  H 2 O 2 
produced by the peptide m ay be directly correlated to the num ber o f  Cu(II) ions bound 
to the peptide and that this production is catalytic in nature (Deraeve et al., 2006).
7.1.4. Ap and iron
Iron is also found localised in plaques, albeit at a m uch low er concentration o f  around 
1 pM  although this could be a secondary effect due to copper as copper can m ediate 
cellular iron uptake (Lovell et al., 1998). A lthough iron is redox active and prom otes 
aggregation Ap, it is unclear w hether it takes part in the electron transfer reactions 
w ith Ap as Ap is not believed to interact directly with iron in vivo as they do not co- 
purify. It is thought that the altered iron hom eostasis seen in AD m ay be due to 
secondary effects such as altered activities o f  oxidatively dam aged enzym es or sim ply 
due to copper-m ediated cellular iron uptake (Sm ith et al., 2007a).
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7.1.5. Ap and zinc
Zinc irons are released into the synapse during signal transm ission to a concentration 
o f  200-300 pM , but like copper ions, their concentration is increased in senile plaques 
to as high as 1 mM  (A ssaf and Chung, 1984; Lovell et al., 1998). However, only 
m ature cored senile plaques test positive for zinc reactivity (Lee et al., 1999), 
im plying that the sequestration into plaques is a later event in the am yloid pathology 
o f  AD. Zinc is found at increased levels in the CSF o f  AD patients (Hershey et al., 
1983). The role o f  zinc in the pathogenesis o f  AD is unclear due to some conflicting 
data. A ffinity calculations o f  the interaction o f  zinc w ith Ap indicate they m ay 
interact under physiological conditions (Bush et al., 1994). Zinc has been found to 
prom ote aggregation and plaque form ation, w ith the m etal precipitating Ap at alkaline 
pHs. However, Ap40 and Ap42 are equally affected (Atwood et al., 1998). Further 
data suggests that zinc m ight be m ore neuroprotective rather than neurotoxic as it 
appears to attenuate the toxicity o f  Ap to neuronal cortical cultures (Lovell et al., 
1999). It has been proposed that zinc ions may protect against m em brane 
perm eability changes seen in AD. The zinc ions m ay provide com petition for the 
copper ions for Ap binding, thereby inhibiting the toxic copper m ediated A p redox 
chem istry (Cuajungco et al., 2000; Smith et al., 2007a).
7.1.6. Aims
Earlier w ork had identified that Ap generated H 2 O 2 w ithout the addition o f  m etal ions 
to aggregating solutions. It has also been observed that Ap not only generates but also 
degrades H2 O 2  in different proportions when prevented from  aggregating at different 
tim e points during its aggregation, im plicating the involvem ent o f  specific Ap species 
in each o f  these processes. Both o f  these processes are likely to be reliant on the
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presence o f  trace levels o f  m etal ions in solution. A lthough the effects o f  metal ions 
on Ap aggregation have been investigated previously, this study set out to com plete a 
system atic investigation, not only looking at the aggregation o f  Ap over tim e, but also 
at how  this effects H 2 O 2  generation by Ap over this period. As the binding o f  metal 
ions m ay induce m ultiple effects, altering the aggregation o f  A p but also m ediating its 
redox capabilities, the addition o f  metal ions m ay have com plex effects on the 
resultant generation o f  H 2 O 2 over the course o f  its aggregation.
7.2. Results
A lthough the effects o f  m etal ions on Ap aggregation have been studied, here metal 
ions have been tested to enable observation o f  their effects on H 2 O 2  generation 
throughout the aggregation process. This m ay be m ediated by com plex m etal-A p 
interactions altering aggregation kinetics and also facilitating redox reactions. A 
limited study has been perform ed on the effect o f  iron and zinc ions on aggregation 
and H 2 O 2 generation. N onetheless copper is considered to be principal m etal ion 
involved in A p-m ediated toxicity (H ung et al., 2010). For this reason m ost o f  the 
w ork presented here is focused on copper-m ediated effects.
7.2.1. Copper and Ap
7.2.1.1. Primary effects of copper on Ap40 and Ap42 aggregation state
The relatively high affinity o f  copper for Ap has the potential to induce rapid changes
in the aggregation state o f the peptide. This can be seen in figure 7.2 where a range o f
copper concentrations have been added to Ap40 and Ap42. Over the range o f  copper
to Ap ratios tested (1:100000 to 10:1) Ap40 exhibited a uniform increase in thioflavin
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T signal at T=0. The increase in thioflavin T  fluorescence was concurrent to increases 
in im m unoassay fluorescence. However, the im m unoassay suggests that there are 
differences in the level o f  oligom er content over the concentration range tested, with 
the lower concentrations exhibiting slightly larger fluorescence increases. When 
tested w ith Ap42, the effect on thioflavin T and im m unoassay fluorescence w as not 
constant across the concentrations tested nor is there a clear concentration dependent 
effect, w ith significant increases in fluorescence seen at copper to Ap ratios o f  10:1 
and 1:1000, and at 1:100000 in the im m unoassay only (Tukey HSD, p < 0.000).
7.2.1.2. Aggregation and H2O2 generation of Ap40 with copper
Ap40 w as aggregated over 72 hrs with this range o f  copper concentrations to observe 
their effects on aggregation and H 2 O 2 generation. W ith no copper added H 2 O 2 was 
m ade during the first 6 hrs, corresponding w ith small rises in both thioflavin T and 
im m unoassay fluorescence (see figure 7.3). In fact, the im m unoassay showed a 10 
fold increase in fluorescence from the m onom eric starting fluorescence. This was 
follow ed by a decrease in Am plex red fluorescence, actually below  control levels 
which corresponded to increases in thioflavin T and im m unoassay fluorescence. All 
the sam ples w ith copper added to them  at 1:1000 copper to Ap40 and below  exhibited 
very sim ilar H 2 O 2 generation w ithin the first 6 hrs. However, subsequent H 2 O 2 
generation/quenching differed between these samples. The aggregation and H 2 O 2 
generation from AP40 with the lowest copper concentration was sim ilar to that with 
no copper added (see figure 7.3B). Despite the initial increase in thioflavin T  and 
im m unoassay fluorescence from this sam ple, aggregation actually proceeded 
m arginally, slow er than with no copper. Concurrently, the H2 O 2 generated by this 
sam ple appeared to decrease less-so than the sam ple with no added copper.
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F ig u re  7.2. T h e  effect o f co p p e r on in itia l ag g reg a tio n  s ta te  o f Ap40 an d  42
TFA and HFIP treated AP40 and 42 were solubilised to 25 pM  in 10 mM PB, pFI 7.4 with and without 
the presence o f  copper (II) chloride. C opper concentrations used ranged from 250 pM to 250 pM and 
expressed as a ratio to AP concentration. Results are means ± S.D. (Thioflavin T: n=3, Immunoassay: 
n=4), * indicates Tukey HSD p < 0.000.
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W hen the concentration o f  copper was increased to 1:10000 copper to Ap40, the 
aggregation o f  Ap40 appeared to be equivalent to that w ith 1:100000, w ith no 
significant differences in fluorescence at any tim e point throughout its aggregation in 
either thioflavin T or im m unoassay (Tukey HSD p > 0.05 at all tim e points after T=0) 
(see figure 7.3C). In contrast to the 1:100000 sam ple, H 2 O 2 levels continued to rise to 
m ore than tw ice those o f  the sam ple w ith 10 fold less copper added.
A t 10 fold higher copper concentration (1:1000 copper to Ap40, figure 7.4D), A(340 
showed increased thioflavin T and im m unoassay fluorescence over the course o f  the 
72 hrs incubation com pared to those less copper present. How ever, follow ing the 
initial rise in H 2 O 2 concentration, the level gradually decreased. W hen the 
concentration o f  copper was raised to 1:100 further early increases in the 
im m unoassay fluorescence w ere observed, yet thioflavin T results showed a small 
reduction (see figure 7.4A). This was corresponded w ith a significant increase in 
H2 O 2  generation (Tukey HSD p < 0.000). In fact during the first 6 hrs >50%  m ore 
H2 O 2  was generated than any o f  the lower copper concentrations at this tim e point. 
This effect was m agnified when the ratio o f  copper to Ap was brought to 1:10 (see 
figure 7.4B). Here the im m unoassay results indicate further increases in early 
oligom er form ation, together with equivalent thioflavin T fluorescence up to 48 hrs 
incubation. Increasing the copper concentration to equim olar and above showed 
increasingly reduced aggregation in both thioflavin T and im m unoassay (see figure 
7.4C and D). The shape o f  the curve obtained for H 2 O 2 generation was sim ilar for 
both. However, the equim olar sam ple generated nearly 3 tim es the concentration o f 
H2 O 2 than Ap40 alone over the first 6 hrs, w hereas the 10:1 sam ple generated only 
slightly m ore than Ap40 alone. Over the rem inder o f  the incubation tim e the level o f 
H 2 O 2 in the solution gradually decreased in both samples.
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F ig u re  7.3. T he  effect o f co p p e r on ag g reg atio n  an d  H 2 O 2 g en e ra tio n  by Ap40
TFA and HFIP treated AP40 was solubilised to 25 pM  in 10 mM PB, pH 7.4 with and w ithout the 
presence o f  copper (II) chloride and incubated at 37°C for 72 hrs. Samples were taken for thioflavin T 
(ThT), Immunoassay (Imm) and Amplex red (H 20 2) over 72 hrs. Copper concentrations used ranged 
from 250 pM to 250 pM and are expressed as a ratio to Ap concentration. A = No copper added, B = 
250 pM copper, C = 2.5 nM copper, D = 25 nM copper. Results are means ± S.D. (Thioflavin T and 
Amplex red: n=3, Immunoassay: n=4)
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F ig u re  7.4. T h e  effect o f co p p e r on ag g reg atio n  an d  H 2 O 2 g en e ra tio n  by A04O, 
p a r t  2
TFA and HFIP treated AP40 was solubilised to 25 pM in 10 mM PB, pH 7.4 with and w ithout the 
presence o f  copper (II) chloride and incubated at 37°C for 72 hrs. Samples were taken for thioflavin T 
(ThT), Immunoassay (Imm) and Amplex red (H 20 2) over 72 hrs. Copper concentrations used ranged 
from 250 pM to 250 pM and are expressed as a ratio to Ap concentration. A = 250 nM copper, B = 2.5 
pM copper, C = 25 pM copper, D = 250 pM copper. Results are means ± S.D. (Thioflavin T and 
Amplex red: n=3, Immunoassay: n=4)
Tim e - hours
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As Ap40 aggregation proceeds slowly at 6  hrs incubation the effects on H2 O2 
generation can be seen as a two stage effect (see figure 7.5). Up to 1:1000 copper to 
Ap, the concentration o f  H2 O2 generated rem ained constant. As the copper 
concentration increased past 1 : 1 0 0 0  the concentration o f  H 2 O 2 generated at this point 
gradually increased. W hen copper was in excess (10:1) H 2O 2 generation decreases 
and was subsequently quenched from solution.
A m plex R ed 6 h rs
0.40 1
Copper 100000 10000 1000
R atio  o f C opper:A p
F ig u re  7.5. C o p p e r d ep e n d an t H 2 O 2 g en e ra tio n  by Ap40 a t  6 h rs  agg reg atio n
TFA and HFIP treated Ap40 was solubilised to 25 pM  in 10 mM PB, pH 7.4 with and w ithout the 
presence o f  copper (II) chloride. Copper concentrations used ranged from 250 pM to 250 pM  and 
expressed as a ratio to Ap concentration. H 20 2 concentration was assessed by Amplex red assay at 6 hrs 
incubation at 37°C. Results are means ± S.D. (n=3)
7.2.1.3. A ggregation  an d  H 2 O 2 g en e ra tio n  o f Ap42 w ith  co p p er
As with Ap40, the effects on A042 o f  a range o f  copper concentrations on aggregation
and H2 O 2 generation were determ ined. W ith no added copper, AP42 exhibited an
im m unoassay peak at around 1 2  hrs incubation, followed by a peak in the thioflavin at
24 hrs (see figure 7.6A). In concordance with earlier experim ents, H2 O 2 was
generated to a peak at 12 hrs, where the curve plateaued. Addition o f  1 in 100000
copper to Ap42 showed no significant change in thioflavin T fluorescence throughout
the incubation period com pared to with no copper added, w ith later tim e points highly
hom ogenous (Tukey HSD p > 0.959, T=12-48) (see figure 7.6B). The im m unoassay
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data was also very sim ilar although an increase in fluorescence was observed at 12 hrs 
incubation. This corresponded to an increase in H 2 O 2 generation, in particular, a slow 
steady rise from 12-48 hrs. W hen the copper concentration was increased to 1 in 
10000, im m unoassay fluorescence was again increased at 12 hrs com pared to no 
added copper. However, this was less so than the 1:100000 copper to Ap42 sample 
and concurrent w ith an increase in thioflavin T fluorescence throughout the course o f  
the experim ent (see figure 7.6C). H 2 O2 generation was increased com pared to no 
added copper, but reduced in com parison to the 1:100000 sample.
Increasing the copper:A p ratio to 1:1000 showed further increases in H 2 O 2  generation 
again rising sharply to 12 hrs w here it steadily increased over the rem aining 
incubation tim e (see figure 7.6D). H ow ever, at this concentration o f  copper, 
aggregation appeared to be inhibited with the peak o f  im m unoassay fluorescence 
being broad betw een 12 and 24 hrs together w ith a significant decrease in thioflavin T 
fluorescence from T=6 onwards (Tukey HSD p < 0.002). A nother 10 fold increase in 
copper showed further decreases in aggregation-associated fluorescence in both the 
thioflavin T  and im munoassay. This was together with a significant increase in H 2 O 2 
generation by Ap42 at 12 hrs incubation (Tukey HSD p < 0.001) w hich w as sustained 
over the follow ing 36 hrs (see figure 7.7A). This effect was supported by increasing 
the copper to Ap to 1:10, which further increased early H 2 O 2 generation, despite 
aggregation m easured by thioflavin T fluorescence appearing to be prom oted.
W hen copper was elevated to equim olar the im m unoassay detected small increases in 
oligom eric content during the early incubation period, corresponding to a slight 
increase in H2 O 2 concentration during the first 6 hrs (see figure 7.7C). This peaked at 
12 hrs but then decreased over the following 36 hrs, coinciding w ith a peak o f  
im m unoassay fluorescence at 24 hrs and greatly reduced thioflavin T fluorescence.
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F ig u re  7.6. T he  effect o f co p p e r on ag g reg atio n  an d  H 2C>2 g en e ra tio n  by Ap42
TFA and HFIP treated AP42 was solubilised to 25 pM in lOmM PB, pH 7.4 with and without the 
presence o f  copper (II) chloride and incubated at 37°C for 72 hrs. Samples were taken for thioflavin T 
(ThT), Immunoassay (Imm) and Amplex red (H 20 2) over 72 hrs. Copper concentrations ranged from 
250 pM to 250 pM and are expressed as a ratio to AP concentration. A = No copper added, B = 250 pM 
copper, C = 2.5 nM copper, D = 25 nM copper. Results are means ± S.D. (Thioflavin T and Amplex 
red: n=3, Immunoassay: n=4)
162
C h ap te r 7 M etal ions and H 20 2 genera tion  from  Ap
A. 1 in 100
GO. ( j  to
<*- Uo o
4> S  
6 J D  C  « e
<u 2
Si 1










Tim e - hours
B. 1 in 10
3  a
CO. o  •X* =*>"  4*4- -O O
W D  C  « e
S 2
Si .§« Xa. « 
E
4)










Tim e - hours
<•> E —










Tim e - hours
3  s
CQ. u  ■X* <*J
o o
0» *2 WD« e
41 2










Tim e - hours
F ig u re  7.7. T he  effect o f co p p e r on ag g reg atio n  an d  H 2 O 2 g en e ra tio n  by Ap42, 
p a r t  2
TFA and HFIP treated AP40 was solubilised to 25 pM in 10 mM PB, pH 7.4 with and without the 
presence o f  copper (II) chloride and incubated at 37°C for 72 hrs. Samples were taken for thioflavin T 
(ThT), Immunoassay (Imm) and Amplex red (H 20 2) over 72 hrs. Copper concentrations used ranged 
from 250 pM to 250 pM and are expressed as a ratio to AP concentration. A = 250 nM copper, B = 2.5 
pM copper, C = 25 pM copper, D =  250 pM copper. Results are means ± S.D. (Thioflavin T and 
Amplex red: n=3, Immunoassay: n=4)
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Increasing the copper concentration to 10 tim es the A(342 concentration prevented 
aggregation o f  A|342 as m easured by thioflavin T and im m unoassay (see figure 7.8D). 
Thioflavin T fluorescence barely increased over the entire time course. H2 O2 
generation over the first 3 hrs was increased com pared to the equim olar solution yet 
this was followed by greater quenching o f  the H2 O 2 . A t this tim e point there was a 
concentration-dependent effect o f  copper on the very early generation o f  H2 O2 (see 
figure 7.8). This was m ost prom inent between 1:1000 and 10:1 copper to Ap.
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F ig u re  7.8. C o p p e r d ep e n d an t H 2 O 2 g en e ra tio n  by Ap42 a t  3 h rs  agg reg atio n
TFA and HFIP treated A f42  was solubilised to 25 pM  in 10 mM PB, pH 7.4 w ith and without the 
presence o f  copper (II) chloride. Copper concentrations used ranged from 250 pM to 250 pM  and 
expressed as a ratio to A f concentration. H20 2 concentration was assessed by Am plex red assay at 6 hrs 
incubation at 37°C. Results are means ± S.D. (n=3)
The com plex m ediation o f  aggregation by copper was also seen when looking at 
thioflavin T fluorescence at 48 hrs incubation (see figure 7.9). W ithin this exponential 
rise in copper concentration there seemed to be 2  concentration dependent effects 
where fibrillisation was promoted and then inhibited. The data in this figure also 
shows non-incubated controls for thioflavin T with the highest concentration o f 
copper. This confirm s that any observed deviation from the control fluorescence (no 
added copper) is due to the effect o f  copper on the aggregation state.
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F ig u re  7.9. T h e  effect o f co p p e r a f te r  48 h rs  on ag g reg a tio n  o f A042
TFA and HFIP treated AP42 was solubilised to 25pM  in lOmM PB, pH 7.4 with and without the 
presence o f  copper (II) chloride and incubated at 37°C for 48 hrs. C opper concentrations used ranged 
from 250pM  to 250pM  and expressed as a ratio to Ap concentration. Results are means ± S.D. (n=3)
7.2.1.4. C o m p ariso n  o f A p40 w ith  Ap42
There are some obvious sim ilarities between the reaction o f  Ap40 and Ap42 when 
incubated with this range o f  copper concentrations. The lower four concentrations 
had little effect on H2C>2 generation by the peptide during the first 6 or 12 hrs (Ap40 
and Ap42 respectively) incubation at 37°C. This low level o f  copper appeared to 
exert its effects later in the aggregation tim e course. As copper concentration was 
increased to 1 : 1 0 0  and 1 : 1 0  both Ap40 and Ap42 show consecutive elevations in 
H2 O2 generation. Further increases in copper concentration to 1:1 and 10:1 showed 
increasing prevention o f  aggregation along with concurrent decreases in H 2 O2 
generation. These sim ilarities, despite the different starting aggregation state and 
propensity for further aggregation, identify these effects as potentially being relevant 
to function o f  the Ap species.
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7.2.2. Iro n
7.2.2.1. P r im a ry  effects o f iron  on ag g reg a tio n  s ta te  o f A04O an d  Ap42
In contrast to the effects observed when copper was added to Ap40, no significant 
increases in fluorescence were observed from either the thioflavin T or immunoassay 
(All Tukey HSD com parisons p > 0.05), when iron was added to Ap40 (see figure 
7.10). W hen iron was added to A(342 changes w ere observed but only in 
im m unoassay fluorescence; thioflavin T  fluorescence rem ained constant (Tukey HSD 
p > 0.938) whilst the addition o f  1:100, 1:10 and 1:1 iron to Ap42 all generated an 
increase in im m unoassay fluorescence (Tukey HSD p < 0.000). This effect was not 
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F ig u re  7.10. T he  effect o f iron  on the  in itia l agg reg atio n  s ta te  o f A p40 an d  Ap42
TFA and HFIP treated A f40 and Ap42 was solubilised to 25 pM  in 10 mM PB, pH 7.4 with and 
w ithout the presence o f  Iron (III) chloride. Iron concentrations used ranged from 250 nM to 250 pM 
and expressed as a ratio to A f concentration. Results are means ± S.D. (Thioflavin T: n=3, 
Immunoassay: n=4), * indicates Tukey HSD p < 0.000 compared to No F eC f.
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F ig u re  7.11. T he  effect o f iron  on agg reg atio n  an d  H 2O 2 g en e ra tio n  by Ap40
TFA and HFIP treated Ap40 was solubilised to 25 pM in IO111M PB, pH 7.4 with and w ithout the 
presence o f  iron (III) chloride and incubated at 37°C for 96 hrs. Samples were taken for thioflavin T, 
Immunoassay and Amplex red over 96 hrs. Iron concentrations ranged from 250 nM to 25 pM  and are 
expressed as a ratio to Ap concentration. Results are means ± S.D. (Thioflavin T and Amplex red: n=3, 
Immunoassay: n=4), * indicates Tukey HSD p < 0.000.
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F ig u re  7.12. T h e  effect o f iron  on ag g reg atio n  an d  H 2O 2 g en e ra tio n  by Ap42
TFA and HFIP treated Ap42 was solubilised to 25 pM in lOmM PB, pH 7.4 with and without the 
presence o f  iron (III) chloride and incubated at 37°C for 72 hrs. Samples were taken for thioflavin T, 
Immunoassay and Amplex red over 72 hrs. Iron concentrations ranged from 250 nM to 25 pM  and are 
expressed as a ratio to Ap concentration. Results are means ± S.D. (Thioflavin T and Amplex red: n=3, 
Immunoassay: n=4)
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7.2.2.2 . Aggregation and H2O2 generation of Ap40 with iron
25 pM  A p40 was aggregated in the presence o f  this range o f  iron concentrations. The 
presence o f  the iron appeared to make very little difference to the early aggregation 
and H 2 O 2 generation from  any o f  the peptide sam ples w ith all sam ples generating 
-2 0 0  nM  H 2 O2 over the initial 9 hr incubation at 37°C. However, at 48 hrs w hen the 
concentration o f  iron was increased, the oligom eric im m unoassay detected significant 
fluorescence increases (Tukey HSD p < 0.000) yet this had no significant effect on 
H 2 O 2 generation (Tukey HSD p > 0.727).
7.2.2.3 . Aggregation and H2O2 generation of Ap42 with iron
The aggregation and H 2 O2  generation from 25 pM  A p42 was m easured over the 
course o f  72 hrs incubation at 37°C, in the presence o f  1 TOO, 1:10 and 1:1 iron to Ap 
concentration (see figure 7.12). Sim ilarly to AP40, the effects o f  these concentrations 
o f  iron were very small, especially in com parison to the effects o f  copper observed. 
The aggregation o f  Ap42 m easured by thioflavin T fluorescence was not significantly 
different to the control with no added iron at any concentration o f  iron tested (all 
ANO VAs, p > 0.1). In the oligom eric im m unoassay there m ay have been some 
prom otion o f  aggregation with small increases in the fluorescence observed. H ow ever 
these did not correspond to any significant differences in the H 2 O 2 generated by any o f  
the sam ples (all A NOVAs p > 0.1).
7.2.3. Zinc
7.2.3.1. Primary effects of zinc on the aggregation state of Ap40 and Ap42
W hen zinc was tested for its effects on Ap40 and Ap42 there w ere changes observed
in both the im m unoassay and thioflavin T. Initially, w ith 1:100, 1:10 and 1:1 zinc to
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Ap40 no significant differences were observed in the thioflavin T (Tukey HSD, p =
0.148). However, there was a small reduction in im m unoassay fluorescence at 1:1 
zinc to Ap40 (Tukey HSD, p < 0.05) (see figure 7.13). This was in contrast to the 
initial effects o f  zinc on AP42. Both thioflavin T and oligom eric im m unoassay 
m easured significant increases in fluorescence when zinc ions were added at 25 pM  to 
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F ig u re  7.13. T h e  effect o f zinc on th e  in itia l agg reg atio n  s ta te  o f A p40 an d  Ap42
TFA and HFIP treated AP40 and Ap42 was solubilised to 25 pM in 10 mM PB, pH 7.4 with and 
w ithout the presence o f  Zinc (II) chloride. Zinc concentrations used ranged from 250 nM to 250 pM 
and expressed as a ratio to Ap concentration. Results are means ± S.D. (Thioflavin T: n=3, 
Immunoassay: n=4), * indicates Tukey HSD p < 0.05 compared to No ZnCl2
7.2.3.2. A ggregation  an d  H 2 O 2 g en e ra tio n  o f Ap40 w ith  zinc
The aggregation and H2 O 2 generation o f  25 pM Ap40 incubated over 96 hrs at 37°C 
was determ ined with the addition o f  zinc at I.TOO to 1:1 zinc to Ap40. The addition
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o f  the zinc induced visible effects at these different concentrations on the aggregation 
state o f  the peptide as m easured by thioflavin T and im m unoassay (see figure 7.14). 
Ap40 w ith no added zinc aggregated slow ly over the initial 48 hrs then both thioflavin 
T and im m unoassay fluorescence increased significantly over the rem aining 48 hrs 
(Tukey HSD p < 0.000). The addition o f  1 TOO zinc generated a small reduction in the 
thioflavin T  fluorescence at 96 hrs. H owever, throughout the tim e course the 
im m unoassay fluorescence from the sam ple barely reached 20%  o f  the maximum 
achieved w ith no zinc present. W hen the concentration o f  zinc was increased 10 fold, 
both thioflavin T and im m unoassay fluorescence w ere decreased com pared to the 
control w ith no zinc. Thioflavin T fluorescence was further reduced from  the 1:100 
sam ple, yet the im m unoassay fluorescence w as increased. A further increase to an 
equim olar concentration o f  zinc and A|340 generated very early increases in thioflavin 
T and im m unoassay fluorescence. These early increases continued over tim e but at a 
very low rate, only reaching 40%  and 60%  o f  the m axim um  fluorescence observed 
w ith A(340 alone, for thioflavin T  and im m unoassay respectively.
H2 O 2  generation was m onitored from  these sam ples yet it could not be expressed as a 
percentage o f  that made by Ap40 alone as this batch o f  Ap40 generated very little 
H 2 O 2 (<100 nM). Batch to batch variability is a huge issue for research o f  Ap. 
Deseeding m assively reduced this variability, nevertheless it still occurs. It is for this 
reason that aggregation and H2 O 2 generation has not been directly com pared where 
data was collected from different experim ents, but especially where different batches 
were used. Only sam ples prepared from the sam e batch at the same time, w ith all the 
reagents m ade and used at the same time have been com pared. Experim ental repeats 
aim to reproduce and identify trends in the data, not the exact values.
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F ig u re  7.14. T h e  effect o f z inc on the  ag g reg atio n  Ap40
TFA and HFIP treated Ap40 was solubilised to 25 pM in lOmM PB, pH 7.4 with and without the 
presence o f  zinc (II) chloride and incubated at 37°C for 96 hrs. Samples were taken for thioflavin T 
(ThT) and Im munoassay (Imm) over 96 hrs. Iron concentrations ranged from 250 nM to 25 pM  and are 
expressed as a ratio to Ap concentration. A = No zinc, B = 250 nM, C = 2.5 pM and D = 25 pM  zinc. 
Results are means ± S.D. (Thioflavin T: n -3 , Immunoassay: n=4)
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The effect that zinc had on the generation o f  H 2 O 2  appears to be com plicated (see 
figure 7.15). As already stated, the Ap40 w ith no zinc generated a very small amount 
o f  H2 O 2 over the initial 24 hrs, which was degraded over the rest o f  the tim e course. 
The sample o f  Ap40 with equim olar zinc added showed greatly reduced fibrillisation 
o f  the peptide in the thioflavin T  and im m unoassay and prom otion o f  the form ation o f 
an oligom eric species o f  the peptide. However, this concentration o f  zinc showed 
reduced H 2 O 2 generation over the initial 24 hrs. The rem ainder o f  the time course 
increased H 2 O 2 was present com pared to the control with no zinc. The 1:100 sample 
generated a sim ilar concentration o f  H 2 O 2 over the first 24 hrs but this increased over 
the follow ing 48 hrs to over 300 nM H 2 O 2 . The 1:10 sam ple o f  zinc to Ap40 similarly 
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F ig u re  7.15. T he  effect o f zinc on th e  H 2 O 2 g en e ra tio n  from  Ap40
TFA and HFIP treated AP40 was solubilised to 25 pM in lOmM PB, pH 7.4 with and w ithout the 
presence o f  zinc (II) chloride and incubated at 37°C for 96 hrs. Samples were taken for Amplex red 
determination o f  H20 2 concentration over 96 hrs. Zinc concentrations ranged from 250 nM to 25 pM 
and are expressed as a ratio to A f concentration. Results are means ± S.D. (n=3)
7.2.3.3. A ggregation  an d  H 2 O 2 g en e ra tio n  o f Ap42 w ith  zinc
Several o f  the trends observed with Ap40 were repeated when testing AP42. There 
was a clear, concentration dependant reduction in thioflavin T fluorescence com pared
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to the control with no zinc added, indicating a reduction in the fibrillisation o f  the 
peptide (see figure 7.16). In addition, when the concentration o f  zinc was increased to 
equim olar, the thioflavin T  curve loses its sigm oidal shape, becom ing shallow  in its 
fluorescence increases in a sim ilar m anner to that seen with A p40. Im m unoassay 
fluorescence showed small decreases in fluorescence at 1:100 and 1:10 zinc to Ap42. 
H owever, at equim olar zinc to A p42, oligom eric im m unoassay fluorescence was 
raised above control levels and was m aintained at this level. H 2 O 2 generation by these 
sam ples rem ained reasonably constant. Only at equim olar zinc was a small reduction 
in H 2 O 2 generation detected (see figure 7.16 and 7.17).
For each o f  these experim ents the controls w ere perform ed at every concentration 
tested and at every tim e point w ith no Ap present in the m etal containing buffer. 
Results from  these showed that for the large part, no differences in A m plex red 
fluorescence was detected com pared to PB alone (see figure 7.18). Copper showed no 
clear differences across the concentrations tested. However, both iron and zinc 
showed a small increase at the highest concentration o f  25 pM  in the 10 mM  PB 
follow ing incubation for 48 hrs. This indicates at these higher concentrations a very 
small am ount o f  H 2 O 2 may have been generated (less than 70 nM  in both cases). 
Despite this, results from Ap peptides incubated with these m etal ions w ere calculated 
from  the subtraction o f  the appropriate control reading at each time point; H 2 O 2 
concentrations calculated are for the contribution o f  Ap to the generation o f  H 2 O 2 . It 
is acknow ledged that the zinc controls all showed small fluorescence increases at 48 
hrs com pared to T=0. However, this was likely due to the light sensitivity o f  the 
Am plex red w orking solution. Precautions were taken to try to prevent light exposure, 
yet som etim es small increases in fluorescence were observed across all sam ples tested 
at the same time.
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F ig u re  7.16. T he  effect o f zinc on agg reg atio n  an d  H 2C>2 g en e ra tio n  by Ap42
TFA and HFIP treated Ap42 was solubilised to 25 pM in lOmM PB, pH 7.4 with and w ithout the 
presence o f  zinc (II) chloride and incubated at 37°C for 96 hrs. Samples were taken for thioflavin T 
(ThT), Immunoassay (Imm) and Amplex red (H 20 2) over 72 hrs. Zinc concentrations ranged from 250 
nM to 25 pM and expressed as a ratio to Ap concentration. A = N o zinc, B = 250 nM, C = 2.5 pM  and 
D = 25 pM zinc. Results are means ± S.D. (Thioflavin T and Amplex red: n=3, Immunoassay: n=4)
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F ig u re  7.17. T he  effect o f zinc on H 2 O 2 g en e ra tio n  from  Ap a t  24 h rs  incu b atio n
T FA  and H F IP  trea ted  A p42 w as so lub ilised  to  25 pM  in 10 m M  PB , pH  7.4 w ith  and w ith o u t the 
p resence  o f  z inc  (II) ch loride. Iron  concen tra tions used ranged from  250 nM  to  25 pM  and expressed as 
a ratio  to  A p concen tra tion . H 20 2 concen tra tion  w as assessed  by A m plex  red assay  at 24 hrs incubation 
at 37°C . R esu lts are m eans ±  S.D . (n=3)
7.2.3. M eta l che la tion  by ED T A
To test the metal ion dependency o f  the generation o f  TbCT from Ap42, 
ethylenediam inetetraacetic acid (EDTA) at a range o f  concentrations was added to 25 
pM  Ap42 in 10 mM  PB and incubated at 37°C. The samples were then tested for their 
fluorescence in the thioflavin T, oligom eric im m unoassay and Am plex red at various 
time points over a 48 hr incubation period (see figure 7.19). Thioflavin T and 
im m unoassay fluorescence readings showed that the chelation o f  metal ions from the 
solution m ade very little difference to the aggregation o f  the Ap42 with no clear 
concentration dependant effects observed. In com plete contrast, A m plex red 
fluorescence from the Ap42 solutions incubated with EDTA showed significant 
effects at all time points tested with Tukey HSD analysis identifying different 
hom ogenous subgroups at all time points. At T=0 increased EDTA concentration 
caused increased Amplex red fluorescence indicative o f  up to 250 nM H 2 O2 being 
made. However, as aggregation proceeded, increasing the concentration o f  EDTA 
caused a decrease in the concentration o f  H2 O2 generated with T=24 becoming 
significantly negatively correlated (r = -0.529, p = 0.024).
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F ig u re  7.18. T he  effect o f co p p er, iro n  an d  zinc on fluorescence o f PB  in th e  
A m plex red  assay
Every concentration o f  metal ion tested was also monitored by Amplex red assay throughout the time 
course o f  the aggregation experiments. Shown are the fluorescence readings obtained from the 
solutions at 0 and 48 hrs. A = copper, B = iron and C = zinc. Results are means ± S.D. (n=3)
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F ig u re  7.19. T h e  effect o f ED T A  on ag g reg atio n  an d  H 2C>2 g en e ra tio n  by Ap42
TFA and HFIP treated Ap42 was solubilised to 25 pM in lOmM PB, pH 7.4 with and without the 
presence o f  EDTA and incubated at 37°C for 96 hrs. Samples were taken for thioflavin T, 
Immunoassay and Amplex red over 48 hrs. EDTA concentrations ranged from 25 nM to 250 pM  and 
expressed as a ratio to Ap concentration. A = thioflavin T, B = oligomeric immunoassay and C = 
Amplex red. Results are means ± S.D. (Thioflavin T and Amplex red: n=3, Immunoassay: n=4)
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F ig u re  7.20. T h e  effect o f E D T A  on fluorescence in th e  th io flav in  T , o ligom eric 
im m unoassay  an d  A m plex red  assay
A range o f  EDTA concentrations were made in lOmM PB, pH 7.4. Samples were taken for thioflavin 
T, Immunoassay and Amplex Red. EDTA concentrations ranged from 25 nM to 250 pM. A = 
thioflavin T, B = oligomeric immunoassay and C = Amplex red. Results are means ± S.D. (Thioflavin 
T and Amplex red: n=3, Immunoassay: n=4)
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Controls for this experim ent show ed no evidence that ED TA  caused increased or 
decreased fluorescence from  any o f  the assays (see figure 7.20). This provides 
evidence that the observed observations o f  ED TA  on Ap42 w ere due to its action in 
m etal chelation w ithin the sam ple and not influenced by any effect on the reagents 
used in the reading o f  fluorescence in any assay.
7.3. Discussion
Evidence that redox active m etal ions are a contributor to the pathogenesis o f  AD is 
strong. Four key pieces o f  evidence im plicate m etal ions as central to pathogenic 
events leading to neurodegeneration (Huang et al., 2004; H ureau and Faller, 2009; Liu 
et al., 2006):
1. Age dependant concentration o f  these metal ions is observed in the neocortex
2. Their localisation w ithin senile plaques
3. Their ability to generate oxidative dam age in biological system s and the 
w idespread oxidative dam age observed in AD brains
4. Their influence on Ap aggregation
A lthough it was originally thought that Ap could generate ROS w ithout the presence 
o f  metal ions, it has become clear that sufficient trace metal ions are present within 
buffer solutions to enable the redox reactions that generate ROS (Butterfield, 2002; 
D ikalov et al., 2004; Guilloreau et al., 2007; Turnbull et al., 2001b). Even before 
solubilisation synthetically made Ap contains significant concentrations o f  copper and 
iron (Turnbull et al., 2001b). This chapter investigated the effects that the addition o f 
copper, iron and zinc, the 3 key m etal ions im plicated in AD pathogenesis, had on 
both the aggregation and H 2 O 2 generation o f  Ap40 and Ap42.
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7.3.1. Copper
Ap has been found to have an unusually  strong affinity for binding copper, suggesting 
a potential functional role for this binding in vivo (A twood et al., 2000b). This was 
firstly investigated by looking at the changes in thioflavin T  and immunoassay 
fluorescence at T=0, the sam ples taken im m ediately follow ing the w etting and 
sonication o f  the samples. D espite the strength o f  copper binding its coordination by 
Ap is suggested to be dynam ic, w ith several binding m odes rapidly exchanging at 
room  tem perature (Hureau and Faller, 2009). For this reason a wide range o f  copper 
concentrations was tested from 1:100000 to 10:1 copper to Ap to help elucidate 
binding effects at different concentrations.
W hen Ap40 w as tested increases in both thioflavin T and im m unoassay fluorescence 
were observed at all copper concentrations com pared to the sam ple w ith no copper 
added. This suggested that even significantly sub-m olar concentrations o f  copper 
could induce early self-interactions in this largely m onom eric solution o f  Ap40. The 
increase in fluorescence was uniform in the thioflavin T. H ow ever in the 
im m unoassay the low er concentrations showed slightly m ore oligom eric content than 
the higher concentrations. This may indicate that copper binding Ap40 prom otes 
d ifferent se lf  interactions at different concentrations as the effect is not w holly 
concentration dependent. This data also reflects the increased sensitivity that the 
im m unoassay has for early oligom eric interactions com pared to thioflavin T. 
Evidence that copper (prom oted by the presence o f  H 2 O 2) form s dityrosine cross-links 
(A twood et al., 2004) was investigated in chapter 5. During those experim ents it was 
found Ap40 to require 24 hrs for SDS-stable cross-links to be detected using a range 
o f  copper and H2 O 2 concentrations. This suggests that the increased fluorescence 
observed here is not due to the form ation o f  dityrosine dim ers, or any other form o f
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SDS-stable oligom eric Ap species. In w hich case, the presence o f  the copper m ay be 
prom oting rapid structural changes, such as prom oting the sw itch to p-sheet 
conform ation, but also having an effect on the ability  o f  the Ap40 to self-interact and 
perhaps the stability o f  those interactions w ithout form ing covalently cross-linked Ap.
W ith Ap42 there was no concentration dependant effect o f  these levels o f  copper on 
the initial aggregation state o f  the peptide. A t 1:1000 and 10:1 copper to Ap42 rapid 
interactions were observed, significantly increasing thioflavin T  and im munoassay 
fluorescence (Tukey HSD p < 0.000). W ith Ap42 several different types o f  early 
species m ay be present at T=0. The different concentrations o f  copper m ay be 
encouraging changes in these A p42-A p42 interactions in different w ays for different 
species o f  Ap42. Another, not exclusive explanation is that different levels o f  
m etalation o f  Ap42 m ay prom ote different form s o f  Ap self-interacting species. It has 
been reported that Ap42 could theoretically bind up to 2.5 Cu(II) ions per peptide unit 
(A twood et al., 2000b). This may be the case where excess copper was added to the 
Ap (10:1), yet it is unlikely that this is also the case at 1:1000 copper ions to Ap42 
subunits. Yet, both generated increases in fluorescence in both assays. This supports 
different binding interactions between the Ap42 and copper possibly prom ote different 
aggregation pathways. S im ilarly to Ap40 though, cross-linking experim ents 
suggested these copper prom oted increases in A p-A p interactions were not due to 
SDS-stable interactions such as the form ation o f  dityrosine dimers.
Ap40, being largely m onom eric upon wetting, aggregated slowly w ith no copper
added, generating H2 O 2 over the initial 6 hours follow ed by a decrease in A m plex red
fluorescence indicating H 2 O 2 degradation. This suggests that, if  a specific early Ap
species is responsible for H 2 O 2  generation, then it is form ed early in Ap40
aggregation, but does not persist in the solution. Ap42 aggregated at an increased
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rate, generated m ore H 2 O 2 and did not show  the sharp decreases in H 2 O2  concentration 
that w ere observed in A p40 solutions. This m ay be related to a greater biological 
function o f  Ap40 as an antioxidant rather than pro-oxidant. Interpretation o f  Ap42 
results are com plicated by its greater tendency for aggregation and the fact that even 
deseeded sam ples contain some proportion o f  aggregated A(342. M easurem ents 
should be to be considered the net effect o f  copper on a range o f  Ap42 species present 
at any particular point in time.
All sam ples o f  Ap40 w ith 1:1000 or less copper added to them  show ed sim ilar 
aggregation and H 2 O 2 generation over the initial 6 hrs aggregation. A fter 6 hrs 
how ever, the H2 O 2 m easured from  these sam ples differs between further generation 
and degradation. This shows that these low concentrations o f  copper have little effect 
on the form ation o f  the H 2 O 2  generating species o f  Ap, but m ay affect its longevity in 
solution as degradation o f  H 2 O 2  was not as pronounced with only 1:100000 copper 
added. The degradation o f  H 2 O 2 observed w ith Ap40 supports the idea that that Ap 
aggregation consists o f  different stages that differentially generate and degrade H 2 O 2 
(as observed in chapter 4 and 6). It is possible that this is directly determ ined by the 
oxidation state o f  the peptide and m ediated by H 2 O 2 directed oxidation o f  susceptible 
Ap residues. These processes may be proceeding concurrently in an aggregating 
solution, and may contribute to the aggregation process via m oderation o f  Ap se lf­
oxidation, i.e. the stabilising effect o f  dityrosine dim ers.
Like AP40, aggregation o f  Ap42 at 1:100000 and 1:10000 copper to Ap, can be 
considered very sim ilar to the sam ple with no copper, except there is an increase in 
oligom eric im m unoassay fluorescence. Concurrently, the generation o f  H 2 O 2 rem ains 
reasonably equivalent up to 12 hrs incubation yet after this point there is an increase in 
H2 O 2 generation by these sam ples. This supports observations with AP40 that these
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low copper concentrations m ay act to prolong oligom eric interactions conducive o f  
H 2 O 2  generation. Increasing the concentration a further tenfold, does not show  further 
increases in im m unoassay fluorescence. Instead a broader peak  was observed together 
w ith decreased fibrillisation, indicated by thioflavin T fluorescence. Concurrently, 
H 2 O 2 generation was increased again, possibly due to extending the lifespan o f 
oligom eric Ap and subsequently the period in w hich H 2 O 2  was generated.
As copper concentration increases within the sam ples o f  Ap, the generation o f  H 2 O 2 
during the tim e course appears to be the result o f  a trade-off betw een concurrent 
effects o f  copper on the AP: increasing copper concentration appears to increase the 
stability/longevity o f  the H 2 O 2 generating species together w ith increasing their redox 
potential, yet also prom otes further aggregation. W hen copper was raised to 1:100 
and 1:10 m olar ratio w ith Ap40, aggregation, particularly in the im m unoassay was 
increased, indicating prom otion o f  the form ation o f  oligom eric Ap. This was 
concurrent to significantly m ore H 2 O 2 being generated by these sam ples by 6 hrs, w ith 
1:10 m ore so than 1:100 (Tukey HSD p < 0.000, Pearson’s r = 0.854, p = 0.000) 
supporting evidence that a key oligom eric species is responsible for H2 O 2 generation. 
A sim ilar concentration dependent effect o f  copper on increasing H 2 O 2 generation was 
also observed with Ap42. This suggests that these copper concentrations m ay be 
playing a role in the form ation o f  the H 2 O 2 generating oligom eric species in addition 
to preserving its existence in solution and increasing facilitation o f  redox reactions.
Further increases in copper concentration to 1:1 and 10:1 appeared to prevent
fibrillisation o f  Ap40 and Ap42. Both peptides showed early H2 O 2 generation to be
prom oted at 1:1 copper to Ap but this rapidly declined. This effect was em phasized at
10:1 copper to AP as aggregation was further inhibited and degradation o f  the H 2 O 2
generated prom oted. High copper concentrations prom ote H2 O 2 generation
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presum ably due to its coordination w ithin a greater num ber o f  Ap molecules 
prom oting the redox abilities o f  both peptides, yet, m aybe this prom otes the formation 
o f  non-b^Ch generating Ap species rather than fibrils. High levels o f  copper m ay bind 
in such a w ay as to prevent the proliferation o f  P-sheet structure via Ap fibrillisation. 
This is supported by evidence by Smith and colleagues that supra-m olar 
concentrations o f  copper do not form  fibrils but form  spherical and am orphous Ap 
aggregates (Sm ith et al., 2007b). It may be that these high copper concentrations 
result in prolific Ap oxidation, cross-linking the peptide into these aggregates possibly 
halting generation o f  H 2 O 2 by the Ap. Follow ing the research o f  copper/T^C^ cross- 
linking (chapter 5) it would be my hypothesis that the spherical oligom ers observed by 
Dr. D.P. Smith m ay be com posed o f  the Ap42 tetram ers observed by SDS-PAGE.
The concentration dependant effects o f  copper on H 2 O 2 generation could be seen at 6 
hrs and 3 hrs incubation for Ap40 and Ap42 respectively. Ap42 showed early H 2 O 2 
generation to be concentration dependent im plicating copper binding as key in Ap 
m ediated form ation o f  H 2 O 2 . W ith A p40, sufficiently low concentrations o f  copper 
had very little effect on early aggregation nor were the redox capabilities o f  the 
peptide increased due to copper binding: the concentration o f  H 2 O 2  generated 
rem ained reasonably constant. As the copper concentration increases past 1:1000 
early aggregation interm ediates were prom oted over fibrils, concurrent to increased 
levels o f  copper binding to the peptide, thus the concentration o f  H 2 O 2 generated 
gradually increases. W hen copper was in excess (10:1) Ap becom es m axim ally 
copper bound and oxidised rapidly, driving it through its H 2 O 2 generating phase 
quickly, degrading that which is made.
A point to rem em ber is that in the brain the subject o f  oxidation events is likely not to 
be prim arily Ap itself but other biological targets such as m em brane lipids especially
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if  Ap is m em brane associated. A t low copper concentrations Ap40, despite generating 
som e H 2 O 2 initially, m ay actually have greater antioxidant properties in vivo. As 
copper increases though it loses its antioxidant properties and becom es a pro-oxidant, 
due to increased A p/copper m ediated redox reactions. W ith a reduction in subsequent 
self-oxidations the lifespan o f  early oligom ers m ay be extended greatly. Ap42 
generates m ore H 2 O 2 , probably due to an increased interaction w ith copper and 
tendency for aggregation form ing H2 O 2  generating oligom ers. With increased copper 
binding again the copper prom otes structural changes increasing H 2 O 2  generation 
further which, in vivo, may continue to be generated if  other targets are the subject o f  
oxidation reactions rather than Ap. It m ay be that these interactions are actually 
relevant to  the yet to determ ined biological function o f  Ap.
The reactions that generate H 2 O 2 from redox cycling o f  copper require Cu(II) to be 
reduced to Cu(I). As discussed in chapter 4, w ithout the addition o f  an external 
reductant, M et35 is the m ost likely candidate for this electron donation. Research 
perform ed w ith the addition o f  a reductant has found A p/copper com plexes to 
generate m ore H 2 O 2 than copper and reductant alone (Hureau and Faller, 2009). This 
seem s quite reasonable to expect as a potent reductant would be expected to be more 
efficient at reducing Cu(II) than M et35. However, this seem s an irrelevant 
com parison to make as free copper is kept to an absolute m inim um  in the body to 
ensure its dam aging redox activities are kept to an absolute m inim um . Instead copper 
is kept bound to copper binding proteins. A m ore relevant com parison observed by 
Hureau and Faller is that A p/copper com plexes generate m ore ROS than other copper 
com plexes (Guilloreau et al., 2007; Hureau and Faller, 2009). This shows that it is 
more oxidative than other com plexes, in a biologically relevant manner.
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W ork by N adal and colleagues that initially appeared to contradict our findings with 
A p/copper com plexes actually supported our observations. They found that 
m onom eric and fibrillar A p/copper not to generate H 2 O 2 (again in com parison to 
copper plus reductant -  a biologically irrelevant sam ple), but did not test any 
interm ediate Ap species (Nadal et al., 2008). In agreem ent, my research has found no 
evidence that either m onom ers or fibrils were capable o f  H 2 O 2  generation. 
Unfortunately, if  they had been able to test oligom eric Ap they w ould have probably 
com e to the same conclusion as they only allow ed 1 hr for the generation o f  H 2 O 2 , and 
their assay was not sensitive enough to m easure the levels o f  H 2 O2  that we have 
determ ined to be m ade from  Ap. The fact rem ains that testing oligom eric Ap is 
fraught w ith issues due to the heterogeneous and ever-changing com position o f  a 
solution o f  Ap. H opefully further developm ent o f  the im m obilisation technique 
(described in chapter 6) m ay help in this respect. They suggest that m onom eric Ap 
m ay act as an antioxidant in so far as it binds free copper, rem oving its free copper 
redox potential from solution. The fact is that if  this binding then prom otes H 2 O 2 
generation in oligom eric forms o f  Ap it becom es a pro-oxidant. A lthough this m ay 
not be m ore so than Cu(II) alone, it may be biologically relevant and directed at 
susceptible cellular features such as the PM.
The fact that copper does not exist freely in the brain poses another line o f  
investigation: using the addition o f  chelated copper to solutions o f  Ap. This would 
enable determ ination o f  how increasing copper concentrations effects H 2 O 2  
generation, in w hat m ay be considered a m ore biologically relevant manner.
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7.3.2. Iron
Despite iron being found localised in senile plaques, Ap is not believed to bind to iron 
as it does w ith copper although it has been reported to prom ote Ap aggregation (Smith 
et al., 2007a). The effect o f  iron on aggregation o f  A p40 and Ap42 was tested, 
alongside its effects on the generation o f  H2C>2 . D ata certainly indicated iron to have a 
m uch reduced effect on the aggregation state o f  the peptides. W ith Ap40 neither 
thioflavin T nor im m unoassay fluorescence show ed any difference to the sample with 
no iron added at T=0. Com pared to copper, this indicates any interaction the Ap40 
m ay have w ith iron does not have a rapid effect on the aggregation state o f  the 
peptide. W hen tested on Ap42, iron showed some increases in im m unoassay 
fluorescence at T=0 com pared to the sam ple w ith no iron. H owever, these increases 
were not paralleled by changes in thioflavin T fluorescence suggesting that AP-AP 
interactions m ay have been increased som ew hat yet are not associated w ith structural 
changes prom oting P-sheet.
A ggregation o f  AP40 with iron showed some concentration dependent increases in 
aggregation, notably at 48 hrs incubation w hen the Ap40 initially starts to aggregate. 
However, these differences in aggregation did not correspond to any changes in 
A m plex red fluorescence that m ight im plicate iron partaking in redox cycling w ith 
Ap40. If  A p40 was able to reduce Fe(III) to Fe(II) then we w ould expect to see 
variation in the H 2 O 2 generated. These results were em ulated by incubation o f  Ap42 
with iron; the addition o f  iron som ewhat prom oting aggregation associated increases, 
yet no significant differences in H20 2 generation was observed (All Tukey HSD 
com parisons p > 0.1). This suggests that although weak interactions m ay occur 
between Ap and iron that may prom ote early aggregation to some extent, these 
interactions are not facilitative o f  redox reactions and H 2 O 2 generation. This suggests
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that the copper binding site m ay not the sam e as the site o f  iron interaction as 
d isplacem ent o f  copper ions would presum ably reduce H 2 O 2 generation. An 
interesting control experim ent to test this w ould be to try cross-linking A p w ith iron 
and H 2 O 2 to see if  iron is also unable to oxidatively m odify Ap, reactions that copper 
readily partakes in. This supports evidence from  others that Ap does not directly bind 
iron and that altered iron hom eostasis and sequestration into senile plaques m ay be 
due to secondary effects (Sm ith et al., 2007a).
7.3.3. Zinc
Existing evidence o f  the role played by zinc in the aggregation o f  A p and its 
connections to the pathogenesis o f  AD is unclear and som etim es conflicting. Unlike 
iron, evidence does suggest A p-zinc interactions to be physiologically relevant (Bush 
et al., 1994). However, w hether this interaction is neurotoxic, neuroprotective or even 
relevant to AD is up for debate. Upon w etting o f  the peptides both Ap40 and AP42 
were found to have rapid changes in their aggregation associated fluorescence, 
although in different respects. Ap40 despite being largely m onom eric following 
deseeding showed a small decrease in im m unoassay fluorescence w hen at 1:1 AP to 
zinc. On the other hand, Ap42 showed concentration dependent increases in both 
thioflavin T  and im m unoassay fluorescence at T=0. This indicates that zinc binds 
rapidly to Ap to induce these changes. In Ap40 the binding o f  zinc prom otes a 
conform ation facilitating m onom eric Ap40. However, in Ap42 its binding prom otes 
P-sheet form ation and self-interactions indicative o f  prom otion o f  aggregation.
W hen Ap40 was aggregated w ith these levels o f  zinc, com plex concentration 
dependent binding effects were observed. At 1:100 zinc to Ap40 im m unoassay 
fluorescence was reduced yet thioflavin T fluorescence shows only a small reduction.
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Interpretation o f  this isn’t straightforw ard. Both low -order oligom ers and fibrils 
generate low im m unoassay fluorescence perhaps aiding its explanation. I f  zinc binds 
Ap40 w ith a strong affinity it is possible that one effect is produced from  those 
m olecules bound by the zinc and another by those not zinc-bound: a proportion o f  the 
sam ple m ay aggregate to fibrils, but the low level o f  zinc ions binding to Ap40 was 
able to prevent aggregation o f  a proportion o f  oligom ers. Increasing zinc to Ap40 to 
1:10 and further to 1:1 supports this idea, generating separate zinc-bound and non 
zinc-bound effects. The increased proportion o f  Ap40 that was zinc-bound was 
increasingly prevented from fibrillisation (reducing thioflavin T fluorescence) and 
preferentially form s zinc bound oligom ers (increasing early im m unoassay 
fluorescence).
The effect that zinc had on H 2 O 2 generation by Ap40 was com plex but m ay be 
attributed to a com bination o f effects: the decreased fibrillisation rate prolonging the 
longevity o f  oligom eric species, the proportion o f  oligom ers zinc bound and the 
reduced capacity for H2 O 2 generation by zinc-bound oligom ers. The reduced 
fibrillisation exerted by the presence o f  zinc appeared to also reduce the degradation 
o f  H2 O 2 im plying zinc binding m ay protect A(3 against oxidative events. In this 
respect it may also be o f  interest to test the effects o f  zinc on the copper/H 2 0 2  
dependent cross-linking perform ed in chapter 5. W ould cross-linking be prevented, or 
may be it that different Ap cross-linked species may be form ed?
Results w ith Ap42 support the deductions from Ap40; the binding o f  zinc to AP42 
appeared to inhibit fibrillisation yet prom ote the form ation/longevity o f  certain 
oligom eric species o f  Ap. The m ain difference was the increased speed at which 
Ap42 aggregation proceeds. H 2 O 2 generation from these sam ples was consistent, 
except for a small decrease in its generation when at 1:1 zinc to Ap42 supporting
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observations w ith Ap40: zinc appears not to facilitate redox reactions by the peptide 
and its binding to Ap42 prom otes form ation o f  oligom ers have a reduced capacity for 
H 2 O 2  generation com pared to non-zinc bound species.
It has been determ ined that copper and zinc ions would be coordinated by the same 3 
histidine residues. Therefore, in theory, zinc w ould have to displace copper to cause a 
reduction in its H2 O 2 generation. The quantities o f  zinc tested here were equim olar 
w ith Ap and lower, but the endogenous copper present in the solution would be far 
reduced in com parison. In these sam ples a concentration dependent proportion o f  the 
Ap present w ould be either zinc or copper bound. However, as soon as AP-Ap 
interactions occur, an oligom eric Ap species m ay be bound by zinc, copper or both 
m etal ions increasing the potential for a range o f  effects to be elicited dependant on 
the levels o f  these m etal ions. This im plicates zinc in playing a regulatory role in 
binding Ap, perhaps by providing com petition for copper binding. This may go some 
w ay to explaining the contradictory effects observed when testing the effects o f  zinc 
w ith Ap as they are highly concentration and tim e dependant. The observation that 
the generation o f  H2 O 2 by Ap was augm ented greater by zinc with A p40 than Ap42, 
suggests that Ap40 m ay have a greater inclination than Ap42 to bind zinc over copper. 
This m ay be directly linked to the enhanced toxicity o f  Ap42 over Ap40 or possibly 
the actual biological function o f  Ap.
There is evidence that Ap, in AD, may be a corrupted antioxidant, w ith gain o f  
toxicity being concentration, m etalation and oxidation dependent (Sm ith et al., 2007a). 
This bares sim ilarities to the hypothesised pathogenesis o f  Am yotrophic Lateral 
Sclerosis (ALS) where m utations in the gene for superoxide dism utase (SOD1) cause 
the familial disease (Bruijn et al., 1998). Presum ably these m utations disable the 
antioxidant properties o f  the protein leading to increased oxidative stress. It has even
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been postulated that Ap m ay act as a SOD m im etic as it bears sim ilar properties at low 
concentrations (A tw ood et al., 2000b; Lynch et al., 2000). W hen bound to both 
copper and zinc sim ultaneously (like in SOD1) Ap has been shown to have catalytic 
SO D-like activity with oxidative stress stim ulating its production (Lynch et al., 2000). 
The supposition that Ap m ay be an antioxidant w hen interacting w ith both copper and 
zinc, the zinc providing structural integrity (preventing fibrillisation) and regulating 
copper/A p redox activity is supported by the observations in this study (Lynch et al., 
2000). In support o f  these interactions being related to neurodegeneration in AD, 
Ap42 incubated with both copper and zinc has been found to have a low er toxicity 
than Ap42 incubated w ith copper alone, reportedly due to zinc suppressing copper 
m ediated production o f  H2 O 2 (Cuajungco et al., 2000). Testing o f  zinc and copper by 
the im m obilisation technique described in chapter 6 m ay help clarify the roles o f  these 
m etal ions.
7.3.4. H2O2 generation is metal dependent
The dependency o f  redox metal ions for the generation o f  H 2 O 2 was tested by the 
addition o f  a range o f  EDTA concentrations. ED TA  is a strong m etal chelating agent 
for metal ions such as Cu(II) and Fe(III) due to its ability to act as a hexadentate 
ligand, coordinating the metal ion in a stable and soluble state. At no concentration 
did the presence o f EDTA alter the aggregation o f  Ap42. This was not wholly 
unexpected as it had been observed that the addition o f  very low concentrations o f 
m etals (below  1 in 10000 copper to Ap) had only m inor effects on the aggregation o f 
AP; chelation o f the trace m etals in solution would also generate only slight 
differences. This implies that the residual metal ion concentration in the sam ples is 
low but also that metal interactions are not actually needed for aggregation o f  Ap42.
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On the other hand, the generation o f  H 2 O 2 was severely reduced by the addition o f  
EDTA, w here clear concentration dependent decreases in the generation o f  H 2 O2  were 
observed. On a side note, at T=0 increasing the level o f  ED TA  actually showed a 
sm all increase in H 2 O 2 detected. This im plies that loss o f  copper ions from A(342 to 
EDTA m ay have actually caused som e redox cycling o f  the copper form ing H 2 O 2 . 
This however, is rapidly quenched and overall the chelation o f  the residual metal ions 
in the sam ples prevented the interaction o f  Ap w ith the ions, inhibiting Ap m ediated 
generation o f  H 2 O 2 . Considering the evidence presented, copper is presum ably the 
principle ion involved in H2 O 2  generation. This supports evidence that the low level 
o f  residual copper in buffer solutions and even in the peptide at point o f  m anufacture 
are sufficient to support H 2 O 2 generation by Ap.
It actually required a relatively high concentration o f  ED TA  to rem ove H 2 O 2 
generation from  the Ap42. This w ould appear to suggest that either Ap has a very 
high affinity for copper, or, there is m ore copper present in the sam ples than originally 
thought. H owever, trace levels o f  other m etals such as iron w ould also be present, 
w hich would presum ably be chelated preferentially to binding copper that is already 
Ap-bound.
7.4. Conclusions
•  M etal ions may have a central role in the pathogenesis o f  AD
•  The experim ental results support the generation o f  H 2 O 2 as being a factor o f  
the longevity and redox potential o f  Ap aggregation interm ediates
•  Both Ap40 and Ap42 showed rapid increases in aggregation associated A p-A p 
interactions when incubated w ith copper, even at very low concentrations
193
Chapter 7 Metal ions and H20 2 generation from Ap
•  The effects o f  copper on Ap aggregation and its generation o f  H 2 O2  are 
com plex and highly interconnected
•  Low sub-m olar copper concentrations appear to increase the stability and 
longevity o f  the A p species generating H 2 O 2
•  Increasing copper tow ards equim olar and above appears to prom ote the 
form ation o f  Ap-A p interactions that facilitate H 2 O 2 generation
•  Increasing copper concentration increases the redox potential o f  the Ap 
solution. However, the increased generation o f  H 2 O 2 has the potential for 
oxidizing Ap at susceptible residues, which appears to halt its ability to 
generate H 2 O 2
•  A ny interaction o f  iron w ith Ap appears to be w eak w ith very little effect on 
aggregation but also iron does not appear to take part in A P-m ediated redox 
reactions generating H 2 O 2
•  The effects o f  zinc were com plex but the ion appeared to bind Ap preventing 
fibrillisation and prom oting the form ation/stabilization o f  a pre-flbrillar form 
o f  Ap that appeared to have a reduced capacity for H 2 O 2 generation
•  Zinc did not appear to facilitate A p-m ediated redox reactions but instead 
appeared to have a regulatory role
•  The chelation o f  metal ions had no effect on the aggregation o f  A p42 yet metal 
chelation elim inated H 2 O 2 generation from Ap42 show ing the interaction o f 
metal ions, m ost likely copper, w ith Ap42 is critical for the redox reactions 
generating H 2 O 2
•  These experim ents clearly show that Ap requires the binding o f  copper to be 
able to generate H 2 O 2 from redox reactions initiated by the Ap m ediated 
reduction o f  Cu(II) to Cu(I).
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Chapter 8 
The effect of short peptide aggregation 
inhibitors on H20 2 generation by p-amyloid
8.1. Introduction
The developm ent o f  drugs w hich could alter the course o f  the disease is focused 
largely on reducing Ap load. There are several different approaches being 
investigated w hich can be largely grouped into either trying to reduce Ap production 
and aggregation or increase the clearance o f  Ap (B lennow  et al., 2006). Strategies 
include m odulation o f  secretase action, im m unotherapy, inhibition o f  aggregation and 
antioxidant therapy. In this chapter, a group o f  short peptide inhibitors have been 
investigated to assess their ability to inhibit the very early stages o f  aggregation, 
oligom er form ation and H 2 O2  generation.
8.1.1. Secretase modulation
The tw o enzym es responsible for the production o f  Ap are P-secretase (BACE1) and 
y-secretase. Inhibiting the action o f  BACE1 is a highly attractive therapeutic strategy 
considering BACE1 knockout mice have no Ap production together w ith no clinical 
phenotype (Luo et al., 2001). However, extrapolating these observations to humans 
requires consideration o f  the differences betw een the species; m urine Ap is different 
to hum an Ap, Ap production may be essential in hum ans or APP m ay not be B A C E ’s 
physiological substrate. Inhibitors have been developed and have been found to lower 
the concentration o f  Ap in the brain o f  AD transgenic m ice (Chang et al., 2004). y- 
secretase also cleaves other biological substrates (such as notch) and is consequently 
far less attractive as a therapeutic strategy. However, some y-secretase inhibitors have
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been developed that are not thought to affect the notch signalling pathways and these 
show good tolerability in phase I studies (Petit et al., 2001; Siem ers et al., 2005). a- 
secretase stim ulation is another strategy w hich w ould theoretically shift processing o f 
APP tow ards the non-am yloidogenic pathway. An anticancer treatm ent in clinical 
trials called Bryostatin has been found to stim ulate a-secretase, reducing Ap 
production in AD transgenic m ice (Etcheberrigaray et al., 2004).
8.1.2. Ap immunotherapy
R esearch using AD transgenic m ice found active im m unisation w ith fibrillar Ap raises 
antibodies against Ap that attenuates deposition o f  Ap into plaques (Schenk et al., 
1999). Passive im m unisation using anti-A p antibodies has also been found to halt 
plaque form ation (Bard et al., 2000). The effect o f  anti-Ap antibodies has been 
attributed to either binding Ap in plaques, activating m icroglia to clear the peptide, or, 
binding soluble Ap in the periphery, hence driving the efflux o f  Ap from  the brain. 
Follow ing successful anim al testing, a pre-aggregated Ap42 vaccine called AN1792 
w ent into clinical trials (Schenk et al., 2004). D isappointingly 6% o f  cases developed 
encephalitis, thus phase Ila trials had to be interrupted (Orgogozo et al., 2003). This 
was thought to be due to the m id- and C-term inal parts o f  Ap inducing a T-cell 
response. Long term  follow  up exam ination determ ined that plaques were cleared in 
patients w ith AD yet this did not prevent progressive neurodegeneration (Holm es et 
al., 2008). This has led to the developm ent o f  Ap im m unoconjugates to deliver active 
im m unisation. These should avoid the adverse im mune system activation as ju s t the 
N -term inal fragm ent o f  Ap is used, attached to either a carrier protein o f  a virus-like 
particle. These w ent into phase II trials along with passive im m unisation with 
hum anised anti-Ap m onoclonal antibodies (Schenk et al., 2004).
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8.1.3. Ap fibrillisation inhibition
This approach relies on inhibiting the interaction o f  pro-fibrillisation agents with Ap. 
In theory, i f  the conform ation o f  Ap can be prevented from becom ing p-sheet rich 
subsequent fibrillisation would be prevented. One tactic aim s to disrupt interactions 
betw een Ap and ApoE and with other A p-interacting m olecules, obstructing potential 
interactions that augm ent form ation o f  p-folded Ap. Two small peptides have been 
developed that have been shown to interact in this fashion, reducing Ap fibrillisation 
and Ap load in vitro and in AD transgenic m ice. These peptides have so far been 
found to act with no activated im m une response (Perm anne et al., 2002; Sadowski et 
al., 2004b). C olostrinin (CLN) is a proline rich polypeptide derived from  colostrums 
w hich is thought to reduce Ap fibril content, protecting cultured cells from  its toxic 
effects (Schuster et al., 2005). A nother tactic has been to prevent the interaction o f 
glycosam inoglycans w ith Ap w hich reportedly binds Ap prom oting its aggregation. A 
m im etic glycosam inoglycan w hich can interfere w ith this interaction has entered 
phase III trials (B lennow et al., 2006; van Horssen et al., 2003).
8.1.4. Antioxidants
O xidative stress m ay be the prim ary cause o f  neurodegeneration in AD and other 
form s o f  dem entia, with the senile plaque form ation and NFTs being dow nstream  
events. This m akes it an attractive target for potential therapeutics as it has the 
potential to be able to alter the course o f  the disease. A ntioxidants are thought to slow 
the sym ptom s o f  AD and other dem entias. H ow ever due to CNS being non- 
regenerative, and the w idespread neurodegeneration upon diagnosis o f  AD, their use 
m ay be best reserved as a prophylactic throughout aging (M oreira et al., 2006; Sano, 
2003). The protective value o f  taking antioxidants throughout life seem s logical as
197
Chapter 8 Short peptide inhibitors and H20 2 generation from Ap
free radicals and oxidative stress have long been thought to be the source o f  aging. 
However, they do not tackle the source o f  the generation o f  ROS. It is suggested that 
it is unlikely that a high enough concentration could be adm inistered to detoxify the 
cascade o f  ROS produced once the disease has taken hold (Sm ith et al., 2007a).
Several studies have found direct links between antioxidant intake in the elderly and a 
decreased incidence o f  dementia. D ietary antioxidants, such as V itam in C and E, 
ubiquinone, lipoic acid, |3-carotene, m elatonin, ginkgo biloba and curcum in, are able 
to scavenge free radicals, detoxifying them . V itam ins C and E have been reported to 
inhibit A|3-mediated production o f  nitric oxide (NO), a type o f  ROS (Chauhan and 
Chauhan, 2006). Some reports suggest AD  risk m ay be reduced by these vitamins. 
It’s reported that m oderate to severe AD  patients taking vitam in E (a-tocopherol) for 2 
yrs show ed a slight im provem ent in neurological decline. O ther trials have had 
sim ilar results but some have shown no benefit (Petersen et al., 2005; Sano et al., 
1997). The contrary results may reflect the neuronal loss upon diagnosis and that by 
this point antioxidant treatm ent may only have m arginal effects. In several animal 
m odels G inkgo biloba extract EGb 761 is described as having neuroprotective effects 
attributed to its antioxidant activities. A p-induced free radical production and 
apoptosis were found to be prevented by its addition to cell cultures. It is also 
reported to improve or at least m aintain AD cognitive function, nevertheless a recent 
double blind trial showed no significant benefit (Schneider et al., 2005; Yao et al., 
2001). A yellow phenolic pigm ent found in turm eric called curcum in has also been 
associated w ith neuroprotective properties (Sm ith et al., 2007a). This spice is used in 
Indian cooking and, perhaps coincidentally, prevalence o f  AD in India is around 4.4 
fold less than in the USA (Ganguli et al., 2000). It has been found to protect against 
Ap-m ediated toxicity, is anti-am yloidogenic and has anti-oxidant properties.
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Curcum in binds redox active m etals copper and iron effectively acting as a chelator o f 
these ions, perhaps preventing their disease associated interactions w ith Ap (Cole et 
al., 2005; Yang et al., 2005). This is being investigated as a potential therapy for AD. 
O ther sources o f  antioxidants have been suggested as having neuroprotective 
properties, such as w alnuts which are high in antioxidants and inhibit Ap fibrillisation 
(C hauhan et al., 2004; Chauhan and Chauhan, 2006).
M etal chelators have been o f  interest as m etals can prom ote Ap aggregation and also 
perm it oxidative reactions. C lioquinol (PBT-1) is one such m etal chelator being 
investigated that has been found to decrease Ap aggregates in AD transgenic m ice but 
phase II trials had to be discontinued as a toxic im purity was form ed (Ritchie et al., 
2003). Further trials are now  underw ay on an adapted chelator (PBT-2) w hich should 
avoid this toxicity. C lioquinol has been found to inhibit FFCb production by Ap-m etal 
com plexes, possibly a key pathogenic event leading to neurodegeneration (Bam ham  et 
al., 2004). The BBB is an obstacle for treatm ent. In nature metal chelators are largely 
hydrophilic and so cannot cross the BBB. H ow ever clioquinol is hydrophobic and 
reportedly can pass through the BBB (Sm ith et al., 2007a).
In addition, present therapeutic Galantam ine, has been found to som ewhat inhibit Ap 
aggregation and protect against Ap m ediated cell death in SH-SY5Y hum an 
neuroblastom a cells and oxidative stress induced by Ap in cortical neurons (M atharu 
et al., 2009; M elo et al., 2009).
8.1.5. Short peptide inhibitors
Strengthening evidence suggests that A p-m ediated toxicity is due to early soluble
oligom ers and may be directly responsible for neurodegeneration in AD (C leary et al.,
2005; Haass and Selkoe, 2007; Kim et al., 2003; Lam bert et al., 1998; Lashuel et al.,
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2002; W alsh et al., 2002; W alsh and Selkoe, 2007). Consequently, one key strategy 
for preventing Ap toxicity is to inhibit the very early  stages o f  aggregation. An 
inhibitor that is lim ited to reducing the elongation rate o f  fibrillar m aterial may 
prolong the longevity o f  earlier Ap species, including the im plicated toxic species. 
Inhibiting oligom er form ation may target the underlying cause o f  AD m aking it a 
significant potential therapeutic strategy (De Felice et al., 2 0 0 4 ).
Several peptide-based approaches have evolved to prevent Ap aggregation (Sciarretta 
et al., 2006). Central to their developm ent is consideration o f  the region o f  Ap 
thought to be responsible for the self-association reactions that initiate Ap 
oligom erisation. This has been identified as being via residues 16-22 (KLVFFAE) 
(T jem berg et al., 1999; Tjem berg et al., 1996). However, for propagation o f  
aggregation, other residues o f  Ap around this sequence are required (T jem berg et al., 
1999). A short peptide based on this sequence can theoretically bind to this region o f 
an Ap m olecule thus preventing AP-AP interaction. One approach incorporates 
proline residues to fonn “P-sheet breaker” peptides that bind to Ap but the proline 
residues prevent p-sheet form ation, potentially a prerequisite for oligom er form ation 
(Soto et al., 1996). A different strategy uses N -m ethylation o f  the inhibitor sequence. 
This m odification allows hydrogen bonding to Ap, but the replacem ent o f  a backbone 
N H  group with N -m ethylation prevents further hydrogen bonding o f  the P-sheet 
form ation (Kokkoni et al., 2006).
Here, the inhibitors OR1 and OR2 have been investigated. These peptides contain the 
sequence KLVFF, residues 16-20 o f  Ap. To aid solubility and to prevent its own self­
association (which may actually seed Ap aggregation) a cationic arginine has been 
added at both the N- and C-term inus o f  the peptide, together with a Glycine spacer. 
This spacer residue is designed to improve binding o f  the KLVFF sequence to the
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corresponding Ap sequence (show n in figure 8.1) (Austen et al., 2008). Both OR1 
and OR2 have been found to inhibit fibrillogenesis but only OR2 (w ith an am idated C- 
term inus) is thought to prevent oligom er form ation. This peptide also prevented Ap 
m ediated toxicity to SH-SY5 Y neuroblastom a cells (Austen et al., 2008).
ORl H2N-R~>G ►K~^ L-^ V-+F—>F-*G~-*R-COOH
OR2 H2N-R-^G^K-+L^V-*F-+F-+G-*R-NH2
RI-OR2 H2N-r«-G<—k*-l+-v<—f<-£<—G*-r-Ae
Figure 8.1. Structures of O Rl, OR2 and RI-OR2
L-amino acids are in uppercase and D-amino acids in lowercase, with the direction o f  the peptide bonds 
indicated by arrows (Glycine has no separate enantiomers).
OR2 m ay prevent oligom er form ation but its susceptibility to proteolytic attack means 
that it is not viable as a drug candidate. The peptide has been subsequently developed 
to retain the inhibitory properties yet avoid in vivo proteolysis. For this a “retro- 
inverso” version o f  OR2 has been made, nam ed RI-OR2. In retro-inverso peptides all 
o f  the natural L-am ino acids are replaced by the D-entantiom er, along w ith reversal o f  
the peptide bonds (Chorev and Goodm an, 1995). This approach should maintain a 
sim ilar 3-dim ensional shape to OR2 and retain its inhibition o f oligom erisation, whilst 
preventing its proteolytic degradation.
Here, these peptides have been tested to evaluate their ability to prevent aggregation 
but also their effects on H 2 O 2 generation by Ap. M uch o f  the evidence reported in this 
thesis im plicates early oligom ers to have this property w hich m ay be directly linked to 
the toxicity o f  Ap. If  these inhibitors prevent toxic oligom er form ation, m aybe H 2 O 2 
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8.2.1. Ap42 with ORl and OR2
Upon initial investigation o f  these inhibitors O R l and OR2 w ere tested for their 
effects on aggregation o f  A|342 as m easured by thioflavin T  and oligomeric 
im m unoassay. Concurrently the H 2 O 2 concentration o f  these aggregating solutions 
was assessed to look for any relationship betw een aggregation inhibition and H 2 O2 
generation. Initial experim ents w ere perform ed w ith A|342 at 50 pM  and inhibitor at 
100 pM  (see figure 8.2). By 4 hrs Ap42 alone had largely aggregated, w ith a large 
increase in thioflavin T fluorescence and oligom eric content (im m unoassay). This can 
also be observed in the AFM  images (see figure 8.3) where not only fibrillar but also 
very sm all pre-fibrillar m aterial can be distinguished. M easurem ents indicate these 
oligom ers to be less than 1 nm in height.
W ith the presence o f  O R l, thioflavin T fluorescence was approxim ately h a lf  that o f  
A(342 alone. Conversely, im m unoassay fluorescence with O R l was increased 
com pared to Ap42 alone. AFM  images show  the inhibitor has caused the form ation o f 
a largely hom ogeneous solution o f  spherical oligomers, m easuring 40-60 nm in 
diam eter and 4-5 nm in height (see figure 8.4). Even accounting for tip-associated 
w idening o f  features, these can be considered large. However, by 24 hrs the solution 
contains tw ice the p-sheet content o f  Ap42 alone from the thioflavin T  fluorescence 
accom panied by a sharp reduction in im m unoassay fluorescence. AFM  images 
showed irregular clum ps o f  aggregated m aterial to be m ade rather than fibrils (sim ilar 
can be seen in figure 8.7E and F).
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F ig u re  8.2. T h e  effects o f O R l an d  O R 2 on ag g reg a tio n  an d  H 2 O 2 g en e ra tio n  by 
A042
HFIP treated Ap42 was solubilised at 50 pM  in 10 mM PB, w ith and w ithout the presence o f  100 pM 
O R l or OR2. Aggregation was monitored over 24 hrs by thioflavin T fluorescence (A), Oligomeric 
immunoassay (B) and H20 2 generation measured by Amplex red fluorescence (C). Results are means ± 
S.D. (Thioflavin T and Amplex red: n=3, Immunoassay: n=4)
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The presence o f  OR2 in the solution show ed a m arked reduction in thioflavin T 
fluorescence across the full 24 hrs. Furtherm ore, the im m unoassay fluorescence was 
lower than that o f  A|342 alone. In addition AFM im ages taken o f  this sample (see 
figure 8.5) showed a reduction in oligom eric as well as fibrillar Ap com pared to both 
Ap42 alone and with O R l. The A m plex red data depicting H 2 O 2 generation showed 
Ap42 incubated alone to generate H 2 O 2 very early in the aggregation process, with the 
latter stages producing no net increase in H 2 O 2 . Both O R l and OR2 at 4 hrs 
incubation generated significantly less H 2 O 2 than Ap42 alone (Tukey HSD, p < 
0.000). However, by 24 hrs the presence o f  both inhibitors has actually enabled an 
increase in H 2 O 2 generation.
F ig u re  8.3. A F M  im ages o f Ap42 w ith  no O R  a t  4 h rs
50 pM AP42 incubated with no added OR in 10 mM PB, pH 7.4 for 4 hrs at 37°C was diluted 10 fold 
into M illiQ w ater and 2 pi spotted into the centre o f  a piece o f  cleaved mica. This was then imaged 
using a Digital Instrum ents SPM using tapping mode. Left hand image shows the height o f  objects, 
right hand image is phase contrast. Bar represents 2 pm in A, 400 nm in B and 200 nm in C.
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F ig u re  8.4. A F M  im ages o f A042 w ith  O R l an d  O R 2 a t  4 h rs
50 pM  Ap42 incubated with lOOpM O R l or OR2 in 10 mM  PB, pH 7.4 for 4 hrs at 37°C was diluted 
10 fold into MilliQ w ater and 2 pi spotted into the centre o f  a piece o f  cleaved mica. This was then 
imaged using a Digital Instruments SPM using tapping mode. Left hand image shows the height o f  
objects, right hand image is phase contrast. Images A, B and C are with O R l, D, E and F are with 
OR2. Bar represents 2 pm in A and D, 1 pM in E, 400 nm in B and 200 nm in C and F.
8.2.2. AP40 w ith  O R l and  O R 2
The effect o f  these inhibitors was also investigated on the less am yloidogenic Ap40 
(see figure 8.5). Over this 24 hr tim e period A|340 alone exhibits greatly reduced 
fluorescence in both thioflavin T and im m unoassay com pared to Ap42; thioflavin T 
fluorescence is -3 0 %  that o f  Ap42 and im m unoassay <10% . This suggests that over 
this period Ap40 has undergone very little aggregation. Despite this at 4 hrs 
incubation both inhibitors appear to be exerting an effect on its aggregation. The 
presence o f  OR2 prevents any increase in thioflavin T fluorescence over the first 4 hrs 
and the increase in im m unoassay fluorescence is less than one third o f  AP40 alone.
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F ig u re  8.5. T he  effect o f O R l an d  O R 2 on ag g reg a tio n  an d  H 2 O 2 g en e ra tio n  by 
A04O
HFIP treated Ap40 was solubilised at 50 pM  in 10 mM PB, with and without the presence o f  100 pM 
O R l or OR2. Aggregation was monitored over 24 hrs by thioflavin T fluorescence (A), Oligomeric 
immunoassay (B) and H20 2 generation measured by Amplex red fluorescence (C). Results are means ± 
S.D. (Thioflavin T and Amplex red: n=3, Immunoassay: n=4)
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However, by 24 hrs both assays show ed m arked increases in fluorescence for OR2. 
O R l showed a sim ilar increase in thioflavin T fluorescence to Ap40 alone over the 
first 4 hrs incubation, and approxim ately h a lf  the im m unoassay fluorescence. By 24 
hrs both assays were reduced in com parison to Ap40 alone. A m plex red data showed 
Ap40 generating -6 0 %  o f  the H 2 O 2 m ade by Af342 in this tim e period, w ith two thirds 
o f  this being m ade during the initial 4 hrs. In the presence o f  the inhibitors O R l and 
OR2 very little difference is observed in this H 2 O 2  generation over the initial 4 hrs.
8.2.3. Slowed aggregation of Ap42 with ORl and OR2
Ap42 w as also tested with these inhibitors at a reduced concentration, but keeping the 
ratio o f  inhibitor to peptide at 2:1. As has been observed in chapter 4, reducing Ap 
concentration reduces its aggregation rate, hopefully perm itting the inhibitors greater 
influence over the aggregation o f  the highly am yloidogenic Ap42. It w as very clear 
from these results that both O R l and OR2 inhibit Ap42 aggregation, again w ith OR2 
being the m ore efficient inhibitor (see figure 8.6).
O R l showed steady increases in thioflavin T fluorescence over the aggregation time 
course w ith concurrent increase in im m unoassay fluorescence, but both reduced in 
com parison to Ap42 alone. AFM images from this sam ple showed the clear 
appearance o f  uniform oligom eric Ap at -4 5  nm in length, -1 0  nm in w idth and 0.8 
nm in height together with some protofibril m aterial by 24 hrs, but by 48 hrs this had 
been sequestered together, not into fibrils, but into irregular “clum ps” (see figure 8.7). 
These clum ps were random in size and shape, but always bum py in texture. In 
conjunction with this, the presence o f  the inhibitor reduced the concentration o f  H 2 O 2 
generated by AP42 by -5 0 %  at 24 hrs. However, w hereas Ap42 generation o f  H 2 O 2 
plateaued, the presence o f  O R l perm itted it to continue to rise steadily.
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F ig u re  8.6. T h e  effect o f  O R l an d  O R 2 on ag g reg atio n  a n d  H 2 O 2 g en e ra tio n  by 
AP42
HFIP treated Ap42 was solubilised at 25 pM in 10 mM PB, with and w ithout the presence o f  50 pM 
O R l or OR2. Aggregation was monitored over 24 hrs by thioflavin T fluorescence (A), Oligomeric 
immunoassay (B) and H20 2 generation measured by Amplex red fluorescence (C). Results are means ± 
S.D. (Thioflavin T and Amplex red: n=3, Immunoassay: n=4)
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F ig u re  8.7. A F M  im ages o f Ap42 w ith  O R l a t  24 an d  48 h rs
25 pM  AP42 incubated with 50 pM  O R l in 10 m M  PB, pH 7.4 for 24 and 48 hrs at 37°C was diluted 
10 fold into MilliQ w ater and 2 pi spotted into the centre o f  a piece o f  cleaved mica. This was then 
imaged using a Digital Instrum ents SPM using tapping mode. Left hand image shows the height o f  
objects, right hand image is phase contrast. Images A, B and C are at 24 hrs, D, E and F are at 48 hrs. 
Bar represents 2 pm in D, 1 pm in E and 200 nm in A, B, C and F.
When OR2 was incubated with A(342, there was only a very small increase in 
thioflavin T fluorescence in the sam ple over the course o f  the 48 hrs, yet oligomeric 
content increased steadily over this time. AFM images (figures 8 .8 ) confirm ed that 
this inhibitor was very effective at preventing the form ation o f  fibrils. W hat appears 
to be small oligom eric Ap m aterial predom inated, yet these were sparse at 24 hrs 
largely consisting o f  spherical oligom ers o f  a sim ilar size to those observed in figure 
8.4 (Ap42 with OR2 at 4 hrs) but also containing the occasional aggregate resem bling 
a short chain o f  beads on a string (figure 8 .8 C). At 48 hrs, the aggregates do not 
appear to have increased in size yet there appears to be an increased abundance o f
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very small oligom eric m aterial. The H 2 C>2 generation from this sample was found to 
be reduced com pared to Ap42 over the initial 24 hrs o f  incubation (<50%  o f  A|342 
alone), yet this increased to nearly 80%  by 48 hrs.
F ig u re  8.8. A F M  im ages o f Ap42 w ith  O R 2 a t  24 an d  48 h rs
25 pM  Ap42 incubated with 50 pM  OR2 in 10 mM PB, pH 7.4 for 24 and 48 hrs at 37°C was diluted 
10 fold into MilliQ water and 2 pi spotted into the centre o f  a piece o f  cleaved mica. This was then 
imaged using a Digital Instrum ents SPM using tapping mode. Left hand image shows the height o f  
objects, right hand image is phase contrast. Images A, B and C are at 24 hrs, D E and F are at 48 hrs. 
Bar represents 2 pm in A and D, 1 pm in B, 400 nm in E and 200 nm in C and F.
8.2.4. Ap w ith  R I-O R 2
The developm ent o f  RI-OR2 was hoped to provide a m eans o f  retaining the inhibitory 
properties o f  the peptide yet be resistant to proteolysis. In fact, this alteration appears 
to improve upon the inhibition o f  the parent peptide (see figure 8.9). Thioflavin T 
results showed no increase in p-sheet over the course o f  48 hrs when RI-OR2 was 
incubated with either Ap40 or Ap42.
210




25000 - No Inhibitor







30 40 500 10 20
B. A04O
















T im e - hou rs
40 50
F ig u re  8.9. T h e  effect o f O R 2 an d  R I-O R 2  on ag g reg atio n  o f Ap
HFIP treated Ap40 and 42 were solubilised at 25 pM  in 10 mM PB, with and without the presence o f  
50 pM OR2 or RI-OR2. Aggregation was monitored over 48 hrs by thioflavin T fluorescence for Ap42 
(A) and AP40 (B). Results are means ± S.D. (n=3)
AFM images taken support this w ith no fibrillar m aterial detected, but also no small 
oligom ers. The larger spherical oligom eric species are again present, yet even these 
appear to be sparse (see figure 8.10). In addition, at T=0 a clear reduction in 
thioflavin T fluorescence was observed upon w etting the peptide (the reduction in 
im m unoassay fluorescence was less so) (figure 8.11). N on-incubated controls have 
shown that this effect was not due to the presence o f  the inhibitor reducing thioflavin 
T fluorescence by an alternative mechanism.
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F ig u re  8.10. A F M  im ages o f A042 w ith  R I-O R 2  a t  48 h rs
25 pM AP42 incubated with 50 pM RI-OR1 in 10 mM PB, pH 7.4 for 48 hrs at 37°C was diluted 10 
fold into MilliQ w ater and 2pl spotted into the centre o f  a piece o f  cleaved mica. This was then imaged 
using a Digital Instrum ents SPM using tapping mode. Left hand image shows the height o f  objects, 
right hand image is phase contrast. Bar represents 1pm in A, 400 nm in B and 200 nm in C.
The im munoassay results also showed the presence o f  RI-OR2 had reduced 
fluorescence at 48 hrs to approxim ately one third o f  the initial fluorescence o f  the 
peptide. Again non-incubated controls confirm ed that any changes in fluorescence 
com pared to the peptide alone were due to the action o f  the inhibitor on Ap 
aggregation. Concurrently, the generation o f  H2 O 2 from the Ap42 incubated with RI- 
OR2 showed a significant increase in its form ation com pared to Ap42 alone (T=6, 24 
and 48 Tukey HSD, p < 0.004) (see figure 8.12).
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F ig u re  8.11. T he  effect o f O R 2 an d  R I-O R 2  on ag g reg a tio n  o f Ap
HFIP treated AP42 was solubilised at 25 pM  in 10 mM PB. with and w ithout the presence o f  50 pM 
OR2 or RI-OR2. Aggregation was m onitored over 48 hrs by thioflavin T fluorescence (A) and 
oligomeric immunoassay (B). Non-incubated controls w'ere taken at 48 hrs. Results are means ± S.D. 
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F ig u re  8.12. T h e  effect o f R I-O R 2 on th e  H 2 O 2 g en e ra tio n  o f Ap42
25 pM A(J42 was solubilised in 10 mM PB with and without the presence o f  50 pM  RI-OR2. H 20 2 
generation was monitored over 48 hrs by A m plex red fluorescence. Results are means ±  S.D. (n=3)
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8.3. Discussion
Strategies for the developm ent o f  disease altering drugs for AD follow  several 
different approaches, but concentrate largely on the reduction o f  Ap load. This 
chapter has investigated the effects o f  one such approach: the developm ent and 
subsequent effects o f  short peptide inhibitors on the aggregation o f  A p40 and Ap42 
and also on A p-m ediated H2 O 2 generation. Evidence strengthens in support o f  early 
soluble Ap oligom ers being responsible for A p-m ediated neurotoxicity (C leary et al., 
2005; Haass and Selkoe, 2007; Kim et al., 2003; Lam bert et al., 1998; Lashuel et al., 
2002; W alsh et al., 2002; W alsh and Selkoe, 2007). The developm ent o f  short 
peptide sequences designed to target and bind to the region o f  Ap responsible for Ap 
se lf interactions, has the potential to interfere with the origin o f  oligom er formation. 
I f  oligom eric Ap is the source o f  toxicity then preventing their generation m ay target 
the underlying cause o f  AD, m aking it a significant potential therapeutic strategy.
8.3.1. The effects of OR1 and OR2 with Ap42
Ap42 aggregation was m onitored w ith and w ithout the presence o f  OR1 and OR2 at 2 
d ifferent concentrations o f  Ap42, keeping the ratio o f  Ap to inhibitor a t 1:2. A 
concentration dependent effect on the aggregation o f  Ap had been established in our 
laboratory (Taylor et al., 2010). This resulted in the selection o f  a 1:2 ratio for the 
com parison o f  effects o f  these inhibitors on Ap aggregation and H 2 O 2  generation. At 
the higher Ap42 concentration o f  50 pM , aggregation proceeded at pace, yet the 
inhibitors were able to cause m ajor effects on thioflavin T and im munoassay 
fluorescence and in addition on the images obtained by AFM. It appeared that both 
OR1 and OR2 prevented aggregation o f  Ap42 how ever OR2 appeared to be m uch 
m ore effective in this respect. In fact at 4 hrs incubation the form ation o f  fibrils could
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be seen in A FM  pictures o f  Ap42 w ith no inhibitor added yet both sam ples w ith OR1 
and OR2 added showed no fibrillar m aterial. Concurrently thioflavin T  fluorescence 
was reduced at 4 hrs for both OR1 and OR2 containing sam ples. H owever, in the 
im m unoassay, only OR2 generated reduced fluorescence, whereas OR1 im m unoassay 
fluorescence was actually raised com pared to that w ith no inhibitor. This is indicative 
o f  a rise in oligom er form ation when incubated w ith OR1 and is supported by the 
observation o f  spherical Ap species rather than fibrillar by AFM .
These results support observations by A usten and colleagues that OR1 inhibits fibril 
form ation but not the generation o f  oligom ers (Austen et al., 2008). They claim ed that 
OR2 also prevents oligom er form ation. H owever, the results I obtained clearly show 
increases in fluorescence with both thioflavin T and im m unoassay indicative o f 
aggregation associated events. These changes are greater in the im m unoassay (albeit 
reduced com pared to AP42 alone or w ith OR1), w hich im plies that oligom eric Ap is 
m ade and is only som ewhat reduced com pared to Ap42 alone. T his w as confirm ed by 
A FM  w hich identified sim ilar small Ap species that appear far few er in num ber than 
those observed with Ap42 alone or w ith OR1. This shows that the m odification o f 
OR1 to have 2 amino term ini (rather than norm al N - and C-term ini) im proves the 
binding affinity o f  the OR sequence to the hydrophobic region o f  Ap thus preventing 
Ap se lf interactions that prom ote aggregation.
The generation o f  H2 O 2 by these solutions suggests that a particular oligom eric form 
o f  Ap that is responsible. Aggregation is slowed by the presence o f  both inhibitors 
due to Ap binding the inhibitor rather than other Ap subunits. H 2 O 2 generating Ap is 
formed albeit at a reduced rate due to the com petition provided by the inhibitor. Thus 
at 4 hrs aggregation, H 2 O 2 generation from the Ap42 sam ples w ith OR1 and OR2 
added is reduced com pared to the Ap42 with no inhibitor added. This effect is greater
215
Chapter 8 Short peptide inhibitors and H20 2 generation from A0
for OR2  correlating w ith the reduced oligom er form ation observed by this sample. 
However, w here the Ap42 H 2 O 2 concentration plateaus from the sequestration o f  
H 2 O 2 generating Ap species into fibrils, the generation from the sam ples w ith OR1 
and OR2 continues to rise. This supports earlier evidence that slowing aggregation 
m ay have the consequence o f  generating m ore H 2 O 2 ultim ately; H 2 O 2 generation is 
slow er yet sustained. There is a reduced rate o f  form ation o f  H 2 O 2  generating Ap, 
together w ith a decrease in the rate o f  sequestration into fibrils, having the net effect 
o f  prolonging the longevity o f  the H 2 O 2 generating oligomers.
To slow  A p42 aggregation further the concentrations o f  Ap and inhibitor were 
reduced to provide the inhibitors greater opportunity to augm ent Ap aggregation. 
W ith aggregation proceeding at a reduced speed, despite all interactions rem aining 
dynam ic w ith a variety o f  Ap species in existence, the hom ogeny o f  the solution 
w ould be som ew hat im proved. This was hoped to aid interpretation o f  the effects o f 
the inhibitors, particularly on oligom er and H 2 O 2  generation. These results backed up 
the earlier observations w ith both OR1 and OR2 able to prevent aggregation 
associated increases in fluorescence, OR2 being more efficient in this respect. This 
correlated w ith a reduction in H 2 O 2 generation by these sam ples in com parison to 
Ap42 with no inhibitor added, suggesting a reduction in the form ation o f  H 2 O 2  
generating Ap. The observation that an inhibitor designed to prevent Ap self 
interactions reduces H 2 O 2 generation supports the notion that these interactions are 
needed for Ap to be capable o f  generating H 2 O 2 , and m onom eric Ap is not 
responsible. AFM  images lend further insight into these results. At 24 hrs, the Ap42 
sam ple with OR1 added has m any m ore, small, oligom eric Ap than that o f  the OR2 
sam ple (together w ith some small protofibrillar Ap). This corresponds to greater 
H2 O 2 generation in the 0R 1/A p42  sam ple. The H 2 O 2  generation from  the sample
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with OR1 has begun to plateau at 48 hrs. AFM  im ages show these sm all oligom ers 
and protofibrils to “clum p” together, presum ably lim iting their capacity for H 2 O 2 
generation (as well as their antibody binding in the im munoassay). This is com pared 
to OR2/A p42 w hich continues to generate H 2 O 2  as it retains sm aller oligom eric A|342 
preventing its fibrillisation or “clum ping” . This provides strong support that an early 
species o f  Ap is responsible for H 2 O 2 generation. However, the solutions do still 
contain a m ixture o f  aggregating Ap species m aking any further stipulations on the 
identity o f  the H 2 O 2  generating species highly tenuous. Yet, this investigation 
dem onstrated the im portance o f  considering both assays and A FM  im ages when 
considering the effects o f  inhibitors.
8.3.2. The effect of Ap40 with OR1 and OR2
Testing the inhibitors on Ap40 was hoped to help identify the effects OR1 and OR2 
have on early Ap se lf interactions, due to the largely m onom eric nature o f  AP40 upon 
wetting. Observation that OR2 but not OR1 prevented any thioflavin T  fluorescence 
increase at 4 hrs (with concurrent reduced im m unoassay fluorescence) indicated OR2 
to interact w ith Ap40 rapidly inhibiting aggregation associated changes in the Ap40 
solution. This suggests OR2 was able to prevent early P-folding events and oligom er 
form ation but furtherm ore, that oligom ers exist that contain very little/no P-folding. 
However, OR2 fluorescence in both assays then rises above that seen for OR1. This 
suggests that OR1 is less able to inhibit initial Ap self-interactions, yet it is capable o f 
reducing later aggregation. This may be due to OR2 having a greater affinity for 
m onom eric or low P-sheet content Ap40, w hereas OR1 has a greater affinity for AP40 
that has initiated the shift to p-sheet and/or self-interacting. This is different to results 
seen w ith Ap42, where OR2 appears to have greater affinity than OR1 throughout the
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aggregation o f  A(342. This m ay be solely due to the greater heterogeneity o f  Ap42 
com pared to Ap40 upon w etting w hich consequently com plicates interpretation o f  
results. However, it m ay also be due to different affinities that the 2 sim ilar inhibitors 
have for these 2 sim ilar Ap peptides. Ap40 has a reduced propensity for aggregation 
com pared to Ap42 due to the om ission o f  the final 2 residues. This reduces the 
overall hydrophobicity o f  the m olecule, and its tendency for propagating se lf 
interactions. It seems reasonable to suggest that the OR inhibitors m ay not bind Ap40 
w ith as strong affinity o f  Ap42 as the OR inhibitors are actually designed to imitate 
the KLVFF sequence at residues 16-20 that is thought to be responsible for the self 
interactions o f  Ap. It would also be reasonable to suspect that OR1 and OR2 m ay 
bind w ith different affinities during the aggregation process as the A p changes in 
respect o f  its structure and conform ation over tim e. W ith OR2 appearing to act so 
early in binding Ap40, it may be expected that it would reduce H 2 O 2  generation, yet 
this was not observed, im plicating the H 2 O 2 generating Ap to be form ed very early in 
the aggregation process. This would support evidence that electron abstraction from 
M et35 is enabled by the a-helical structure (Kanski et al., 2002b).
As fibrillisation o f  AP40 has not truly begun by 24 hrs (even at this concentration) no 
conclusions can be m ade on the capability o f  each o f  these inhibitors on preventing 
fibrillisation from this data. Ap40 and Ap42 have m any sim ilar qualities but also 
m any differences. As Ap40 is less toxic than AP42, inhibiting AP42 oligom erisation 
is the prim ary objective. However, results observed w ith Ap42 are com plicated by the 
aggregation state o f  the peptide upon wetting, which inevitably incurs greater 
heterogeneity on the subsequent aggregation o f  the solution. The m easured effect o f  
an inhibitor on aggregation and H2 O 2 generation for Ap42 is the net result for possibly 
several different effects on a wide range o f  different Ap species present. For this
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reason, consideration o f  results obtained w ith Ap40 over this early aggregation phase 
m ay be useful for the interpretation o f  observations with Ap42. W ith this in mind, 
H2 O 2 generation was observed to be form ed very early  in the aggregation process. In 
addition, the generation o f  H 2 O 2  by Ap40 w ith OR2 present is alm ost identical to 
Ap40 alone. As no increase in thioflavin T fluorescence was observed w ith OR2 
present during this 4 hr incubation the im plication arises that this oligom er with 
little/no p-folding is responsible for H 2 O 2 generation and it is also invisible in the 
thioflavin T  assay. However, it is possible that different Ap species are responsible 
for H2 O 2  generation by Ap40 and Ap42.
8.3.3. The effects of RI-OR2 on aggregation and H2O2 generation from Ap40 and 
Ap42
The success o f  OR2 at preventing A p-A p interactions and reducing early H 2 O 2 
generation lead to testing o f  the retro-inverso version o f  OR2. This should m aintain 
the inhibitor qualities o f  OR2 but be resistant to proteolysis. This proved more 
successful than anticipated as aggregation was inhibited more so than that observed 
with OR2. N ot only did it inhibit aggregation but it appeared to prom ote 
disaggregation o f  Ap42, particularly so in the thioflavin T assay. The fact that this 
effect was not seen as strongly at T=0 in the im m unoassay as in the thioflavin T may 
allude to the mode o f  action o f  this inhibitor; RI-OR2 binding Ap rapidly encourages 
loss o f  p-sheet content w hich slowly perm its the disaggregation o f  any pre-aggregated 
m aterial. Interestingly, RI-OR2 was far less effective at inhibiting A p40 aggregation 
than Ap42. It does show greater inhibition than OR2, yet there was a small but 
significant increase in thioflavin T fluorescence at T=0 com pared to the Ap40 alone 
(Tukey HSD, p = 0.008). The fact that the Ap40 starting m aterial is largely
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m onom eric obviously m eans that the inhibitor cannot act to disaggregate as it does 
w ith Ap42. There w as also no increase in thioflavin T fluorescence over the 48 hrs 
w hereas the sam ple with no inhibitor and w ith OR2 both showed thioflavin T 
fluorescence increases. The inhibitor appears to be prom oting an oligom eric species 
in both Ap peptides that is low in p-sheet content indicated by the thioflavin T 
fluorescence. Perhaps the aggregation state o f  both peptides converges on this 
alternative oligom erisation pathw ay/species w hen incubated w ith RI-OR2 that binding 
the inhibitor provides.
A FM  im ages o f  Ap42 at 48 hrs aggregation clearly show  the lack o f  fibrillar material, 
but also show a relatively low num ber spherical oligom eric Ap, very sim ilar to  those 
observed w ith OR2 and Ap42. This leads to speculations that the m ode o f  action o f 
these O R inhibitors m ay prom ote the form ation o f  these oligom eric species as an 
alternative to fibrillisation. In our laboratory RI-OR2 has also been found to prevent 
AP-m ediated toxicity to SH-SY5Y neuroblastom a cells (Taylor et al., 2010). This 
suggests that the action o f  the RI-OR2 in inhibiting normal oligom erisation and 
aggregation o f  Ap is successful in rem oving its toxicity; the toxic oligom er is not 
formed. However, unlike OR1 and OR2 which showed reduced H 2 O 2  generation 
com pared to Ap42 alone, RI-OR2 appears to increase the H 2 O 2 m easured from  an 
aggregating sam ple o f  Ap42 (see figure 8.12). This does not necessarily negate H 2 O 2 
generation by the peptide as playing a role in augm enting Ap toxicity in AD. It may 
be that not only does it prevent Ap42 aggregation but also inhibit access to the site o f  
action for toxicity. If for exam ple, m em brane insertion is a pre-requisite for Ap 
toxicity, or indeed A p-generated H2 O 2 m ediated toxicity (discussed in 4.3.5), and RI- 
OR2 binds in such a way as to prevent this insertion, then toxicity w ould be 
prevented. It does confirm  that a very early oligom eric species m ust be responsible
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for the generation o f  H 2 O 2 as RI-OR2 appears to be extrem ely effective at inhibiting 
aggregation. M aybe the spherical oligom ers observed by AFM , are, or are com posed 
o f  H 2 O 2 generating species o f  Ap. H owever, it is also possible that the H 2 O 2  
generating species is too sm all to be identified by AFM  and that the spherical 
oligom ers observed are an alternative sequestration event to fibrils. This seems 
perhaps m ore likely due to their increased occurrence with OR2 and the increased 
aggregation w ith OR2 showing reduced generation o f  H 2 O 2 .
It w ould be o f  interest to test these inhibitors for their effects using the immobilisation 
technique to assess the Ap species generated by the action o f  the O R inhibitors. This 
m ay help identify the H 2 O 2 generating species o f  A p, but also, if  the generation o f 
H 2 O 2  is linked to Ap neurotoxicity, then identifying inhibitors that also act to reduce 
its existence may prove useful in disease course altering therapeutic developm ent.
The generation o f  H 2 O 2  from solutions o f  Ap42 that are inhibited from aggregating 
data lends strong support to the hypothesis that a specific early oligom er is 
responsible. However, the heterogeneous nature o f  aggregating solutions is a resilient 
issue when interpreting data. The AFM  im ages obtained whist studying these 
inhibitors com bined with the data from the aggregation assays appears to suggest that 
fibrillisation and oligom erisation should be considered as 2 separate pathways, both 
proceeding throughout Ap aggregation. Som e oligom ers may be part o f  the 
fibrillisation process (“O n” the fibrillisation pathway) but there does seem to be a 
subset that can be considered “O f f ’ the fibrillisation pathway (see figure 8.13). The 
relationships betw een m onom eric Ap and the 2 populations o f  oligom ers are unclear 
(dashed lines). Both OR1 and OR2 can be considered to inhibit the fibrillisation 
pathway, but also, to varying degrees early oligom eric interactions.
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F ig u re  8.13. D iag ram  o f the  “ o n ” a n d  “ o f f ’ fib rillisa tio n  p a th w ay s
M onom eric Ap oligom erises during aggregation to fibrils. Some oligom ers may be considered “on” 
(grow into or directly sequestered into fibrils) or “o f f ’ (cannot directly grow  into or be sequestered in 
fibrils) the fibrillisation pathway. W hether monom eric can assemble directly into both on and o ff 
oligomers, and the interaction between on and o ff  oligomers is unclear.
The evidence gathered cannot at present identify if  the oligom er responsible for H 2C>2 
generation is on or o ff the fibrillisation pathway. W ithout elucidation o f  the 
relationships that control the early evolution o f  oligom ers both possibilities can be 
explained by the data. However, considering Ap accum ulates and aggregates on a 
vastly increased time scale (many years com pared to 48 hrs) in the AD brain an 
inhibitor based on OR2 may prove a useful therapeutic. The short burst o f  H 2 O2 
generated would be prolonged and sustained in the brain with biological targets. 
A lthough H2 O 2 generation with the inhibitors present prolongs its generation, an 
inhibitor that reduces oligom er form ation and H 2 O 2 generation in this accelerated 
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8.4. Conclusions
•  Evidence suggests inhibiting A p-A p interactions m ay be a logical strategy for 
preventing neurotoxicity in AD
• Short peptide inhibitors, designed to bind to the se lf interaction, KLVFF 
sequence o f  Ap were found to be effective at preventing Ap aggregation with 
their efficacy being RI-O R2 > OR2 > OR1
•  Incubation o f  Ap with RI-OR2 actually  appeared to disaggregate Ap42
•  Inhibition o f  Ap aggregation was m ore effective w hen the inhibitors were
tested on Ap42 com pared to Ap40
•  The inhibitors m ay provide an alternative aggregation pathw ay into spherical 
oligom ers and am orphous aggregates rather than fibrils
•  W ith the less effective OR1 and OR2, H 2 O 2 generation from  Ap42 was
decreased yet prolonged, suggesting they acted to decrease the form ation o f
Ap species able to generate H 2 O2  yet increased its longevity in solution
•  W ith RI-OR2, the generation o f  H 2 O 2 from  Ap42 was increased com pared to
Ap42 alone suggesting it acted to prom ote the form ation, longevity or
capability o f  H2 O 2 generating Ap42
•  Evidence from these studies suggests H 2 O 2 generation is from a very early
species o f  Ap, appearing to be o f  low P-sheet content.
•  RI-OR2 m ay prevent A p-m ediated cell death yet this appears not be due to 
loss o f  the generation o f  H2 O 2 by Ap.
•  I f  the generation o f  H 2 O 2 by Ap is linked to its toxicity then it w ould appear 
that the binding o f  RI-OR2 prevented Ap toxicity via an additional m echanism  
such as inhibiting m em brane insertion
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Strong evidence now  im plicates soluble early oligom eric Ap as being responsible for 
neurotoxicity in AD (C leary et al., 2005; Haass and Selkoe, 2007; K im  et al., 2003; 
Lam bert et al., 1998; Lashuel et al., 2002; W alsh et al., 2002; W alsh and Selkoe, 
2007). To investigate these early Ap species, rigorous deseeding protocols were 
tested. They identified TFA treatm ent (which prom otes a-helix) in the presence o f  
4 .5%  thioanisol (which protects from  M et35 oxidation) as able to provide the optimal 
Ap, containing the fewest seeds. E fficient and reproducible deseeding o f  Ap was 
critical because the generation o f  H 2 O 2 is believed to be an early event in Ap 
aggregation (Tabner et al., 2005). This im plicates H 2 O 2 form ation as a potential 
property o f  these early oligom eric Ap species and is possibly linked to A p-m ediated 
cellular toxicity.
Ap42 has been found to generate m ore H 2 O 2 than Ap40, corresponding to the 
increased aggregation and toxicity attributed to Ap42. This also correlated with 
increased covalent cross-linking o f  Ap42 w hen subjected to oxidative insults, w ith the 
copper/FECE system  generating tetram ers preferentially and H R P/H 2 O 2 generating 
larger m ultim ers o f  -4 5  and 56 kDa from Ap42. Ap not only generates H 2 O 2 but can 
be the subject o f  oxidative attack. This may be directly linked to the form ation or 
stabilisation o f  toxic Ap oligom ers, but could also feed into the aggregation o f  the 
peptide. Bearing in mind the m em brane association o f  Ap, the generation o f  H 2 O 2 is 
likely to be directed in vivo at lipid m em branes rather than Ap self-oxidation (M urray
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et al., 2005). Therefore, once form ed, these Ap species m ay be capable o f  continuing 
to generate H 2 O 2  rather than their rapid sequestration into fibrils, so extensively 
oxidatively m odifying the m em brane and altering its perm eability.
A ttem pts to im m obilise Ap at different stages o f  aggregation to study its capacity for 
H 2 O 2 generation have had limited success thus far. However, the technique shows 
prom ise, and the data do suggest that earlier aggregation species generate increased 
H2 O 2  com pared to later aggregation species. In fact, m ature fibrils appear to be a sink 
for oxidative stress, w ith the ability to degrade H 2 O 2 added externally, perhaps 
indicating an anti-oxidative neuroprotective m echanism . The ‘dual nature’ o f  Ap (both 
anti-oxidant and pro-oxidant) has been noted by other investigators (Fang, 2010).
Using the HRP/H 2 O 2 system, TyrlO has been identified as being critical for the 
form ation o f  covalently cross-linked Ap, as detected by SDS-PA GE. However, it is 
not essential for the form ation o f  fibrillar Ap. This m ay indicate that some oligomer 
form ation is not on the fibrillisation pathway. The dityrosine dim ers are a potential 
source o f  H 2 O2  as they can bring 2 copper ions w ithin close vicinity o f  each other. 
H ow ever H2 O 2 generation from AP42-Y10A indicates that dityrosine dim ers are not 
the source, or at least not the sole source, o f  H 2 O 2  generation. This tyrosine residue 
does appear to be the prim e target for oxidative m odification o f  Ap42 and m ay be key 
for the stabilisation o f  early oligom eric Ap in vivo. The stabilisation o f  oligom eric Ap 
m ay be directly linked to prolonging its m ode o f  toxicity, potentially via the 
generation o f  H2 O 2 .
The binding o f  copper ions to Ap appears to be critical for H 2 O 2 generation, 
supporting evidence that copper m odulates Ap toxicity (Sm ith et al., 2006), yet trace 
levels are sufficient for this. Ap42 substituted peptides that would be hypothesised to
225
Chapter 9 Final Discussion
have reduced copper binding capabilities indeed show  a m arked reduction in H 2 O 2 
generation. The binding o f  copper appears to have com plex effects on Ap aggregation 
and its generation o f  H 2 O 2  w hich are highly interconnected. Increasing copper 
concentration provides the m eans for greater generation o f  H 2 O 2 via its reduction to 
Cu(I) and subsequent redox reactions. However, copper ion binding m ay also 
prom ote the stability and longevity o f  oligom eric Ap, and as copper concentration 
increases, Ap-Ap interactions m ay be prom oted, facilitating H2 O 2 generation. Copper 
concentration increases to equim olar and above further increase early H 2 O 2 generation 
and potentially  cause the aberrant oxidation o f  Ap, halting its generation o f  H 2 O2 . 
This observation m ay bear lesser relevance in vivo as Ap is unlikely to be the prim e 
target for oxidation. Fully m etalated Ap m ay generate large quantities o f  H 2 O 2 
directed at lipid m em branes with reduced potential for self-oxidation com pared to 
these aggregation studies. M et35, im plicated in the reduction o f  the copper ion, was 
not critical for H 2 O 2  generation im plying that another residue, possibly TyrlO, can 
also reduce the copper ion, albeit at a reduced rate. The substituted peptides thought 
to have decreased copper reduction capabilities, due to a loss o f  M et35 or a histidine 
for copper coordination, all show reduced cross-linking com pared to w t AP42 perhaps 
indicating the importance o f  copper in early A p-A p interactions.
The other metal ions tested did not facilitate Ap generation o f  H 2 O 2 . Iron appeared to 
have very little effect on Ap aggregation whereas the effects o f  zinc were com plex and 
possibly regulatory o f  copper binding. B inding o f  zinc appeared to prevent Ap 
fibrillisation, instead prom oting a pre-fibrillar form o f  Ap with reduced generation o f 
H 2 O 2 . This evidence suggests that the binding o f  copper and zinc to various forms o f 
Ap may play an im portant role in the regulation o f  AP aggregation and its redox
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properties in vivo, supporting evidence from toxicity studies, that zinc m ay protect 
against A p-copper m ediated cell death (Lovell et al., 1999).
It m ay be that H 2 O 2 generation by oligom eric Ap is not determ ined by a specific 
oligom eric form  but m any different forms. Early Ap-A p interactions m ay ju s t 
facilitate the bringing together o f  2 (or m ore) copper ions prim ed for redox reactions. 
O ther factors, such as metal binding and Ap oxidation play a role in prom oting or 
preserving the form ation o f  early A p-A p interactions and thus the activity o f  the 
subsequent redox reactions. C ertain oligom eric Ap species m ay be superior to others 
in H 2 O 2 generation yet other factors such as its ability to direct H 2 O 2 at biological 
targets i.e. lipid m em branes m ay influence their toxicity.
This study, including the investigation o f peptide-based inhibitors that can prevent 
Ap-A p interactions, supports the generation o f  H 2 O 2  as being the result o f  the 
longevity and redox potential o f  Ap aggregation interm ediates. Preventing these 
interactions largely reduced the levels o f  TLCL detected during early aggregation and 
yet prolonged its generation, presum ably due to increasing the longevity o f 
interm ediates capable o f  producing H 2 O 2 . However observation that the most 
efficient version o f  this inhibitor prom oted disaggregation o f  A p42, yet actually 
increased the levels o f  H 2 O 2 produced indicates that a very early species o f  Ap 
oligom er is capable o f  H 2 O 2 generation. Despite this, the inhibitor appeared to 
prevent A p-m ediated cell death (Taylor et al., 2010), im plying that the generation o f 
H2 O 2 m ay not be pertinent to A p-m ediated toxicity. However, this effect on Ap 
m ediated toxixity may be due to other reasons. In support o f  this, OR2 has also been 
found to prevent A p-m ediated toxicity (Austen et al., 2008) yet this inhibitor was 
found to reduce AP generated H 2 O 2 . It is possible these inhibitors m ay block the site 
responsible for the insertion o f  Ap into lipid m em branes, preventing the Ap from
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causing toxicity  despite altered redox capacity. In addition, this w ork has highlighted 
the m etal ion, concentration and tim e dependency o f  H 2 O2  generation by Ap w hich 
m ay not directly correspond to toxicity m easurem ents. These experim ents m easuring 
H 2 O 2 generation from Ap need to be conducted in unison w ith cell toxicity  studies to 
investigate these effects further.
9.2. Future work and Conclusions
The idea that the generation o f  H 2 O 2  is an im portant aspect o f  the pathophysiology o f  
Ap requires continuing investigation, not only for research into AD, but also because 
o f  the sim ilarities that exist betw een this disease and other neurodegenerative 
am yloidopathies. The oxidative stress that is observed in the AD brain, com bined 
w ith age-related m etal accum ulation, and the central role that Ap appears to play in 
AD pathogenesis, m akes the generation o f  H 2 O 2 by early oligom eric Ap an attractive 
hypothesis for explaining its neurotoxicity. Identification o f  the source o f  oligom er 
toxicity in AD m ay lead to the developm ent o f  disease course altering drugs.
The developm ent o f  the im m obilisation technique is one m ethod that may be 
beneficial for identification o f  the species responsible for A p-m ediated H 2 O 2 
generation. Im provem ent o f  the capture and recovery o f  Ap present m ay enable the 
HRP/H 2 O 2  cross-linked Ap to be properly tested for their ability to generate H 2 O 2 . It 
m ay also be interesting to test the substituted Ap peptides in the copper/TLC^ system 
especially considering the effects that copper alone had on Ap aggregation and H 2 O2 
generation. W ithout the presence o f  HRP, cross-linked Ap made via this m ethod may 
be easier to test for its ability to generate H 2 O 2 . It may also be useful to test the 
effects o f  copper on H 2 O 2 generation from pre-im m obilized Ap. This w ay the effects
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o f  copper concentration on A p-m ediated H 2 O 2  generation could be observed w ithout 
its effects on aggregation altering the Ap species present.
Research into the properties o f  the potentially toxic oligom eric species o f  Ap is 
severely ham pered by their transient nature and irreversible sequestration into mature 
fibrils. M anipulating cross-linking and im m obilisation reactions m ay provide a means 
o f  studying low-order soluble oligom eric A p not only in respect o f generation o f  H 2 O 2  
but also in com bination m ay prove valuable to both potential diagnostic m arker and 
drug developm ent for AD.
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